<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>f8k090615ex2i_cambridge.htm
<DESCRIPTION>AGREEMENT AND PLAN OF REORGANIZATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;<B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>AGREEMENT AND PLAN OF REORGANIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>BY AND AMONG</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CAMBRIDGE CAPITAL ACQUISITION CORPORATION,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CAMBRIDGE HOLDCO CORP.,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ABILITY COMPUTER &amp; SOFTWARE INDUSTRIES
LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AND </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>THE SECURITYHOLDERS OF ABILITY COMPUTER &amp;
SOFTWARE INDUSTRIES LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>DATED AS OF SEPTEMBER 6, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>AGREEMENT AND PLAN OF REORGANIZATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THIS AGREEMENT AND PLAN
OF REORGANIZATION is made and entered into as of September 6, 2015, by and among Cambridge Capital Acquisition Corporation, a Delaware
corporation (&ldquo;<U>Cambridge</U>&rdquo;), Cambridge Holdco Corp., a Cayman Islands company and wholly-owned subsidiary of Cambridge
(&ldquo;<U>Holdco</U>&rdquo;), Ability Computer &amp; Software Industries Ltd., an Israeli company (&ldquo;<U>Company</U>&rdquo;),
and each of the persons or entities listed under the caption &ldquo;Signing Securityholders&rdquo; on the signature page hereof
for the limited purpose of the sections of this Agreement (as defined below) identified on such page, such persons being the holders
of all of the outstanding capital stock of the Company (each a &ldquo;<U>Stockholder</U>&rdquo; and collectively the &ldquo;<U>Stockholders</U>&rdquo;).
The term &ldquo;<U>Agreement</U>&rdquo; as used herein refers to this Agreement and Plan of Reorganization, as the same may be
amended from time to time, and all schedules hereto (including the Company Schedule and the Cambridge Schedule, as defined in the
preambles to Articles II and III hereof, respectively).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">RECITALS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon the terms and
subject to the conditions of this Agreement and in accordance with the Delaware General Corporation Law (the &ldquo;<U>DGCL</U>&rdquo;),
the Companies Law (2013 Revision) of the Cayman Islands as amended from time to time (the &ldquo;<U>Cayman Companies Law</U>&rdquo;)
and the Companies Law 5759-1999 of Israel (the &ldquo;<U>Israeli Companies Law</U>&rdquo;) and other applicable law (collectively,
the &ldquo;<U>Applicable Law</U>&rdquo;), Cambridge and the Company intend to enter into a business combination transaction by
means of (i) a merger of Cambridge with and into Holdco, with Holdco surviving the merger and becoming the public company (the
&ldquo;<U>Redomestication Merger</U>&rdquo;) and (ii) immediately following the Redomestication Merger, an exchange of 100% of
the ordinary shares of the Company (the &ldquo;<U>Company Common Shares</U>&rdquo;) by the Stockholders for ordinary shares of
Holdco, including the right to receive certain contingent shares, and cash as provided herein (the &ldquo;<U>Share Exchange</U>&rdquo;
and, together with the Redomestication Merger, the &ldquo;<U>Transactions</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The board of directors
of each of Cambridge (including any committee or subgroup thereof, the &ldquo;<U>Cambridge Board</U>&rdquo;), Holdco (including
any committee or subgroup thereof, the &ldquo;<U>Holdco Board</U>&rdquo;) and the Company (including any committee or subgroup
thereof, the &ldquo;<U>Company Board</U>&rdquo;) has determined that the Transactions are fair to, and in the best interests of,
its respective company and securityholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the covenants, promises and representations set forth herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as follows (defined terms used in this Agreement are listed alphabetically
in Article IX, together with the Section and, if applicable, paragraph number in which the definition of each such term is located):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
I.</B></FONT><BR>
<B>THE MERGER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>The
Merger and Share Exchange</U></B>. At the Effective Time (as defined in Section&nbsp;1.2) and subject to and upon the terms and
conditions of this Agreement and Applicable Law:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
shall be merged with and into Holdco, the separate existence of Cambridge shall cease and Holdco shall continue as the surviving
corporation in the Redomestication Merger (the &ldquo;<U>Surviving Pubco</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Immediately
following the consummation of the Redomestication Merger, all of the outstanding shares of the Company shall be exchanged for ordinary
shares of Holdco, including the right to receive certain contingent shares as provided for in Section 1.13 hereof, and cash as
provided herein, and the Company shall become a wholly owned subsidiary of Surviving Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Effective
Time; Closing</U></B>. Subject to the conditions of this Agreement, as soon as practicable on or after the Closing Date (as hereinafter
defined), the parties hereto shall cause (i) a certificate of merger (the &ldquo;<U>Delaware Certificate of Merger</U>&rdquo;)
with the Secretary of State of the State of Delaware in accordance with the applicable provisions of the DGCL and (ii) a plan of
merger (the &ldquo;<U>Plan of Merger</U>&rdquo; and, together with the Delaware Certificate of Merger, the &ldquo;<U>Certificates
of Merger</U>&rdquo;) to be filed with the Cayman Islands Registrar of Companies in accordance with the applicable provisions of
the Companies Law (the time of such filing, or such later time as may be agreed in writing by the Company and Cambridge and specified
in the Plan of Merger being the &ldquo;<U>Effective Time</U>&rdquo;)<I> </I>and (iii) the consummation of the Share Exchange as
provided herein. The consummation of each of the Redomestication Merger and Share Exchange is conditioned upon the consummation
of the other.<I> </I>Unless this Agreement shall have been terminated pursuant to Section 8.1, the consummation of the transactions
contemplated by this Agreement (the &ldquo;<U>Closing</U>&rdquo;), other than the filing of the Certificates of Merger, shall take
place at the offices of Graubard Miller, counsel to Cambridge, 405 Lexington Avenue, New York, New York 10174 at a time and date
to be specified by the parties, which shall be no later than the third (3<SUP>rd</SUP>) Business Day after the satisfaction or
waiver of the conditions set forth in Article VI, or at such other time, date and location as the parties hereto agree in writing
(the &ldquo;<U>Closing Date</U>&rdquo;). Closing signatures may be transmitted by facsimile or by emailed PDF file.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Effect
of the Transactions</U></B>. At the Effective Time, the effect of the Transactions shall be as provided in this Agreement and the
provisions of the Applicable Law. Without limiting the generality of the foregoing, and subject thereto, at the Effective Time,
(i) all the issued and outstanding securities of Cambridge shall be automatically converted into securities of Surviving Pubco
as provided herein, (ii) all the property, rights, privileges, powers and franchises of Cambridge shall vest in Surviving Pubco
and all debts, liabilities and duties of Cambridge shall become the debts, liabilities and duties of Surviving Pubco and (iii)
the Company shall continue its existence as a wholly owned subsidiary of Surviving Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Governing
Documents</U></B>. At the Effective Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
constitutional documents of Holdco shall be amended and restated by adoption of the Memorandum and Articles of Association in the
form to be reasonably agreed between the Company and Cambridge and as required to reflect the terms of this Agreement prior to
Closing and shall become the constitutional documents of the Surviving Pubco;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
charter documents of the Company shall be amended and restated in the form of <U>Exhibit A</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Conversion
of Securities</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Subject
to the terms and conditions of this Agreement, and as more particularly set out in the Plan of Merger, the following shall occur
in the Redomestication Merger:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
share of common stock, par value $0.0001 per share, of Cambridge issued and outstanding immediately prior to the Effective Time
(&ldquo;<U>Cambridge Common Stock</U>&rdquo;), including those contained in units of Cambridge (&ldquo;<U>Cambridge Units</U>&rdquo;)
consisting of one share of Cambridge Common Stock and one warrant to purchase one share of Cambridge Common Stock (&ldquo;<U>Cambridge
Warrants</U>&rdquo;), will be automatically converted (subject to Section 1.5(c)) into one ordinary share of Surviving Pubco (&ldquo;<U>Surviving
Pubco Shares</U>&rdquo;) and the holders thereof shall cease to have any further rights as holders of Cambridge Common Stock. Each
certificate that evidenced Cambridge Common Stock immediately prior to the Redomestication Merger (&ldquo;<U>Cambridge Common Certificate</U>&rdquo;)
shall entitle the holder to the applicable number of Surviving Pubco Shares into which the Cambridge Common Stock is convertible
according to this Section 1.5(a)(i); provided, however, that each Cambridge Common Certificate owned by holders who have validly
elected to receive a portion of the proceeds held in Cambridge&rsquo;s Trust Fund (as defined in Section 3.26 hereof) shall entitle
the holder thereof to receive only such portion of the Trust Fund as provided for in Cambridge&rsquo;s Charter Documents (as defined
below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
Cambridge Warrant, including those contained in the Cambridge Units, issued and outstanding immediately prior to the Effective
Time shall remain outstanding immediately following the Effective Time but shall be deemed to have been converted and to represent
a warrant (&ldquo;<U>Surviving Pubco Warrant</U>&rdquo;) to purchase one Surviving Pubco Share on the same terms existing under
the Cambridge Warrants immediately prior to the Effective Time. Immediately following the Redomestication Merger, each certificate
that evidenced Cambridge Warrants immediately prior to the Redomestication Merger (&ldquo;<U>Cambridge Warrant Certificate</U>&rdquo;
and together with the Cambridge Common Certificates, the &ldquo;<U>Cambridge Certificates</U>&rdquo;) shall represent the applicable
number of Surviving Pubco Warrants into which the Cambridge Warrants represented thereby have been converted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
unit purchase option of Cambridge (&ldquo;<U>Cambridge UPOs</U>&rdquo; and together with the Cambridge Common Stock and Cambridge
Warrants, the &ldquo;<U>Cambridge Securities</U>&rdquo;) issued and outstanding immediately prior to the Effective Time shall remain
outstanding immediately following the Effective Time but shall be deemed to have been converted and to represent a unit purchase
option (&ldquo;<U>Surviving Pubco UPOs</U>&rdquo; and together with the Surviving Pubco Shares and Surviving Pubco Warrants, the
&ldquo;<U>Surviving Pubco Securities</U>&rdquo;) to purchase units of Surviving Pubco on the same terms existing under the Cambridge
UPOs immediately prior to the Effective Time. Immediately following the Redomestication Merger, each certificate that evidenced
Cambridge UPOs immediately prior to the Redomestication Merger (&ldquo;<U>Cambridge UPO Certificate</U>&rdquo;) shall represent
the applicable number of Surviving Pubco UPOs into which the Cambridge UPOs represented thereby have been converted</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
share of Cambridge Common Stock and each Cambridge Warrant held by Cambridge or the Company immediately prior to the Effective
Time shall be cancelled and extinguished without any conversion or payment in respect thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Certificates
representing the Surviving Pubco Shares and Surviving Pubco Warrants issuable pursuant to Sections 1.5(a)(i) and 1.5(a)(ii) shall
be issued to the holders of Cambridge Certificates upon surrender of the applicable Cambridge Certificates in the manner provided
in Section 1.5(b) (or in the case of a lost, stolen or destroyed certificate, upon delivery of an affidavit (and indemnity, if
required) in the manner provided in Section 1.8).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Exchange
Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Prior
to the Effective Time, Surviving Pubco shall appoint Continental Stock Transfer &amp; Trust Company (&ldquo;<U>Continental</U>&rdquo;),
as agent (the &ldquo;<U>Exchange Agent</U>&rdquo;), for the purpose of exchanging Cambridge Securities for Surviving Pubco Securities.
Upon surrender of the Cambridge Certificates and delivery of a duly executed letter of transmittal to the Exchange Agent, the holders
of such Cambridge Certificates shall be registered in the register of members of Surviving Pubco and shall receive in exchange
therefor certificates representing Surviving Pubco Securities (&ldquo;<U>Surviving Pubco Certificates</U>&rdquo;) into which their
Cambridge Securities shall be converted at the Effective Time and the Cambridge Certificates so surrendered shall forthwith be
canceled. Surviving Pubco shall make available to the Exchange Agent, as necessary, Surviving Pubco Certificates to be issued in
respect of the Cambridge Certificates surrendered. Until so surrendered, outstanding Cambridge Certificates will be deemed, from
and after the Effective Time, to evidence only the right to receive the shares in Surviving Pubco to which the holder thereof is
entitled pursuant to Sections 1.5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
certificates representing Surviving Pubco Shares are to be held in a name other than that in which the Cambridge Certificates surrendered
in exchange therefor are registered, it will be a condition of the issuance thereof that the Cambridge Certificates so surrendered
will be properly endorsed and otherwise in proper form for transfer, accompanied by an instrument of transfer that is reasonably
satisfactory to the Company and that the persons requesting such exchange will have paid to Surviving Pubco, or any agent designated
by it, any transfer or other taxes required by reason of the issuance of certificates representing shares of Surviving Pubco in
any name other than that of the registered holder of the Cambridge Certificates surrendered, or established to the satisfaction
of Surviving Pubco or any agent designated by it that such tax has been paid or is not payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Fractional
Shares</U>. Fractions of a Holdco Share may be issued as necessary by virtue of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Adjustments
to Exchange Ratios</U>. The number of Surviving Pubco Shares that the Stockholders and the holders of Cambridge Securities are
entitled to receive as a result of the Transactions shall be equitably adjusted to reflect appropriately the effect of (i)&nbsp;any
stock split, reverse stock split, stock dividend (including any dividend or distribution of securities convertible into Cambridge
Common Stock or Company Common Shares), cash dividends, reorganization, recapitalization, reclassification, combination, exchange
of shares or other like change with respect to the Cambridge Common Stock or Company Common Shares occurring on or after the date
hereof and prior to the Effective Time (provided there shall not be any adjustment with respect to the Company Dividend (as defined
in Section&nbsp;5.25)), and (ii) any breach or inaccuracy of either Section 2.3 or 3.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Share
Exchange</U></B>.<FONT STYLE="font-size: 10pt"><B><U> </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Exchange</U></B>.
All of the Company Common Shares issued and outstanding immediately prior to the Effective Time shall be exchanged at the Effective
Time into the right of the holders thereof to receive (collectively, the &ldquo;<U>Exchange Consideration</U>&rdquo;) an aggregate
of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>$18,150,000
in cash (the &ldquo;<U>Cash Consideration</U>&rdquo;),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>17,173,267
Surviving Pubco Shares (the &ldquo;<U>Closing Date Share Consideration</U>&rdquo; and, together with the Cash Consideration, the
&ldquo;<U>Total Closing Date Consideration</U>&rdquo;), and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Net Income Shares (as defined in Section 1.13) in accordance with Section 1.13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Exchange Consideration will be issued to
the Stockholders as set forth on <U>Schedule 1.6</U> pro rata with their ownership of Company Common Shares, subject to the issuance
of a portion thereof to those Persons and in those amounts set forth on <U>Schedule 1.6</U> (each such portion, a &ldquo;<U>Pro
Rata Portion</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Share
Exchange Steps</U></B>. On the Closing Date, the Share Exchange shall occur in two separate steps:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
first step is an exchange of 9.473% of the Company Common Shares in exchange for the Cash Consideration, subject to Section 1.6(c);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
second step, immediately following the first step, is an exchange of the remaining 90.527% of the Company Common Shares in exchange
for the Closing Date Share Consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Cash
Consideration; Put Options</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Cash Consideration equal to $18,150,000 shall be distributed to the Stockholders at Closing, pro rata with their ownership of Company
Common Shares (subject to the issuance of a portion thereof to those Persons and in those percentages set forth on <U>Schedule
1.6)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>At
Closing, an amount of cash equal to $11,850,000 (the &ldquo;<U>Put Option Escrow Cash</U>&rdquo;) shall be deposited by Surviving
Pubco in escrow in accordance with the escrow agreement (the &ldquo;<U>Put Option Escrow Agreement</U>&rdquo;) prescribed in Schedule
5.31 hereto (the &ldquo;<U>Put Option Escrow Account</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
Stockholder (each, a &ldquo;<U>Put Option Holder</U>&rdquo;) shall have the right to put (each, a &ldquo;<U>Put Option</U>&rdquo;
and collectively, the &ldquo;<U>Put Options</U>&rdquo;) to the Surviving Pubco of his Pro Rata Portion of up to 1,173,267 Surviving
Pubco Shares comprising a portion of the Closing Date Share Consideration (the &ldquo;<U>Put Shares</U>&rdquo;) for an amount in
cash equal to (x) the number of Put Shares subject to such exercise, <I>multiplied by</I> (y) $10.10 per Put Share, plus (z) his
Pro Rata Portion of interest, if any, and subject to the pre-ruling granted by the Israel Tax Authority (the &ldquo;<U>ITA</U>&rdquo;),
generated in the Put Option Escrow, as specifically set forth on <U>Schedule 1.6</U>. The Put Option may be exercised by each Put
Option Holder, in whole or in part, on one occasion by giving written notice to the Surviving Pubco at its principal executive
office, together with the delivery of the Put Shares covered by the Put Option, at any time during the sixty (60) day period immediately
following the two (2) year anniversary of the end of the full fiscal year in which Closing occurs (the &ldquo;<U>Put Option Exercise
Period</U>&rdquo;). <B> </B>Any exercise of a Put Option with respect to issued Surviving Pubco Shares shall take effect as a repurchase
as a matter of Cayman Islands law. Each Put Option Holder&rsquo;s written notice shall be signed by such Put Option Holder and
shall state the number of Put Shares with respect to which the Put Option is being exercised. If the Put Option is exercised by
a Put Option Holder during the Put Option Exercise Period for a number of Put Shares that results in an amount of cash in the Put
Option Escrow Account that is less than his or its Pro Rata Portion of the total Put Option Escrow Cash, then his or its Pro Rata
Portion of the Put Option Escrow Cash remaining in the Put Option Escrow Account following distribution of such lesser amount of
cash to such Put Option Holder (or any Permitted Put Option Transferee (as defined below)) with respect to the Put Shares exercised
by such Put Option Holder shall be distributed to the Surviving Pubco.<B> </B>Notwithstanding the foregoing, subject to the Lock-up
Agreements, nothing herein shall restrict any Put Option Holder (or any Permitted Put Option Transferee (as defined below)) from
selling any Put Shares if the Put Option Holder provides at least three (3) trading days prior written notice of any such sale
(the &ldquo;<U>Notice Period</U>&rdquo;) stating the number of Put Shares to be sold (a &ldquo;<U>Proposed Sale Notice</U>&rdquo;),
the Put Option Holder may sell all or a portion of the Put Shares identified in the Proposed Sale Notice during the three (3) trading
days following the expiration of the Notice Period (the &ldquo;<U>Permitted Sale Period</U>&rdquo;) and the Put Option Holder shall
provide written notice of the number of such Put Shares that were sold by the end of the trading day following the expiration of
the Permitted Sale Period (the &ldquo;<U>Final Sale Notice</U>&rdquo;). Notwithstanding the foregoing, during the Put Option Escrow
Period<U>,</U> no Put Option Holder may encumber or otherwise subject the Put Shares applicable to him to any Lien.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>For
purposes hereof, (A) &ldquo;<U>Permitted Put Option Transferee</U>&rdquo; means (x) a beneficiary, &ldquo;family member&rdquo;
(where a &ldquo;family member&rdquo; means any relationship by blood, marriage or adoption, including spouse, lineal descendants,
stepchildren, father, mother, brother or sister of the transferor or of the transferor&rsquo;s spouse) or trusts, family limited
partnerships and similar entities primarily for the benefit of the Put Option Holder or the Put Option Holder&rsquo;s family members
or (y) an Affiliate of the Put Option Holder or any investment fund or entity controlled or managed by the Put Option Holder, including,
if the Put Option Holder is a corporation, partnership, limited liability company or other business entity, a distribution of securities
to limited or general partners, members, shareholders or other equity holders of the Put Option Holder; <U>provided</U>, <U>however</U>,
that in each and any such event it shall be a condition to the transfer that the transferee execute an agreement stating that the
transferee is receiving and holding the Put Option subject to the provisions of this Agreement applicable to the Put Option, and
(B) &ldquo;<U>Put Option Escrow Period</U>&rdquo; means the period through the two (2) year anniversary of the end of the full
fiscal year in which the Closing occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
any Put Option is exercised, the purchase of the Put Shares covered by same and payment therefor shall be consummated within ten
business days of such exercise and the applicable Put Holders and the Surviving Pubco shall cooperate in the prompt consummation
of same; provided that, prior to the release and payment of any Put Option Escrow Cash to an exercising Put Option Holder, such
Put Option Holder shall provide a representation to Surviving Pubco that the Put Shares subject to such Put Option exercise are
free and clear of all Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Surrender
of Company Certificates</U></B>. Subject to Section 1.10 and <U>Schedule 1.6</U>, the Exchange Consideration shall be paid and
issued to the holders of certificates representing the Company Common Shares (the &ldquo;<U>Company Certificates</U>&rdquo;) upon
surrender of their respective Company Certificates (or in the case of a lost, stolen or destroyed certificate, upon delivery of
an affidavit (and indemnity, if required) in the manner provided in Section 1.8, or in the case of an uncertificated share, by
delivery of a copy of the register of members of the Company indicating such holder as entitled to the shares). After the Effective
Time, each outstanding Company Certificate will be deemed for all corporate purposes to evidence only the right to receive the
applicable portion of the Exchange Consideration in accordance with the provisions of this Article I.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>United
States Tax Characterizations</U></B>. With respect to the holders of Cambridge Securities, it is the intention of the parties hereto
that (a) the Redomestication Merger shall be properly treated as a reorganization within the meaning of Section 368(a)(1)(F) of
the Internal Revenue Code of 1986, as amended, and (b) that the Redomestication Merger and the Share Exchange shall otherwise be
treated as integrated transactions for United States income tax purposes for such holders.<B><U> </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Israeli
Tax Matters</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Withholding
of Tax</U></B>. All payments to the Stockholders under this agreement shall be subject to withholding of taxes under the laws of
the State of Israel. Surviving Pubco and the escrow agent appointed for the purposes of subsection (c) of this Section 1.6(f) shall
be entitled to withhold Israeli tax from the payments hereunder at the maximum rate provided for under the Israeli Income Tax Ordinance
and the regulations promulgated thereunder. Notwithstanding the foregoing sentence, in the event that any of the Stockholders shall
timely provide the payor with a valid certificate issued by the Israeli Tax Authority for the exemption from withholding tax or
for the withholding of tax at a lesser percentage or amount provided under the law, the provisions of the said tax certificate
shall prevail. Any amount withheld and paid over to the Israeli Tax Authority shall be deemed paid on account of the respective
amount payable under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Tax
Pre-Ruling</U></B>. The Company and the Stockholders shall be entitled to apply to the Israeli Tax Authority for rulings regulating
the transactions contemplated hereunder for Israeli tax purposes. The language of any such application shall require the prior
written consent of Cambridge only with respect to limitations in the rulings that relate to Surviving Pubco stockholders which
are not the Stockholders or with respect to Surviving Pubco itself, which consent shall not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Distributions Until Surrender of Certificates</U></B>. No dividends or other distributions declared or made after the date of this
Agreement with respect to Surviving Pubco Shares with a record date after the Closing Date will be paid to the holders of any unsurrendered
Cambridge Certificates or Company Certificates with respect to the Surviving Pubco Shares to be issued upon surrender thereof until
the holders of record of such Cambridge Certificates or Company Certificates shall surrender such Cambridge Certificates or Company
Certificates. Subject to Applicable Law, following surrender of any such Cambridge Certificates or Company Certificates with a
properly completed letter of transmittal, Surviving Pubco shall register the record holder thereof in the register of members of
Surviving Pubco and shall deliver to the record holders thereof, without interest, the Surviving Pubco Certificates representing
Surviving Pubco Shares issued in exchange therefor and the amount of any such dividends or other distributions with a record date
after the Closing Date theretofore paid with respect to such Surviving Pubco Shares. For the avoidance of doubt, this Section 1.7
does not affect the distribution of the cash dividend as set forth in Section 5.27.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Lost,
Stolen or Destroyed Certificates</U></B>. In the event that any Cambridge Certificates or Company Certificates shall have been
lost, stolen or destroyed, Surviving Pubco shall issue in exchange for such lost, stolen or destroyed Cambridge Certificates or
Company Certificates, upon the making of an affidavit of that fact by the holder thereof, the certificates representing the Surviving
Pubco Shares that the shares of Cambridge Common Stock, Cambridge Warrants, Company Common Shares formerly represented by such
Cambridge Certificates or Company Certificates were converted into and any dividends or distributions payable pursuant to Section
1.7; provided, however, that as a condition precedent to the issuance of such certificates representing Surviving Pubco Shares
and other distributions, the owner of such lost, stolen or destroyed Cambridge Certificates or Company Certificates shall indemnify
Surviving Pubco against any claim that may be made against Surviving Pubco with respect to the Cambridge Certificates or Company
Certificates alleged to have been lost, stolen or destroyed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Taking
of Necessary Action; Further Action</U></B>. If, at any time after the Effective Time, any further action is necessary or desirable
to carry out the purposes of this Agreement, the then current officers and directors of Cambridge and Surviving Pubco and the officers
and directors of the Company shall take all such lawful and necessary action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Continental
Escrow</U></B>. As the sole remedy for the indemnification obligations set forth in Article VII of this Agreement, a portion of
the Closing Date Share Consideration (the &ldquo;<U>Escrow Shares</U>&rdquo;) having an aggregate value (based on $10.10 per share)
equal to five percent (5%) of the Total Closing Date Consideration shall be deposited in escrow (the &ldquo;<U>Escrow Account</U>&rdquo;),
which escrow amount deposited shall be allocated among the Stockholders in the same proportion as their proportionate share of
the total Company Common Shares immediately prior to the Effective Time, all in accordance with the terms and conditions of the
escrow agreement to be entered into at the Closing as prescribed in <U>Schedule 5.31</U> with Continental Stock Trust and Transfer
serving as escrow agent (&ldquo;<U>Continental Escrow Agent</U>&rdquo;), substantially in the form of <U>Exhibit C</U> hereto (the
&ldquo;<U>Continental Escrow Agreement</U>&rdquo;). On the first anniversary of the Closing Date (the &ldquo;<U>Basic Indemnity
Escrow Termination Date</U>&rdquo;), the Continental Escrow Agent shall release fifty percent (50%) of the original number of Escrow
Shares to the Stockholders, less any of such shares applied in satisfaction of a claim for indemnification pursuant to Article
VIII and any of such shares related to a claim that is then unresolved in the same proportions as originally deposited into escrow.
The remaining Escrow Shares (the &ldquo;<U>Additional Indemnity Shares</U>&rdquo;) shall be available for indemnification only
with respect to Additional Indemnification Claims (each as hereinafter defined). On the earlier of (x) the eighteen (18) month
anniversary of the Closing Date, and (y) the thirtieth (30<SUP>th</SUP>) day following the filing by Surviving Pubco of its Annual
Report on Form 10-K for the year ending December 31, 2016 with the SEC (the &ldquo;<U>Additional Indemnity Escrow Termination Date</U>&rdquo;),
the Continental Escrow Agent shall deliver the Additional Indemnity Shares, less any of such shares applied in satisfaction of
an Additional Indemnification Claim and any of such shares related to an Additional Indemnification Claim that is then unresolved,
to each recipient in the same proportions as initially deposited in escrow. Any Escrow Shares held with respect to any unresolved
claim for indemnification and not applied as indemnification with respect to such claim upon its resolution shall be delivered
to such Persons promptly upon such resolution. &ldquo;<U>Additional Indemnification Claim</U>&rdquo; means a claim for indemnification
pursuant to Article&nbsp;VII.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Representatives</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
hereby appoints Benjamin Gordon as the representative for Surviving Pubco immediately prior to the Effective Time (the &ldquo;<U>Cambridge
Representative</U>&rdquo;) to take actions and make decisions required or permitted to be taken or made by the Cambridge Representative
following the Closing pursuant to this Agreement or the Continental Escrow Agreement. Should the Cambridge Representative resign
or be unable to serve, a new Cambridge Representative shall be selected by majority vote of those Persons who served on the Cambridge
Board immediately prior to the Effective Time. The Cambridge Representative shall not be liable to any Person (including Surviving
Pubco or recipients of Surviving Pubco Shares) for any liability, loss, damage, penalty, fine, cost or expense incurred without
gross negligence by the Cambridge Representative while acting in good faith and arising out of or in connection with the acceptance
or administration of his duties hereunder (it being understood that any act done or omitted pursuant to the advice of counsel shall
be conclusive evidence of such good faith). From and after the Effective Time, a decision, act, consent or instruction of the Cambridge
Representative shall be final, binding and conclusive and not subject to challenge by any recipient. Surviving Pubco is hereby
relieved from any liability to any person for any acts done by Cambridge Representative and any acts done by Surviving Pubco in
accordance with any such decision, act, consent or instruction of the Cambridge Representative. Surviving Pubco and each of its
Affiliates shall be entitled to rely upon, and shall be fully protected in relying upon, the power and authority of the Cambridge
Representative without independent investigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Stockholders hereby appoint Anatoly Hurgin as their representative (the &ldquo;<U>Ability Representative</U>&rdquo;) to take actions
and make decisions required or permitted to be taken or made by the Ability Representative following the Closing pursuant to this
Agreement or the Continental Escrow Agreement. Should the Ability Representative resign or be unable to serve, a new Ability Representative
shall be selected by majority vote of the remaining members of the Company Board who served thereon immediately prior to the Effective
Time. The Ability Representative shall not be liable to any Person (including Surviving Pubco or recipients of Surviving Pubco
Shares) for any liability, loss, damage, penalty, fine, cost or expense incurred without gross negligence by the Ability Representative
while acting in good faith and arising out of or in connection with the acceptance or administration of his duties hereunder (it
being understood that any act done or omitted pursuant to the advice of counsel shall be conclusive evidence of such good faith).
From and after the Effective Time, a decision, act, consent or instruction of the Ability Representative shall be final, binding
and conclusive and not subject to challenge by any recipient. Surviving Pubco is hereby relieved from any liability to any person
for any acts done by Ability Representative and any acts done by Surviving Pubco in accordance with any such decision, act, consent
or instruction of the Ability Representative. Surviving Pubco and each of its Affiliates shall be entitled to rely upon, and shall
be fully protected in relying upon, the power and authority of the Ability Representative without independent investigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Stockholder
Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>By
its execution of this Agreement, each Stockholder, in its capacity as a stockholder of the Company, hereby approves this Agreement
and authorizes the Company and its directors and officers to take all actions necessary for the consummation of the Transactions
and the other transactions contemplated hereby pursuant to the terms of this Agreement and its exhibits. Such execution shall be
deemed to be action taken by the written consent of the Stockholders for purposes of the Israeli Companies Act (&ldquo;<U>Written
Consent</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
Stockholder, for himself only (it being understood that each Stockholder makes the representations contained in this Section 1.12(b)
only with respect to himself and not with respect to any other Stockholder), represents and warrants as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>such
Stockholder has all necessary power and authority to execute and deliver this Agreement and to perform his obligations hereunder
and, to consummate the transactions contemplated hereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>this
Agreement has been duly and validly executed and delivered by such Stockholder and, assuming the due authorization, execution and
delivery thereof by the other parties hereto, constitutes the legal and binding obligation of such Stockholder, enforceable against
such Stockholder in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization or other similar
laws affecting the enforcement of creditors&rsquo; rights generally and by general principles of equity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>all
Surviving Pubco Shares to be acquired by such Stockholder pursuant to this Agreement will be acquired for his account and not with
a view towards distribution thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>he
understands that he must bear the economic risk of the investment in the Surviving Pubco Shares, which cannot be sold by him unless
such shares are registered under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), or an exemption
therefrom is available thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>he
has had both the opportunity to ask questions and receive answers from the officers and directors of Cambridge and all persons
acting on Cambridge&rsquo;s behalf concerning the business and operations of Cambridge and to obtain any additional information
to the extent Cambridge possesses or may possess such information or can acquire it without unreasonable effort or expense necessary
to verify the accuracy of such information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>he
has had access to the Cambridge SEC Reports (as defined in Section 3.7 hereof) filed prior to the date of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>that
his execution and delivery of this Agreement does not, and the performance of its obligations hereunder will not, require any consent,
approval, authorization or permit of, or filing with or notification to, any court, administrative agency, commission, governmental
or regulatory authority, domestic or foreign (a &ldquo;<U>Governmental Entity</U>&rdquo;), including without limitation to the
Israeli Ministry of Defense and/or any agency thereof and/or under any Israeli national security legislation, including, without
limitation, the Security Corporations Act (Protection of Security Interests) &ndash; 2006, the Defense Export Control Law &ndash;
2007 and the Control of Commodities and Services Order (Engagement in Encryption Means) &ndash; 1974, except (1) for applicable
requirements, if any, of the Securities Act, the Securities Exchange Act of 1934, as amended (&ldquo;<U>Exchange Act</U>&rdquo;),
state securities laws (&ldquo;<U>Blue Sky Laws</U>&rdquo;), and the rules and regulations thereunder, and (2) where the failure
to obtain such consents, approvals, authorizations or permits, or to make such filings or notifications, would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect (as defined in Section 10.2(a)) on the Company or
prevent consummation of the Transactions or otherwise prevent the parties hereto from performing their material obligations under
this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>he
is an &ldquo;accredited investor&rdquo; as that term is defined in Rule 501(a) of Regulation D under the Securities Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>he
is not subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under Regulation
D of the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>he
understands that the certificates representing Surviving Pubco Shares to be received by it may bear legends to the effect that
the Surviving Pubco Shares may not be transferred except upon compliance with (1) the registration requirements of the Securities
Act (or an exemption therefrom) and (2) the provisions of this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(xi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>he
owns the Company Common Shares as listed on <U>Schedule 2.3(a)</U> as being owned by him free and clear of all Liens and has not
granted to any other Person any options or other rights to buy such securities, nor has he granted any interest in such securities
to any Person of any nature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Net
Income Shares</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If,
for the fiscal year of Surviving Pubco ending December&nbsp;31, 2015, Surviving Pubco has Net Income equal to or greater than $27,000,000
(the &ldquo;<U>2015 Net Income Target</U>&rdquo;), Surviving Pubco shall issue to the Stockholders, in the aggregate, 3,600,000
Surviving Pubco Shares (the &ldquo;<U>2015 Net Income Shares</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If,
for the fiscal year of Surviving Pubco ending December&nbsp;31, 2016, Surviving Pubco has Net Income equal to or greater than $40,000,000
(the &ldquo;<U>2016 Net Income Target</U>&rdquo;), Surviving Pubco shall issue to the Stockholders, in the aggregate, 1,850,000
Surviving Pubco Shares (the &ldquo;<U>2016 Net Income Shares</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If,
for the fiscal year of Surviving Pubco ending December&nbsp;31, 2017, Surviving Pubco has Net Income equal to or greater than $60,000,000
(the &ldquo;<U>2017 Net Income Target</U>&rdquo;), Surviving Pubco shall issue to the Stockholders, in the aggregate, 2,000,000
Surviving Pubco Shares (the &ldquo;<U>2017 Net Income Shares</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If,
for the fiscal year of Surviving Pubco ending December&nbsp;31, 2018, Surviving Pubco has Net Income equal to or greater than $80,000,000
(the &ldquo;<U>2018 Net Income Target</U>&rdquo;), Surviving Pubco shall issue to the Stockholders, in the aggregate, 1,000,000
Surviving Pubco Shares (the &ldquo;<U>2018 Net Income Shares</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In
the event that Surviving Pubco fails to satisfy the Net Income Target for any fiscal year but Net Income for such fiscal year is
ninety percent (90%) or more of the Net Income Target for such fiscal year, then Surviving Pubco shall issue to the Stockholders,
in the aggregate, such number of Surviving Pubco Shares equal to the product obtained by (x) the Net Income Shares that would have
been issued to the Stockholders had the Net Income Target been achieved <I>multiplied by</I> (y) the quotient obtained by (A) the
Net Income for such fiscal year <I>divided by</I> (B) the Net Income Target for such fiscal year. For instance and solely by way
of illustration, if the Net Income for the 2015 fiscal year equals $24,300,000, the 2015 Net Income Shares issuable to the Stockholders
shall equal 3,240,000 Surviving Pubco Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In
the event that Surviving Pubco fails to satisfy the 2015 Net Income Target but satisfies the 2016 Net Income Target, then Surviving
Pubco shall issue to the Stockholders, in addition to the 2016 Net Income Shares required to be issued by Surviving Pubco as a
result of Surviving Pubco achieving the 2016 Net Income Target, the 2015 Net Income Shares. In addition, (i) if Surviving Pubco
fails to satisfy the 2015 Net Income Target but Net Income for such fiscal year is ninety percent (90%) or more of the 2015 Net
Income Target (i.e., 92%) and Net Income for 2016 is a higher percentage of the 2016 Net Income Target (i.e., 97%), then Surviving
Pubco shall issue to the Stockholders, in addition to the pro rata 2016 Net Income Shares (i.e., 97%) required by Section 1.13(e),
such number of Surviving Pubco Shares for 2015 in accordance Section 1.13(e) based on the difference (i.e. 5%) between the percentage
of Net Income for 2016 as compared to the 2016 Net Income Target (i.e. 97%) and the Net Income for 2015 as compared to the 2015
Net Income Target (i.e. 92%), or (ii) if Surviving Pubco fails to satisfy the 2015 Net Income Target and Net Income for such fiscal
year is less than ninety percent (90%) of the 2015 Net Income Target but Net Income for 2016 is ninety percent (90%) or more of
the 2016 Net Income Target (i.e. 95%), then Surviving Pubco shall issue to the Stockholders, in addition to the&nbsp;pro rata of
2016 Net Income Shares (i.e. 95%) required by Section 1.13(e), such number of Surviving Pubco Shares for 2015 in accordance Section
1.13(e) based on the same percentage of Net Income for 2016 as compared to the 2016 Net Income Target (i.e. 95%). For purposes
of clarity, the catch-up allowance described in this clause (f) shall not apply to any other time periods or targets other than
those specifically referenced in this clause (f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
used herein,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Net
Income</U>&rdquo; means net income of Surviving Pubco as set forth in Surviving Pubco&rsquo;s audited financial statements for
any applicable year, as determined in accordance with generally accepted accounting principles of the United States (&ldquo;<U>U.S.
GAAP</U>&rdquo;). Net Income shall not take into account any net income (loss) that exists for a company acquired by Surviving
Pubco or the Company after the Effective Time at the time of its acquisition; <U>provided</U>, <U>however</U>, any subsequent net
income (loss) after the date of such acquisition shall be taken into account for purposes of determining whether the Net Income
targets have been achieved. For instance and solely by way of illustration, if the Company acquires a company with $1 million of
net income on October 31, 2015, any net income in November 2015 and December 2015 would be taken into account for purposes of determining
whether the 2015 Net Income target has been achieved, and then if net income attributable to such acquisition was $6 million in
2016, then $6 million of such 2016 net income would be taken into account for purposes of determining whether the 2016 Net Income
target has been achieved. In addition, the calculation of Net Income for all purposes under this Section 1.13 shall not include
(x) any expenses paid or incurred by the Company, Surviving Pubco or Cambridge in connection with the transactions contemplated
hereby or as otherwise set forth on Schedule 5.23 of this Agreement; and (y) any and all losses or expenses incurred by the Company,
Surviving Pubco or Cambridge in connection with the litigation described on Schedule 3.10.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Net
Income Shares</U>&rdquo; means, subject to Section 1.13(e), the sum of the 2015 Net Income Shares, the 2016 Net Income Shares,
the 2017 Net Income Shares and the 2018 Net Income Shares issuable pursuant to this Section&nbsp;1.13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Net
Income Target</U>&rdquo; means, as the context requires, each of the 2015 Net Income Target, the 2016 Net Income Target, the 2017
Net Income Target or the 2018 Net Income Target.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Subject
to compliance with Applicable Law, any Net Income Shares to be issued pursuant to this Section 1.13 shall be (i) issued automatically
and without requiring approval from the Surviving Pubco Board other than approvals granted in connection with this Agreement and
the Transactions, (ii) allocated as set forth on <U>Schedule 1.13(h)</U>, and (iii) automatically equitably adjusted to reflect
appropriately (x) the effect of any stock split, consolidation, reverse stock split, share dividend (including any dividend or
distribution of securities convertible into Surviving Pubco Shares), cash dividends, reorganization, recapitalization, reclassification,
combination, exchange of shares or other like change with respect to the Surviving Pubco Shares occurring on or after the date
such Net Income Shares are issued, and (y) any breach or inaccuracy of either Section 2.3 or 3.3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Not
later than 150 days after the fiscal year with respect to which Net Income is calculated, Surviving Pubco shall deliver to the
Cambridge Representative its Net Income calculation (the &ldquo;<U>Net Income Calculation</U>&rdquo;), which shall be conclusive
and binding upon the parties unless the Cambridge Representative, within ten (10) Business Days after its receipt of the Net Income
Calculation, notifies Surviving Pubco in writing that it disputes any of the amounts set forth therein, specifying the nature of
the dispute and the basis therefore. The parties shall in good faith attempt to resolve any dispute and, if the parties so resolve
all disputes, the Net Income Calculation, as amended to the extent necessary to reflect the resolution of the dispute, shall be
conclusive and binding on the parties. If the parties do not reach agreement in resolving the dispute within ten (10) Business
Days after notice is given to Surviving Pubco by the Cambridge Representative, the parties shall submit the dispute to an independent
accounting firm which is mutually agreeable to the parties (the &ldquo;<U>Accounting Arbiter</U>&rdquo;). Within thirty (30) days
of such submission, the Accounting Arbiter shall determine (it being understood that in making such determination, the Accounting
Arbiter shall be functioning as an expert and not as an arbitrator), based solely on written submissions by Surviving Pubco and
the Cambridge Representative, and not by independent review, only those issues in dispute and shall render a written report as
to the resolution of the dispute and the resulting Net Income Calculation which shall be conclusive and binding on the parties.
In resolving any disputed item, the Accounting Arbiter (x) shall be bound by the provisions of this Section 1.13(g) and (y) may
not assign a value to any item greater than the greatest value for such items claimed by either party or less than the smallest
value for such items claimed by either party<B>. </B>The fees, costs and expenses of the Accounting Arbiter shall be borne by Surviving
Pubco. Subject to the requirement to act in good faith in accordance with Section 1.11 herein, the Cambridge Representative shall
be entitled to engage a firm of independent accountants to advise it with respect to the Net Income Calculation, with the all fees
and expenses of such firm to be paid by Surviving Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in Section 1.13(d), Net Income Shares shall be issued to the Persons entitled to them no later than thirty (30) days
after the Net Income Calculation becomes conclusive and binding for the fiscal year with respect to such Net Income Shares are
earned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Sale
Restriction</U></B>. Prior to the Effective Time, (i) those Persons set forth on <U>Schedule 1.14(i)</U> shall enter into a Lock-Up
Agreement in the form of <U>Exhibit D-1</U> (the &ldquo;<U>One Year Lock-Up Agreement</U>&rdquo;), and (ii) those Persons set forth
on <U>Schedule 1.14(ii)</U> shall enter into a Lock-Up Agreement in the form of <U>Exhibit D-2</U> (the &ldquo;<U>Two Year Lock-Up
Agreement,</U>&rdquo; and together with the One Year Lock-Up Agreement, the &ldquo;<U>Lock-Up Agreements</U>&rdquo;).&nbsp; Surviving
Pubco&rsquo;s register of members and the Surviving Pubco Certificates evidencing the Surviving Pubco Shares issued as a result
of the Share Exchange shall each include prominent disclosure or bear a prominent legend evidencing the fact that such shares are
subject to such Lock-Up Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
II.</B></FONT><BR>
<B>REPRESENTATIONS AND WARRANTIES REGARDING THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Subject to the exceptions
set forth in <U>Schedule&nbsp;2</U> attached hereto (the &ldquo;<U>Company Schedule</U>&rdquo;), the Company and the Stockholders
hereby represent and warrant to Cambridge as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Organization
and Qualification</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company is duly incorporated, validly existing and in good standing under the laws of Israel and has the requisite corporate power
and authority to own, lease and operate its assets and properties and to carry on its business as it is now being conducted. The
Company is in possession of all franchises, grants, authorizations, licenses, permits, easements, consents, certificates, approvals
and orders (&ldquo;<U>Approvals</U>&rdquo;) necessary to own, lease and operate the properties it purports to own, operate or lease
and to carry on its business as it is now being conducted, except where the failure to have such Approvals would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company. Complete and correct copies of the
memorandum and articles of association (or other comparable governing instruments with different names) (collectively referred
to herein as &ldquo;<U>Charter Documents</U>&rdquo;) of the Company, as amended and currently in effect, have been heretofore made
available to Cambridge or Cambridge&rsquo;s counsel. The Company is not in violation of any of the provisions of the Company&rsquo;s
Charter Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company is duly qualified or licensed to do business and is in good standing in each jurisdiction where the character of the properties
owned, leased or operated by it or the nature of its activities makes such qualification or licensing necessary, except for such
failures to be so duly qualified or licensed and in good standing that would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect on the Company. Each jurisdiction in which the Company is so qualified or licensed
is listed in <U>Schedule&nbsp;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
minute books of the Company contain, in all material respects, true and accurate records of written minutes for meetings and written
consents in lieu of meetings of its Board of Directors (and any committees thereof), similar governing bodies and stockholders
(&ldquo;<U>Corporate Records</U>&rdquo;) since the time of the Company&rsquo;s organization. Copies of such Corporate Records of
the Company have been made available to Cambridge or Cambridge&rsquo;s counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
stock transfer and ownership records of the Company, if any, contain, in all material respects, true and accurate records of the
securities ownership as of the date of such records and the transfers involving the capital stock and other securities of the Company
since the time of the Company&rsquo;s incorporation. Copies of such records of the Company have been made available to Cambridge
or Cambridge&rsquo;s counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Subsidiaries</U></B>.
The Company has no Subsidiaries, and, other than as set forth on <U>Schedule 2.2</U>, has no participations in joint ventures or
other entities. The Company does not own, directly or indirectly, any ownership, equity, profits or voting interest in any Person
or have any agreement or commitment to purchase any such interest, and has not agreed and is not obligated to make nor is bound
by any written, oral or other agreement, contract, subcontract, lease, binding understanding, instrument, note, option, warranty,
purchase order, license, sublicense, insurance policy, benefit plan, commitment or undertaking of any nature, as of the date hereof
or as may hereafter be in effect under which it may become obligated to make, any future investment in or capital contribution
to any other entity</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Capitalization</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
authorized capital stock of the Company consists of 170,000 Company Common Shares, of which 122,000 shares are issued and outstanding
as of the date of this Agreement, all of which shares are validly issued, fully paid and nonassessable. Other than Company Common
Shares, the Company has no class or series of securities authorized by its Charter Documents. <U>Schedule&nbsp;2.3(a)</U> hereto
contains a list of all of the stockholders of the Company, the number of Company Common Shares owned, or to be owned at the time
of the Closing, by each shareholder and each shareholder&rsquo;s state or province of residence. As of the date of this Agreement,
the Company has no outstanding options to purchase Company Common Shares or outstanding warrants or other rights or derivative
securities to purchase Company Common Shares. All outstanding Company Common Shares have been issued and granted in compliance
with (x) all Applicable Law, and (y) all requirements set forth in any applicable Company Contracts (as defined in Section&nbsp;2.19).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in <U>Schedule&nbsp;2.3(b)</U> hereto, there are no subscriptions, options, warrants, equity securities, partnership
interests or similar ownership interests, calls, rights (including preemptive rights), commitments or agreements of any character
to which the Company is a party or by which it is bound obligating the Company to issue, deliver or sell, or cause to be issued,
delivered or sold, or repurchase, redeem or otherwise acquire, or cause the repurchase, redemption or acquisition of, any shares
of capital stock of the Company or obligating the Company to grant, extend, accelerate the vesting of or enter into any such subscription,
option, warrant, equity security, call, right, commitment or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as contemplated by this Agreement and except as set forth in <U>Schedule&nbsp;2.3(c)</U> hereto, there are no registration rights,
and there is no voting trust, proxy, rights plan, antitakeover plan or other similar agreement or understanding to which the Company
is a party or by which the Company is bound with respect to any equity security of any class of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in <U>Schedule 2.3(d)</U>, no outstanding Company Common Shares are unvested or subjected to a repurchase option,
risk of forfeiture or other condition under any applicable agreement with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as provided for in this Agreement or as set forth in <U>Schedule&nbsp;2.3(e)</U>, as a result of the consummation of the transactions
contemplated hereby, no shares of capital stock, warrants, options or other securities of the Company are issuable and no rights
in connection with any shares, warrants, options or other securities of the Company accelerate or otherwise become triggered (whether
as to vesting, exercisability, convertibility or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Authority
Relative to this Agreement</U></B>. The Company has all necessary corporate power and authority to execute and deliver this Agreement
and to perform its obligations hereunder and, to consummate the transactions contemplated hereby (including the Share Exchange).
The execution and delivery of this Agreement and the consummation by the Company of the transactions contemplated hereby (including
the Transactions) have been duly and validly authorized by all necessary corporate action on the part of the Company (including
the approval by its Board of Directors and stockholders, subject in all cases to the satisfaction of the terms and conditions of
this Agreement, including the conditions set forth in Article&nbsp;VI and approval of the Stockholders by the Written Consent),
and no other corporate proceedings on the part of the Company or its stockholders are necessary to authorize this Agreement or
to consummate the transactions contemplated hereby pursuant to Applicable Law. This Agreement has been duly and validly executed
and delivered by the Company and, assuming the due authorization, execution and delivery thereof by the other parties hereto, constitutes
the legal and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as may be
limited by bankruptcy, insolvency, reorganization or other similar laws affecting the enforcement of creditors&rsquo; rights generally
and by general principles of equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Conflict; Required Filings and Consents</U></B>. Except as set forth in <U>Schedule&nbsp;2.5</U> hereto:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
execution and delivery of this Agreement by the Company does not, and the performance of this Agreement by the Company shall not,
(i) conflict with or violate the Company&rsquo;s Charter Documents, (ii) conflict with or violate any Legal Requirements (as defined
in Section&nbsp;10.2(b)), (iii) result in any breach of or constitute a default (or an event that with notice or lapse of time
or both would become a default) under, or materially impair the Company&rsquo;s rights, or give to others any rights of termination,
acceleration or cancellation of, or result in the creation of a Lien on any of the properties or assets of the Company pursuant
to, any Company Contracts or (iv) result in the acceleration or increase of any payment to any Person pursuant to any Company Contract,
including any &ldquo;change in control&rdquo; or similar provision of any Company Contract, except, with respect to clauses (ii),
(iii) or (iv), for any such conflicts, violations, breaches, defaults, impairments, rights of termination, acceleration or cancellation,
Liens, payment accelerations or increases or other occurrences that would not, individually and in the aggregate, have a Material
Adverse Effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
execution and delivery of this Agreement by the Company does not, and the performance of its obligations hereunder will not, require
any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity, including without
limitation to the Israeli Ministry of Defense and/or any agency thereof and/or under any Israeli national security legislation,
including, without limitation, the Security Corporations Act (Protection of Security Interests) &ndash; 2006, the Defense Export
Control Law &ndash; 2007 and the Control of Commodities and Services Order (Engagement in Encryption Means) &ndash; 1974, or other
third party to any Material Company Contract, except (i) for applicable requirements, if any, of the Securities Act, the Exchange
Act or Blue Sky Laws, and the rules and regulations thereunder, and appropriate documents received from or filed with the relevant
authorities of other jurisdictions in which the Company is licensed or qualified to do business, (ii) the consents, approvals,
authorizations and permits described in <U>Schedule&nbsp;2.5</U>, and (iii) where the failure to obtain such consents, approvals,
authorizations or permits, or to make such filings or notifications, would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect on the Company, or prevent consummation of the Transactions or otherwise prevent the
parties hereto from performing their obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Compliance</U></B>.
Since the date of its establishment, the Company has complied with and is not in violation of any Legal Requirements with respect
to the conduct of its business, except for failures to comply or violations which, individually or in the aggregate, have not had
or would not be reasonably likely to have a Material Adverse Effect on the Company. The Company has not sold or entered into any
Company Contract for the sale of products or goods into any jurisdiction in violation of any trade agreements, treaties or embargoes
imposed by the State of Israel. The Company is not in default or violation of any term, condition or provision of any applicable
Charter Documents. Since the date of the Company&rsquo;s establishment, no written notice of non-compliance with any Legal Requirements
has been received by the Company from any Governmental Entity which currently remains pending or unresolved. The Company is not
in default of any term of any Company Contract, except for defaults which, individually or in the aggregate, have not had or would
not be reasonably likely to have a Material Adverse Effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Financial
Statements</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has provided to Cambridge a correct and complete copies of the (i) audited consolidated financial statements (including
any related notes thereto) of the Company for the fiscal years ended December 31, 2014 and 2013 (the &ldquo;<U>Audited Financial
Statements</U>&rdquo;), and (ii) the unaudited consolidated financial statements of the Company for the three month period ended
June 30, 2015 (the &ldquo;<U>Balance Sheet Date</U>&rdquo;) (including any notes related thereto) (the &ldquo;<U>Unaudited Financial
Statements</U>,&rdquo; and together with the Audited Financial Statements, the &ldquo;<U>Financial Statements</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Financial Statements were prepared in accordance with U.S. GAAP applied on a consistent basis throughout the periods involved (except
as may be indicated in the notes thereto), and fairly present in all material respects the financial position of the Company at
the respective dates thereof and the results of its operations and cash flows for the periods indicated, except, in the case of
the Unaudited Financial Statements, subject to normal audit adjustments that are not expected to have a Material Adverse Effect
on the Company and do not include all footnotes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
books of account and other similar books and records of the Company have been maintained in accordance with good business practice,
are complete and correct in all material respects and there have been no material transactions that are required to be set forth
therein and which have not been so set forth.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as otherwise noted in the Financial Statements, the accounts and notes receivable of the Company reflected on the balance sheets
included in the Financial Statements: (i) arose from bona fide sales transactions in the ordinary course of business and are payable
on ordinary trade terms, (ii) are legal, valid and binding obligations of the respective debtors enforceable in accordance with
their terms, except as such may be limited by bankruptcy, insolvency, reorganization, or other similar laws affecting creditors&rsquo;
rights generally, and by general equitable principles, (iii) are not subject to any valid set-off or counterclaim except to the
extent set forth in such balance sheet contained therein other than possible back charges which to the Company&rsquo;s knowledge
do not exist at this time, which back charges, to the Company&rsquo;s knowledge, either individually or in the aggregate, would
not reasonably be expected to have a Material Adverse Effect upon the Company, (iv) are collectible in the ordinary course of business
consistent with past practice in the aggregate recorded amounts thereof, net of any applicable reserve reflected in such balance
sheet contained therein, and (v) are not the subject of any actions or proceedings brought by or on behalf of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
the knowledge of the Company, the Company&rsquo;s auditor that has audited and reported upon the financial statements to be included
in the Proxy Statement/Prospectus (as defined) has at all required times since the date of enactment of the Sarbanes-Oxley Act
been: (i) a registered public accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act); (ii) &ldquo;independent&rdquo;
with respect to the Company within the meaning of Regulation S-X under the Exchange Act; and (iii) in compliance with subsections
(g) through (l) of Section 10A of the Exchange Act and the rules and regulations promulgated by the SEC and the Public Company
Accounting Oversight Board thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Undisclosed Liabilities</U></B>. Except as set forth in <U>Schedule&nbsp;2.8</U> hereto, the Company has no liabilities (absolute,
accrued, contingent or otherwise) of a nature required to be disclosed on a balance sheet or in the related notes to financial
statements that are, individually or in the aggregate, material to the business, results of operations or financial condition of
the Company, except such liabilities (i) disclosed in the Financial Statements or in the notes thereto, (ii) arising in the ordinary
course of the Company&rsquo;s business since the Balance Sheet Date, and (iii) incurred in connection with the transactions contemplated
by this Agreement, including those incurred by actions permitted by Section 4.1 herein, none of which would, individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect on the Company. The Company is not and has not been a party
to any securitization transactions or &ldquo;off-balance sheet arrangements&rdquo; (as defined in Item 303(c) of Regulation S-K
under the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Absence
of Certain Changes or Events</U></B>. Except as set forth in <U>Schedule&nbsp;2.9</U> hereto and as expressly contemplated by this
Agreement, between the Balance Sheet Date and the date hereof, (i) the Company has conducted its business only in the ordinary
course and in a manner consistent with past practice, (ii) there has not been any Material Adverse Effect on the Company, and (ii)
the Company has not taken any action that, if taken after the date of this Agreement, would constitute a breach of any of the covenants
set forth in Section 4.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Litigation</U></B>.
Except as disclosed in <U>Schedule&nbsp;2.10</U> hereto, there are no claims, suits, actions or proceedings pending or, to the
knowledge of the Company, threatened against the Company before any court, governmental department, commission, agency, instrumentality
or authority, or any arbitrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Employee
Benefit Plans</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Schedule&nbsp;2.11(a)</U>
lists all employee compensation, incentive, fringe or benefit plans, programs, policies, agreements, commitments or other arrangements
(whether or not set forth in a written document) currently covering any active or former employee, director or consultant of the
Company since the date of the Company&rsquo;s establishment, or any trade or business (whether or not incorporated) which is under
common control with the Company, with respect to which the Company has liability (individually, a &ldquo;<U>Plan,</U>&rdquo; and,
collectively, the &ldquo;<U>Plans</U>&rdquo;). All Plans have been maintained and administered in all material respects in compliance
with their respective terms and with the requirements prescribed by any and all statutes, orders, rules and regulations which are
applicable to such Plans, and all liabilities with respect to the Plans have been properly reflected in the financial statements
and records of the Company. No suit, action or other litigation (excluding claims for benefits incurred in the ordinary course
of Plan activities) has been brought, or, to the knowledge of the Company, is threatened, against or with respect to any Plan.
There are no audits, inquiries or proceedings pending or, to the knowledge of the Company, threatened by any governmental agency
with respect to any Plan. All contributions, reserves or premium payments required to be made or accrued as of the date hereof
to the Plans have been timely made or accrued. The Company does not have any plan or commitment to establish any new Plan, to modify
any Plan in any material respect (except to the extent required by law or to conform any such Plan to the requirements of any Applicable
Law, in each case as previously disclosed to Cambridge in writing, or as required by this Agreement), or to enter into any new
Plan. Except as disclosed in <U>Schedule&nbsp;2.11(a)</U>, each Plan can be amended, terminated or otherwise discontinued after
the Closing in accordance with its terms, without liability to the Company (other than ordinary administration expenses and expenses
for benefits accrued but not yet paid).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as disclosed in <U>Schedule&nbsp;2.11(b)</U> hereto, neither the execution and delivery of this Agreement nor the consummation
of the transactions contemplated hereby will (i) result in any payment (including severance, unemployment compensation, golden
parachute, bonus or otherwise) becoming due to any stockholder, director or employee of the Company under any Plan, (ii) materially
increase any benefits otherwise payable under any Plan, or (iii) result in the acceleration of the time of payment or vesting of
any benefits under any Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Labor
Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth on <U>Schedule&nbsp;2.12(a)</U> and pursuant to Applicable Law, the Company is not a party to any collective bargaining
agreement or other labor union contract applicable to persons employed by the Company nor, to the Company&rsquo;s knowledge, are
there any activities or proceedings of any labor union to organize any such employees. There are no pending grievance or similar
proceedings involving the Company, on the one hand, and any of its employees, on the other hand, subject to a collective bargaining
agreement or other labor union contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth on <U>Schedule&nbsp;2.12(b)</U>, each employee and consultant of the Company is terminable &ldquo;at will&rdquo; subject
to Applicable Law and the terms of his/her respective employment agreement. The Company has not received any written notice of
termination of employment from any of its officers or key employees. The Company is in compliance in all material respects with
the terms of the respective employment and consulting agreements between the Company and such individuals. Except as otherwise
disclosed in <U>Schedule&nbsp;2.12(b)</U>, to the knowledge of the Company, there are not, and there have not been, any oral or
informal arrangements, commitments or promises between the Company and any employees or consultants of the Company that have not
been documented as part of the formal written agreements between any such individuals and the Company that have been made available
to Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company is in compliance in all material respects with all Legal Requirements applicable to its employees respecting employment,
employment practices, terms and conditions of employment and wages and hours and are not liable for any arrears of wages or penalties
with respect thereto. All amounts that the Company is legally or contractually required either (x) to deduct from its employees&rsquo;
salaries or to transfer to such employees&rsquo; pension or life insurance, incapacity insurance, continuing education fund or
other similar funds or (y) to withhold from its employees&rsquo; salaries and benefits and to pay to any Governmental Entity as
required by applicable Legal Requirements have, in each case, been duly deducted, transferred, withheld and paid, and the Company
does not have any outstanding obligation to make any such deduction, transfer, withholding or payment. Except as set forth in <U>Schedule
2.12(c)</U>, there are no pending, or to the Company&rsquo;s knowledge, threatened claims or actions against the Company by any
employee in connection with such employee&rsquo;s employment or termination of employment by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
of Company's employees have executed employment agreements incorporating Section 14 of the Israeli Severance Pay Law and the General
Permit of the Minister of Economy, pursuant to which payments made by Company for the benefit of its employees under a pension
plan or a manager's insurance policy (&ldquo;Severance Funds&rdquo;) shall be in lieu of its statutory obligation to pay severance
pay, for the period commencing August 2014. As per the periods prior thereto, severance payments would be made in accordance with
law, for which sufficient funds have been deposited in the Company&rsquo;s employees&rsquo; personal Severance Funds as well as
accrued in the financial statements. The aggregate amounts of all accrued vacation days for all employees of the Company are not
material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Restrictions
on Business Activities</U></B>. Except as disclosed in <U>Schedule&nbsp;2.13</U> hereto and except as set forth in the Company
Charter Documents, there is no agreement, commitment, judgment, injunction, order or decree binding upon the Company or its assets
or to which the Company is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing
any business practice of the Company, any acquisition of property by the Company or the conduct of business by the Company as currently
conducted other than such effects, individually or in the aggregate, which have not had and would not reasonably be expected to
have a Material Adverse Effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Title
to Property</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
real property owned by the Company (including improvements and fixtures thereon, easements and rights of way) is shown or reflected
on the balance sheet of the Company included in the Audited Financial Statements and is listed on <U>Schedule 2.14(a)</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has good, valid and marketable title to the real property owned thereby, and except as set forth in the Audited Financial
Statements or on <U>Schedule&nbsp;2.14(b)</U> hereto, all of such real property is held free and clear of all Liens other than
Permitted Liens and such liens or other imperfections of title, if any, as do not materially detract from the value of or materially
interfere with the present use of the property affected thereby. <U>Schedule&nbsp;2.14(b)</U> hereto also contains a list of all
options or other contracts under which the Company has a right to acquire or the obligation to sell any interest in real property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as otherwise disclosed on <U>Schedule&nbsp;2.14(c)</U>, all leases of real property held by the Company, and all material personal
property and other property and assets of the Company owned, used or held for use in connection with the business of the Company
(the &ldquo;<U>Personal Property</U>&rdquo;) are shown or reflected on the balance sheet included in the Audited Financial Statements,
to the extent required by U.S. GAAP, as of the dates of such Audited Financial Statements, other than those entered into or acquired
on or after the date of the Audited Financial Statements in the ordinary course of business. <U>Schedule&nbsp;2.14(c)</U> hereto
contains a list of all leases of real property and Personal Property held by the Company where the annual lease payments are greater
than $100,000 (other than leases of vehicles, office equipment, or operating equipment made in the ordinary course of business).
The Company has good and marketable title to such Personal Property owned thereby, and all such Personal Property is in each case
held free and clear of all Liens, except for Permitted Liens and Liens disclosed in the Audited Financial Statements or in <U>Schedule&nbsp;2.14(c)</U>
hereto, none of which Liens is reasonably expected to have, individually or in the aggregate, a Material Adverse Effect on such
property or on the present or contemplated use of such property in the businesses of the Company. All assets used in the business
and set forth in financial statements are owned by the Company and will continue to be owned by the Company following the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
leases pursuant to which the Company lease from others material real property or Personal Property are valid and effective in accordance
with their respective terms, and there is not, under any of such leases, any existing material default or event of default of the
Company or, to the Company&rsquo;s knowledge, any other party (or any event which with notice or lapse of time, or both, would
constitute a material default), except where the lack of such validity and effectiveness or the existence of such default or event
of default would not reasonably be expected to have a Material Adverse Effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Taxes</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Tax
Definitions</U>. As used in this Agreement, (i) the term &ldquo;<U>Tax</U>&rdquo; (including, with correlative meaning, the terms
&ldquo;<U>Taxes</U>&rdquo; and &ldquo;<U>Taxable</U>&rdquo;) includes all federal, state, local and foreign income, profits, franchise,
gross receipts, environmental, customs duty, capital stock, severance, stamp, payroll, sales, employment, occupation, ad valorem,
transfer, recapture, unemployment, disability, use, property, withholding, excise, production, value added, occupancy and other
taxes, duties or assessments of any nature whatsoever, together will all interest, penalties and additions, and (ii) the term &ldquo;<U>Tax
Return</U>&rdquo; includes all returns and reports (including elections, declarations, disclosures, schedules, estimates and information
returns) required to be supplied to a Tax authority relating to Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Tax
Returns and Audits</U></B>. Except as set forth in <U>Schedule&nbsp;2.15</U> hereto:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has timely filed all Tax Returns required to be filed by the Company with any Tax authority prior to the date hereof, except
such Tax Returns that are not material to the Company. All such Tax Returns are true, correct and complete in all material respects.<FONT STYLE="color: red"><B>
</B></FONT> The Company has paid all Taxes shown to be due and payable on such Tax Returns. No taxes are currently owed and payable
by the Company that have not been paid. All Taxes to become due for all periods through the date of this Agreement have been, and
all Taxes to become due for all periods through the Closing Date will be, adequately reserved for by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
Taxes that the Company is required by law to withhold or collect have been duly withheld or collected, and have been timely paid
over to the proper governmental authorities to the extent due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has not been delinquent in the payment of any material Tax nor is there any material Tax deficiency outstanding, proposed
or assessed against the Company, nor have the Company executed any unexpired waiver of any statute of limitations on or extending
the period for the assessment or collection of any Tax. The Company has complied with all Legal Requirements with respect to payments
made to third parties and the withholding of any payment of withheld Taxes and has timely withheld from employee wages and other
payments and timely paid over in full to the proper taxing authorities all amounts required to be so withheld and paid over for
all periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
the knowledge of the Company, no audit or other examination of any Tax Return of the Company by any Tax authority is presently
in progress, nor has the Company been notified of any written request for such an audit or other examination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
the knowledge of the Company, no claim has been made by any Tax authority in a jurisdiction in which the Company does not file
Tax Returns that the Company is subject to Tax in that jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
adjustment relating to any Tax Returns filed by the Company has been proposed in writing, formally or informally, by any Tax authority
to the Company or any representative thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has no liability for any material unpaid Taxes which have not been accrued for or reserved on the Company&rsquo;s balance
sheets included in the Audited Financial Statements or Unaudited Financial Statements, whether asserted or unasserted, contingent
or otherwise, other than any liability for unpaid Taxes that may have accrued since the end of the most recent fiscal year in connection
with the operation of the business of the Company in the ordinary course of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>With
respect to periods prior to Closing, none of the Stockholders is a foreign person subject to withholding under Section&nbsp;1445
of the Code and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Environmental
Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as disclosed in <U>Schedule&nbsp;2.16</U> hereto and except for such matters that, individually or in the aggregate, are not reasonably
likely to have a Material Adverse Effect and except for matters which have been resolved with no remaining obligations: (i) the
Company has complied with all applicable Environmental Laws (as defined below); (ii) to the knowledge of the Company, the properties
currently operated or being constructed by the Company (including soils, groundwater, surface water, air, buildings or other structures)
are not contaminated with any Hazardous Substances (as defined below) as a result of the actions or omissions of the Company; (iii)
to the knowledge of the Company, the Company is not subject to liability for any Hazardous Substance disposal or contamination
on any third party or public property (whether above, on or below ground or in the atmosphere or water); (iv) the Company has not
received any written notice, demand, letter, claim or request for information from any Governmental Entity alleging that the Company
is in violation of or liable under any Environmental Law; and (vi) the Company is not subject to any orders, decrees, injunctions
or other arrangements with any Governmental Entity or subject to any outstanding indemnity claim from any third party relating
to liability under any Environmental Law or relating to Hazardous Substances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
used in this Agreement, the term &ldquo;<U>Environmental Law</U>&rdquo; means any international, United States or non-United States
federal, state, local or common-law Laws relating to: (i)&nbsp;releases, discharges, emissions or disposals to air, water, land
or groundwater of Hazardous Substances; (ii)&nbsp;the manufacture, handling, transport, use, treatment, storage or disposal of
or exposure to Hazardous Substances; or (iii)&nbsp;pollution or protection of the environment, health, safety or natural resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
used in this Agreement, the term &ldquo;<U>Hazardous Substance</U>&rdquo; means any substance, material or waste, regardless of
physical form or concentration that is (a)&nbsp;hazardous, toxic, infectious, explosive, radioactive, carcinogenic, ignitable,
corrosive, reactive or otherwise harmful to living things, the environment or natural resources, or (b)&nbsp;is identified, defined,
designated, listed, restricted or otherwise regulated under any Environmental Laws or with respect to which liability or standards
of conduct are imposed under any Environmental Laws, including petroleum or petroleum constituents, asbestos-containing material
or polychlorinated biphenyls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Brokers;
Third Party Expenses</U></B>. Except as set forth in <U>Schedule&nbsp;2.17</U> hereto, the Company has not incurred, nor will it
incur, directly or indirectly, any liability for brokerage fees, investment banking fees, finders&rsquo; fees, agent&rsquo;s commissions
or any similar charges in connection with this Agreement or any transactions contemplated hereby. Except as disclosed in <U>Schedule&nbsp;2.17</U>
hereto, no shares of common stock, options, warrants or other securities of the Company are payable to any third party by the Company
as a result of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Intellectual
Property</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>For
the purposes of this Agreement, the following terms have the following definitions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Intellectual
Property</U>&rdquo; shall mean any or all of the following and all worldwide common law and statutory rights in, arising out of,
or associated therewith: (i) patents and applications therefor and all reissues, divisions, renewals, extensions, provisionals,
continuations and continuations-in-part thereof (&ldquo;<U>Patents</U>&rdquo;); (ii) inventions (whether patentable or not), invention
disclosures, improvements, trade secrets, proprietary information, know how, technology, technical data and customer lists, and
all documentation relating to any of the foregoing; (iii) copyrights, copyrights registrations and applications therefor, and all
other rights corresponding thereto throughout the world (&ldquo;<U>Copyrights</U>&rdquo;); (iv) software and software programs;
(v) domain names, uniform resource locators and other names and locators associated with the Internet (vi) industrial designs and
any registrations and applications therefor; (vii) trade names, logos, common law trademarks and service marks, trademark and service
mark registrations and applications therefor (collectively, &ldquo;<U>Trademarks</U>&rdquo;); (viii) all databases and data collections
and all rights therein; (ix) all moral and economic rights of authors and inventors, however denominated, and (x) any similar or
equivalent rights to any of the foregoing (as applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Company
Intellectual Property</U>&rdquo; shall mean any material Intellectual Property that is owned by, or exclusively licensed to, the
Company, including software and software programs developed by or exclusively licensed to the Company (specifically excluding any
off the shelf or shrink-wrap software).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Registered
Intellectual Property</U>&rdquo; means all Intellectual Property that is the subject of an application, certificate, filing, registration
or other document issued, filed with, or recorded by any government or other legal authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Company
Registered Intellectual Property</U>&rdquo; means all of the Registered Intellectual Property owned by, or filed in the name of,
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>&ldquo;<U>Company
Products</U>&rdquo; means all current versions of products or service offerings of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company owns or has enforceable rights to use each material item of Intellectual Property required for the conduct of its business
as presently conducted or as presently contemplated to be conducted. Except as disclosed in <U>Schedule&nbsp;2.18(b)</U> hereto,
no Company Intellectual Property or Company Product is subject to any material proceeding or outstanding decree, order, judgment,
contract, license, agreement or stipulation restricting in any manner the use, transfer or licensing thereof by the Company, or
which may affect the validity, use or enforceability of such Company Intellectual Property or Company Product, which in any such
case could reasonably be expected to have a Material Adverse Effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as disclosed in <U>Schedule&nbsp;2.18(c)</U> hereto, the Company owns and has good and exclusive title to each material item of
Company Intellectual Property owned by it free and clear of any Liens (excluding non-exclusive licenses and related restrictions
granted by it in the ordinary course of business); and the Company is the exclusive owner of all material registered Trademarks
and Copyrights used in connection with the current operation or conduct of the business of the Company, including the sale of any
products or the provision of any services by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as disclosed in <U>Schedule&nbsp;2.18(d)</U> hereto, to the knowledge of the Company, the operation of the business of the Company
as such business currently is conducted, including the Company&rsquo;s use of any product, device or process, does not infringe
or misappropriate the Intellectual Property of any third party, and the Company has not received any written notice from third
parties alleging any such infringement or misappropriation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
government funding or facilities of a university, college, other educational institution or research center was used in the development
of the Company Intellectual Property owned by the Company. To the knowledge of the Company, no current or former employee, consultant
or independent contractor of the Company, who was involved in, or who contributed to, the creation or development of any Company
Intellectual Property, has performed services for any government, university, college or other educational institution, research
center, security forces or other public services during a period of time during which such employee, consultant or independent
contractor was also performing services for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Stockholders and each of the Company&rsquo;s current employees have entered into written agreements with the Company assigning
to the Company all rights in the Company Intellectual Property, and in all other rights in and to all other product, technology,
know how, or other proprietary information developed in the course of their employment by, or performance of services for, the
Company, the failure of which would not reasonably be expected to have a Material Adverse Effect on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Agreements,
Contracts and Commitments</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><U>Schedule&nbsp;2.19(a)</U>
hereto sets forth a complete and accurate list of all Material Company Contracts (as hereinafter defined), specifying the parties
thereto. For purposes of this Agreement, (i) the term &ldquo;<U>Company Contracts</U>&rdquo; shall mean all contracts, agreements,
leases, mortgages, indentures, notes, bonds, licenses, permits, franchises, purchase orders, sales orders, and other understandings,
commitments and obligations of any kind, whether written or oral, to which the Company is a party or by or to which any of the
properties or assets of the Company may be bound, subject or affected (including notes or other instruments payable to the Company)
and (ii) the term &ldquo;<U>Material Company Contracts</U>&rdquo; shall mean (x) each Company Contract (A) that would be required
to be included as an exhibit to a registration statement with the Securities and Exchange Commission (&ldquo;<U>SEC</U>&rdquo;)
if the Company had a class of equity securities registered under Section 12(b) or 12(g) of the Exchange Act, (B) providing for
payments (present or future) to the Company in excess of $1,000,000 in the aggregate or (C) under or in respect of which the Company
presently have any liability or obligation of any nature whatsoever (absolute, contingent or otherwise) in excess of $1,000,000
in the aggregate, (y) each Company Contract that otherwise is material to the businesses, operations, assets, condition (financial
or otherwise) or prospects of the Company, and (z) the limitations of subclause (x) and subclause (y) notwithstanding, each of
the following Company Contracts:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
mortgage, indenture, note, installment obligation or other instrument, agreement or arrangement for or relating to any borrowing
of money by or from the Company and by or to any officer, director, stockholder or holder of derivative securities of the Company
(&ldquo;<U>Insider</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
mortgage, indenture, note, installment obligation or other instrument, agreement or arrangement for or relating to any borrowing
of money from an Insider by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
guaranty, direct or indirect, by the Company or any Insider of the Company of any obligation for borrowings, or otherwise, excluding
endorsements made for collection in the ordinary course of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
Company Contract of employment of an executive officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
Company Contract, made other than in the ordinary course of business, (x) providing for the grant of any preferential rights to
purchase or lease any material asset of the Company or (y) providing for any right (exclusive or non-exclusive) to sell or distribute,
or otherwise relating to the sale or distribution of, any product or service of the Company involving payments (present or future)
to the Company in excess of $250,000 over the remaining term of such Company Contract;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vi)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
contractual obligation to register any shares of the capital stock or other securities of the Company with any Governmental Entity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(vii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
contractual obligation to make payments, contingent or otherwise, arising out of the prior acquisition of the business, assets
or stock of other Persons by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(viii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
collective bargaining agreement with any labor union;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ix)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
lease or similar arrangement for the use by the Company of real property or Personal Property where the annual lease payments are
greater than $100,000 (other than any lease of vehicles, office equipment or operating equipment made in the ordinary course of
business); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>any
Company Contract to which any Insider of the Company, or, to the knowledge of the Company, any entity owned or controlled by an
Insider, is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on the Company: (i) each
Material Company Contract is in full force and effect and, to the Company&rsquo;s knowledge, is valid and binding upon and enforceable
against each of the parties thereto, except insofar as enforceability may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting creditors&rsquo; rights generally or by principles governing the availability of equitable
remedies, and (ii) neither the Company nor, to the Company&rsquo;s knowledge, any other party thereto is in breach of or in default
under, any Material Company Contract, and no party to any Material Company Contract has given any written notice of any claim of
any such breach, default or event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Subject
to any confidentiality obligations or restrictions, true, correct and complete copies of all Material Company Contracts and all
offers and proposals that, if accepted, would constitute Material Company Contracts (or written summaries in the case of oral Material
Company Contracts) have been made available to Cambridge or Cambridge&rsquo;s counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
purchase orders (including any comprising or made part of any Material Company Contract) for the purchase and sale of the Company&rsquo;s
products, goods and services were entered into on arms-length basis in good faith and the Company has performed under such contracts
and orders in all material respects on a timely basis as required under the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Insurance</U></B>.
<U>Schedule&nbsp;2.20</U> sets forth a summary of the Company&rsquo;s insurance policies and fidelity and surety bonds covering
the assets, business, equipment, properties, operations, employees, officers and directors (collectively, the &ldquo;<U>Insurance
Policies</U>&rdquo;). The insurances provided by the Insurance Policies are adequate in amount and scope in all material respects
for the operation of the Company&rsquo;s business and operations, including any insurance required to be maintained by Company
Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Governmental
Actions/Filings</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company is in possession of all Governmental Actions/Filings (as defined below) necessary to the conduct by the Company of its
business (as presently conducted) except where the failure to have would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect upon the Company. Each such Governmental Action/Filing is in full force and effect and
the Company is in material compliance with all of their obligations with respect thereto. To the knowledge of the Company, no event
has occurred and is continuing which requires or permits, or after notice or lapse of time or both would require or permit, and
consummation of the transactions contemplated by this Agreement or any ancillary documents will not require or permit (with or
without notice or lapse of time, or both), any modification or termination of any such Governmental Actions/Filings except such
events which, either individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect upon
the Company. No Governmental Action/Filing is necessary to be obtained, secured or made by the Company to enable any of them to
continue to conduct its business and operations and use its properties after the Closing in a manner that is consistent with current
practice except for any of such that, if not obtained, secured or made, would not, either individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect upon the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in <U>Schedule&nbsp;2.21(b)</U>, no contractors&rsquo; licenses are necessary to be obtained, secured or made by the
Company to enable any of them to continue to conduct its businesses and operations and use its properties after the Closing in
a manner which is consistent with current practice, except where failure to obtain, secure or make such licenses would not, either
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect upon the Company. All of the contractors&rsquo;
licenses listed on <U>Schedule 2.21(b)</U> have been obtained, secured or made and are in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>For
purposes of this Agreement, the term &ldquo;<U>Governmental Action/Filing</U>&rdquo; shall mean any franchise, license, certificate
of compliance, authorization, order, permit, approval or other action of, or any filing, registration or qualification with, any
federal, state, municipal, foreign or other governmental, administrative or judicial body, agency or authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Violation of Anti-Corruption or Anti-Bribery Laws</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
the Company has, nor, to the knowledge of the Company, has any director, officer, agent, employee, Affiliate or other person acting
on behalf of the Company, (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense;
(ii) made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds;
or (iii) made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
operations of the Company have been conducted at all times in material compliance with all applicable financial recordkeeping and
reporting requirements, the money laundering statutes of Israel and the Organization for Economic Cooperation and Development (collectively,
the &ldquo;<U>Money Laundering Laws</U>&rdquo;) and no action, suit or proceeding by or before any court or Governmental Entity
involving the Company with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
the Company&rsquo;s knowledge, no employee of the Company has provided or is providing information to any law enforcement agency
regarding the commission or possible commission of any crime or the violation or possible violation of any Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company has complied with, and to the Company&rsquo;s knowledge, its officers, directors and employees have complied with, Israel&rsquo;s
criminal laws regarding the prohibition against bribery of foreign government officials, specifically Section 291A of the Israeli
Penal Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Interested
Party Transactions</U></B>. Except as set forth in the <U>Schedule&nbsp;2.23</U> hereto, no employee, officer, director or stockholder
of the Company or a member of his or her immediate family is indebted for borrowed money to the Company, nor is the Company indebted
for borrowed money (or committed to make loans or extend or guarantee credit) to any of such Persons, other than (i) for payment
of salary for services rendered, (ii) reimbursement for reasonable expenses incurred on behalf of the Company, and (iii) for other
employee benefits made generally available to employees in the ordinary course of business. Except as set forth in <U>Schedule&nbsp;2.23</U>,
to the Company&rsquo;s knowledge, none of such individuals has any direct or indirect ownership interest in any Person with whom
the Company is affiliated or with whom the Company has a contractual relationship, or in any Person that competes with the Company,
except that each employee, stockholder, officer or director of the Company and members of their respective immediate families may
own less than 5% of the outstanding stock in publicly traded companies that may compete with the Company. Except as set forth in
<U>Schedule&nbsp;2.23</U>, to the knowledge of the Company, no officer, director or shareholder or any member of their immediate
families has an economic interest in any Material Company Contract with the Company (other than such contracts as relate to any
such Person&rsquo;s ownership of capital stock or other securities of the Company or such Person&rsquo;s employment with the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Board
Approval</U></B>. The board of directors of the Company (including any required committee or subgroup thereof) has, as of the date
of this Agreement, duly approved this Agreement and the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Stockholder
Approval</U></B>. The action by Written Consent of the Stockholders of the Company to approve and adopt this Agreement and the
transactions contemplated (which Written Consent has been obtained as of the date hereof and is in full force and effect) is the
only consent or approval by, or vote of, the holders of any class or series of share capital of the Company necessary for the Company
to adopt this Agreement and the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Sufficient
Funds</U></B>. After giving effect to the Company Dividend, as of the date of this Agreement, the Company has, and immediately
prior to the Closing Date, the Company will have sufficient funds to operate its business in the ordinary course of business consistent
with past practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Relationships</U></B>.
<U>Schedule 2.27(a)</U> hereto sets forth a list of all exclusive supply relationships between the Company, on the one hand, and
suppliers, on the other hand. <U>Schedule 2.27(b)</U> hereto sets forth a list of all exclusive sales agency relationships between
the Company, on the one hand, and agents, on the other hand. Each such relationship is exclusive for the purposes indicated in
the agreements governing such relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Reserved</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Ministry
of Defense Designation</U></B>. The Company is not declared, nor does it meet the conditions for being declared by the Israeli
Ministry of Defense as a &quot;Security Corporation&quot; under the Israeli Security Corporations Act (Protection of Security Interests)
&ndash; 2006, and the Israeli Defense Export Control Law &ndash; 2007 does not apply to the Company's business as currently conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Grants</U></B>.
Except as set forth on <U>Schedule 2.30</U>, within three (3) years of the date hereof, the Company has not received any grants
and/or payments from the government of the State of Israel or any agency thereof, or from any foreign governmental or administrative
agency, including, without limitation, grants from the Israeli Office of the Chief Scientist.(&quot;<U>OCS</U>&quot;). <U>Schedule
2.30</U> provides a complete list of all pending and/or outstanding grants, incentives and subsidies, and applications therefore
(collectively, &ldquo;<U>Grants</U>&rdquo;) from the government of the State of Israel or any agency thereof, or from any foreign
governmental or administrative agency, granted to the Company, including, without limitation, (i) Approved Enterprise Status from
the Investment Center and (ii) grants from the OCS. <U>Schedule 2.30</U> also provides true and accurate the aggregate amounts
of each Grant, and the aggregate outstanding obligations thereunder of the Company (if any) with respect to royalties, or the outstanding
amounts to be paid by the OCS to the Company (if any). The Company is in compliance, in all material respects, with the terms and
conditions of their respective Grants and has duly fulfilled, in all material respects, all the undertakings relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Joint
Venture</U></B>. The Company has entered into a Joint Venture Agreement, entered into on October 10, 2013 (&ldquo;<U>Joint Venture
Agreement</U>&rdquo;), with Ability Security Systems Ltd. (&ldquo;<U>Joint Venture Partner</U>&rdquo;). To the knowledge of the
Company and the Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Since
its inception, the Joint Venture Partner has been operated in compliance with and is not and has not been in violation of any Legal
Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Joint Venture Partner is an Israeli company, duly formed and in good standing under the laws of its jurisdiction of formation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Joint Venture Agreement is in full force and effect and no party thereto is in breach of same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Joint Venture Partner each has all material Approvals to carry on its respective business and as necessary for its operation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
the Joint Venture Partner nor any of its Affiliates is or has been a subject of any proceeding or investigation by any Governmental
Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>There
are no claims, suits, actions or proceedings pending or threatened against the Joint Venture Partner before any court, governmental
department, commission, agency, instrumentality or authority or any arbitrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Joint Venture Partner has no liabilities that are not disclosed and included in the Financial Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Joint Venture Partner has no employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Other
than the consent required by the Israeli Ministry of Defense, there are no contracts, agreements or Legal Requirements that would
prevent the exercise by Surviving Pubco of the Joint Venture Acquisition Option as contemplated by Section 5.28 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 67.5pt">Except for payments required
under the Joint Venture Agreement and as set forth on <U>Schedule 2.17</U>, neither the Company nor any Affiliate thereof has any
indebtedness to the Joint Venture Partner or any Affiliate thereof. Neither the Joint Venture Partner nor any Affiliate thereof
has any indebtedness to the Company or any Affiliate thereof. The Joint Venture Partner neither owns nor has been licensed any
Intellectual Property necessary for the operation of the business of the Company. The Joint Venture Partner has no claims of ownership
with respect to any assets of the Company or any Company Products or Company Intellectual Property (regardless of the stage of
development of such Company Intellectual Property or Company Products). The Company is not a guarantor of any obligation of the
Joint Venture Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 67.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Survival
of Representations and Warranties</U></B>. The representations and warranties of the Company and the Stockholders set forth in
this Agreement shall survive the Closing as set forth in Section&nbsp;7.4(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
III.</B></FONT><BR>
<B>REPRESENTATIONS AND WARRANTIES OF CAMBRIDGE AND HOLDCO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Subject to the exceptions
set forth in <U>Schedule&nbsp;3</U> attached hereto (the &ldquo;<U>Cambridge Schedule</U>&rdquo;), Cambridge and Holdco represent
and warrant to the Company and Stockholders as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Organization
and Qualification</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
is a corporation duly incorporated, validly existing and in good standing under the laws of the State of Delaware and has the requisite
corporate power and authority to own, lease and operate its assets and properties and to carry on its business as it is now being
conducted. Cambridge is in possession of all Approvals necessary to own, lease and operate the properties it purports to own, operate
or lease and to carry on its business as it is now being conducted, except where the failure to have such Approvals would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Cambridge. Complete and correct copies
of the Charter Documents of Cambridge, as amended and currently in effect, have been heretofore delivered to the Company. Cambridge
is not in violation of any of the provisions of Cambridge&rsquo;s Charter Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
is duly qualified or licensed to do business as a foreign corporation and is in good standing in each jurisdiction where the character
of the properties owned, leased or operated by it or the nature of its activities makes such qualification or licensing necessary,
except where the failure to be so duly qualified or licensed and in good standing would not reasonably be expected to have a Material
Adverse Effect on Cambridge. Each jurisdiction in which Cambridge is so qualified or licensed is listed in <U>Schedule&nbsp;3.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Subsidiaries
and Other Interests</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
Cambridge has no Subsidiaries except for Holdco. Cambridge owns all of the outstanding shares of Holdco, free and clear of all
Liens. Except for Holdco, Cambridge does not own, directly or indirectly, any ownership, equity, profits or voting interest in
any Person or have any agreement or commitment to purchase any such interest, and Cambridge has not agreed and is not obligated
to make nor is bound by any written, oral or other agreement, contract, subcontract, lease, binding understanding, instrument,
note, option, warranty, purchase order, license, sublicense, insurance policy, benefit plan, commitment or undertaking of any nature,
as of the date hereof or as may hereafter be in effect under which it may become obligated to make, any future investment in or
capital contribution to any other entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
for Holdco, Cambridge does not own directly or indirectly any interest or investment (whether equity or debt) in any corporation,
partnership, joint venture, business, trust or other entity (other than investments in short term investment securities).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
Following the Redomestication Merger, Surviving Pubco will be an exempted company duly incorporated, validly existing and in good
standing under the laws of the Cayman Islands and will have the requisite corporate power and authority to own, lease and operate
its assets and properties and to carry on its business as it is now being conducted as Cambridge. Surviving Pubco will be in possession
of all Approvals necessary to own, lease and operate the properties it purports to own, operate or lease and to carry on its business
as it is now being conducted, except where the failure to have such Approvals would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect on Surviving Pubco. Complete and correct copies of the Charter Documents of Surviving
Pubco, as amended and currently in effect, have been heretofore delivered to the Company or its counsel. Surviving Pubco is not
in violation of any of the provisions of its Charter Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Surviving
Pubco will be duly qualified or licensed to do business as a foreign corporation and will be in good standing in each jurisdiction
where the character of the properties owned, leased or operated by it or the nature of its activities makes such qualification
or licensing necessary, except for such failures to be so duly qualified or licensed and in good standing that would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect on Surviving Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
Surviving Pubco has no assets or properties of any kind, does not now conduct and has never conducted any business, and has and
will have at the Closing no obligations or liabilities of any nature whatsoever, except for such obligations as are imposed under
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Capitalization</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
of the date of this Agreement, the authorized capital stock of Cambridge consists of 40,000,000 shares of Cambridge Common Stock
and 1,000,000 shares of preferred stock, par value $0.0001 per share (&ldquo;<U>Cambridge Preferred Stock</U>&rdquo;), of which
10,534,625 shares of Cambridge Common Stock and no shares of Cambridge Preferred Stock are issued and outstanding. Except as set
forth in <U>Schedule 3.3(a)</U>, all of such securities are validly issued, fully paid and nonassessable and free of preemptive
rights or rights of first refusal created by statute, the Charter Documents of Cambridge or any agreement to which Cambridge is
a party or by which it is bound, and free of any Liens other than any Liens created by or imposed upon the holders thereof or under
applicable federal or state securities or &ldquo;blue sky&rdquo; laws. Except as set forth in <U>Schedule 3.3(a)</U>, Cambridge
has no outstanding bonds, debentures, notes or other obligations the holders of which have or upon the happening of certain events
would have the right to vote (or which are convertible into or exercisable or exchangeable for securities having the right to vote)
with the stockholders of Cambridge on any matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
for the Cambridge Warrants and Cambridge UPOs or as set forth in <U>Schedule&nbsp;3.3(b)</U>, there are no (i) existing options,
warrants, calls, subscriptions, convertible securities, or other rights, agreements, stock appreciation rights or similar derivative
securities or instruments or commitments which obligate Cambridge to issue, transfer or sell any Cambridge Capital Stock or make
any payments in lieu thereof, (ii) agreements or understandings to which Cambridge is a party with respect to the voting of any
Cambridge Capital Stock or which restrict the transfer of any such shares, nor does Cambridge have knowledge of any such agreements
or understandings with respect to the voting of any such shares or which restrict the transfer of any such shares, (iii) outstanding
contractual obligations of Cambridge to repurchase, redeem or otherwise acquire any Cambridge Capital Stock or any other securities
of Cambridge, (iv) outstanding options to purchase Cambridge Common Stock or Cambridge Preferred Stock granted to employees of
Cambridge or other parties, (v) outstanding warrants to purchase Cambridge Common Stock or Cambridge Preferred Stock or (vi) outstanding
notes, debentures or securities convertible into Cambridge Common Stock or Cambridge Preferred Stock. All shares of Cambridge Common
Stock and Cambridge Preferred Stock subject to issuance as aforesaid, upon issuance on the terms and conditions specified in the
instrument pursuant to which they are issuable, will be duly authorized, validly issued, fully paid and nonassessable. All outstanding
shares of Cambridge Common Stock and all outstanding Cambridge Warrants have been issued and granted in compliance with (x) all
applicable securities laws and (in all material respects) other applicable laws and regulations, and (y) all requirements set forth
in any applicable Cambridge Contracts (as defined in Section&nbsp;3.19).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in <U>Schedule&nbsp;3.3(c)</U>, there are no registrations rights, and there is no voting trust, proxy, rights plan,
antitakeover plan or other similar agreements or understandings to which Cambridge is a party or by which Cambridge is bound with
respect to any security of any class of Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in <U>Schedule&nbsp;3.3(d)</U>, as a result of the consummation of the transactions contemplated hereby, no shares
of capital stock, warrants, options or other securities of Cambridge are issuable and no rights in connection with any shares,
warrants, options or other securities of Cambridge accelerate or otherwise become triggered (whether as to vesting, exercisability,
convertibility or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
The Surviving Pubco Shares to be issued by Surviving Pubco in connection with the Transactions, upon issuance in accordance with
the terms of this Agreement, will be duly authorized and validly issued and such Surviving Pubco Shares will be fully paid and
nonassessable. There are no outstanding options, warrants or other rights to purchase securities of Surviving Pubco (except as
provided in this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
The authorized share capital of Holdco is 50,000 shares, par value $1.00 per share, of which one (1) share is issued and outstanding.
Cambridge owns all of the issued and outstanding equity securities of Holdco, free and clear of all Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Authority
Relative to this Agreement</U></B>. Each of Cambridge and Holdco has full corporate power and authority to: (i) execute, deliver
and perform this Agreement, and each ancillary document that Cambridge or Holdco has executed or delivered or is to execute or
deliver pursuant to this Agreement, and (ii) carry out Cambridge&rsquo;s and Holdco&rsquo;s obligations hereunder and thereunder
and, to consummate the transactions contemplated hereby (including the Transactions). Other than the Cambridge Stockholder Approval
(as defined in Section&nbsp;5.1(a)), the execution and delivery of this Agreement by Cambridge and Holdco and the consummation
by Cambridge and Holdco of the transactions contemplated hereby (including the Transactions) have been duly and validly authorized
by all necessary corporate action on the part of Cambridge and Holdco (including the approval by the Board of Directors of each
of Cambridge and Holdco and the shareholders of Holdco with respect to the Redomestication Merger, as the case may be), and no
other corporate proceedings on the part of Cambridge or Holdco are necessary to authorize this Agreement or to consummate the transactions
contemplated hereby. This Agreement has been duly and validly executed and delivered by Cambridge and Holdco, assuming the due
authorization, execution and delivery thereof by the other parties hereto, constitutes the legal and binding obligation of Cambridge
and Holdco, enforceable against Cambridge and Holdco in accordance with its terms, except as may be limited by bankruptcy, insolvency,
reorganization or other similar laws affecting the enforcement of creditors&rsquo; rights generally and by general principles of
equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Conflict; Required Filings and Consents</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
execution and delivery of this Agreement by Cambridge and Holdco does not, and the performance of this Agreement by Cambridge and
Holdco shall not: (i) conflict with or violate Cambridge&rsquo;s or Holdco&rsquo;s Charter Documents, (ii) conflict with or violate
any Legal Requirements, (iii) result in any breach of or constitute a default (or an event that with notice or lapse of time or
both would become a default) under, or materially impair Cambridge&rsquo;s or Holdco&rsquo;s rights, or give to others any rights
of termination, acceleration or cancellation of, or result in the creation of a Lien on any of the properties or assets of Cambridge
or Holdco pursuant to, any Cambridge Contracts, (iv) result in the acceleration or increase of any payment to any Person pursuant
to any Cambridge Contract, except, with respect to clauses (ii), (iii) or (iv), for any such conflicts, violations, breaches, defaults,
impairments, rights of termination, acceleration or cancellation, Liens, payment accelerations or increases or other occurrences
that would not, individually and in the aggregate, have a Material Adverse Effect on Cambridge or Holdco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
execution and delivery of this Agreement by Cambridge and Holdco does not, and the performance of it hereunder will not, require
any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Entity or other third party
to any Cambridge Contract, except (i) for applicable requirements, if any, of the Securities Act, the Exchange Act, Blue Sky Laws,
and the rules and regulations thereunder, and appropriate documents with the relevant authorities of other jurisdictions in which
Cambridge or Holdco is qualified to do business and (ii) where the failure to obtain such consents, approvals, authorizations or
permits, or to make such filings or notifications, would not, individually or in the aggregate, reasonably be expected to have
a Material Adverse Effect on Cambridge or Holdco, or prevent consummation of the Merger or otherwise prevent the parties hereto
from performing their respective obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Compliance</U></B>.
Each of Cambridge and Holdco has complied with, and is not in violation of, any Legal Requirements with respect to the conduct
of its business, except for failures to comply or violations which, individually or in the aggregate, have not had or would not
reasonably be likely to have a Material Adverse Effect on Cambridge or Holdco. Neither Cambridge nor Holdco is in default or violation
of any term, condition or provision of any applicable Charter Documents. No written notice of non-compliance with any Legal Requirements
has been received by Cambridge or Holdco from any Governmental Entity which currently remains pending or unresolved. Cambridge
is not in default of any term of any Cambridge Contract, except for defaults which, individually or in the aggregate, have not
had or would not be reasonably likely to have a Material Adverse Effect on Cambridge or Holdco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>SEC
Filings; Financial Statements; Internal Controls</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
has made available to the Company and the Stockholders a correct and complete copy of each report, registration statement and definitive
proxy statement filed by Cambridge with the SEC (the &ldquo;<U>Cambridge SEC Reports</U>&rdquo;), which are all the forms, reports
and documents required to be filed by Cambridge with the SEC prior to the date of this Agreement. All Cambridge SEC Reports required
to be filed by Cambridge since its initial public offering were filed in a timely manner. As of their respective dates, the Cambridge
SEC Reports: (i) were prepared in accordance and complied in all material respects with the requirements of the Securities Act
or the Exchange Act, as the case may be, and the rules and regulations of the SEC thereunder applicable to such Cambridge SEC Reports,
and (ii) did not at the time they were filed (and if amended or superseded by a filing prior to the date of this Agreement then
on the date of such filing and as so amended or superseded) contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. As of the date hereof, there are no outstanding or unresolved comments in the comment
letters received from the staff of the SEC with respect to the Cambridge SEC Reports. Except to the extent set forth in this Section,
Cambridge makes no representation or warranty whatsoever concerning any Cambridge SEC Report as of any time other than the date
or period with respect to which it was filed. The certifications and statements required by (A) Rule 13a-14 under the Exchange
Act and (B) 18 U.S.C. &sect;1350 (Section 906 of the Sarbanes-Oxley Act) relating to the Cambridge SEC Reports are accurate and
complete and comply as to form and content with all applicable laws or rules of applicable governmental and regulatory authorities
in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in <U>Schedule&nbsp;3.7(b)</U>, each set of financial statements (including, in each case, any related notes thereto)
contained in Cambridge SEC Reports, including each Cambridge SEC Report filed after the date hereof until the Closing, complied
or will comply as to form in all material respects with the published rules and regulations of the SEC with respect thereto, was
or will be prepared in accordance with U.S. GAAP applied on a consistent basis throughout the periods involved (except as may be
indicated in the notes thereto or, in the case of unaudited statements, do not contain footnotes as permitted by Form 10-Q of the
Exchange Act) and each fairly presents or will fairly present in all material respects the financial position of Cambridge at the
respective dates thereof and the results of its operations and cash flows for the periods indicated, except that the unaudited
interim financial statements were, are or will be subject to normal adjustments which were not or are not expected to have a Material
Adverse Effect on Cambridge or Holdco. Except to the extent set forth in the Cambridge SEC Reports, no report of auditors in such
Cambridge SEC Reports has been withdrawn or modified. The books and records of Cambridge are complete and correct in all material
respects and have been, and are being, maintained in accordance with applicable material legal and accounting requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
financial records, systems, controls, data and information of Cambridge are recorded, stored, maintained and operated under means
that are under the exclusive ownership and direct control of Cambridge or accountants. Cambridge has devised and maintains a system
of internal accounting controls sufficient to provide reasonable assurances regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with U.S. GAAP (&ldquo;<U>Internal Controls</U>&rdquo;).
The Internal Controls for Cambridge satisfy the requirements of Rule 13a-15 under the Exchange Act, and such disclosure controls
and procedures are designed to ensure that all material information concerning Cambridge is made known on a timely basis to the
individuals responsible for the preparation of Cambridge&rsquo;s filings with the SEC and other public disclosure documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
the knowledge of Cambridge, Cambridge&rsquo;s auditor has at all required times since the date of enactment of the Sarbanes-Oxley
Act been: (i) a registered public accounting firm (as defined in Section 2(a)(12) of the Sarbanes-Oxley Act); (ii) &ldquo;independent&rdquo;
with respect to Cambridge within the meaning of Regulation S-X under the Exchange Act; and (iii) in compliance with subsections
(g) through (l) of Section 10A of the Exchange Act and the rules and regulations promulgated by the SEC and the Public Company
Accounting Oversight Board thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Undisclosed Liabilities</U></B>. Neither Cambridge nor Holdco has any liabilities (absolute, accrued, contingent or otherwise)
of a nature required to be disclosed on a balance sheet or in the related notes to the financial statements included in Cambridge
SEC Reports that are, individually or in the aggregate, material to the business, results of operations or financial condition
of Cambridge, except (i) liabilities provided for in or otherwise disclosed in Cambridge SEC Reports filed prior to the date hereof,
(ii) liabilities incurred since June 30, 2015 in the ordinary course of business, and (iii) incurred in connection with the transactions
contemplated by this Agreement, including those incurred by actions permitted by Section 4.1 herein, none of which would, individually
or on the aggregate, reasonably be expected to have a Material Adverse Effect on Cambridge or Holdco. Neither Cambridge nor Holdco
is or has been a party to any securitization transactions or &ldquo;off-balance sheet arrangements&rdquo; (as defined in Item 303(c)
of Regulation S-K under the Exchange Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Absence
of Certain Changes or Events</U></B>. Except as set forth in Cambridge SEC Reports filed prior to the date of this Agreement, and
except as contemplated by this Agreement, between June 30, 2015 and the date hereof, (i) Cambridge has conducted their business
only in the ordinary course and in a manner consistent with past practice, (ii) there has not been any Material Adverse Effect
on Cambridge or Holdco, and (ii) neither Cambridge nor Holdco has taken any action that, if taken after the date of this Agreement,
would constitute a breach of any of the covenants set forth in Section 4.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Litigation</U></B>.
Except as set forth on <U>Schedule 3.10</U> hereto, there are no claims, suits, actions or proceedings pending or to Cambridge&rsquo;s
knowledge, threatened against Cambridge or Holdco, before any court, governmental department, commission, agency, instrumentality
or authority, or any arbitrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Employee
Benefit Plans</U></B>. Cambridge does not maintain, and has no liability under, any Plan, and neither the execution and delivery
of this Agreement nor the consummation of the transactions contemplated hereby will (i) result in any payment (including severance,
unemployment compensation, golden parachute, bonus or otherwise) becoming due to any stockholder, director or employee of Cambridge,
or (ii) result in the acceleration of the time of payment or vesting of any such benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Labor
Matters</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
Cambridge nor Holdco is a party to any collective bargaining agreement or other labor union contract applicable to persons employed
by Cambridge or Holdco and neither Cambridge nor Holdco knows of any activities or proceedings of any labor union to organize any
such employees. There are no pending grievance or similar proceedings involving Cambridge, on the one hand, and any of its employees,
on the other hand, subject to a collective bargaining agreement or other labor union contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
is in compliance in all material respects with all Legal Requirements applicable to its employees respecting employment, employment
practices, terms and conditions of employment and wages and hours and is not liable for any arrears of wages or penalties with
respect thereto. Except as set forth in <U>Schedule 3.12(b)</U>, there are no pending, or to the Cambridge&rsquo;s knowledge, threatened
claims or actions against Cambridge or Holdco by any employee in connection with such employee&rsquo;s employment or termination
of employment by the Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Business
Activities</U></B>. Since its respective organization, neither Cambridge nor Holdco has conducted any business activities other
than activities directed toward the accomplishment of a business combination. Except as set forth in the Cambridge Charter Documents,
there is no agreement, commitment, judgment, injunction, order or decree binding upon Cambridge or Holdco or their assets or to
which Cambridge or Holdco is a party which has or would not reasonably be expected to have the effect of prohibiting or materially
impairing any business practice of Cambridge or Holdco, any acquisition of property by Cambridge or Holdco or the conduct of business
by Cambridge or Holdco as currently conducted other than such effects, individually or in the aggregate, which have not had and
would not reasonably be expected to have, a Material Adverse Effect on Cambridge or Holdco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Title
to Property</U></B>. Neither Cambridge nor Holdco owns or leases any real property or personal property. Except as set forth in
<U>Schedule&nbsp;3.14</U>, there are no options or other contracts under which Cambridge or Holdco has a right or obligation to
acquire or lease any interest in real property or personal property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Taxes</U></B>.
Except as set forth in <U>Schedule&nbsp;3.15</U> hereto:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
taxes are currently owed by Cambridge or Holdco and all Taxes to become due for all periods through the date of this Agreement
have been, and to become due for all periods through the Closing Date will be, adequately reserved for by Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Each
of Cambridge and Holdco has timely filed all Tax Returns required to be filed by Cambridge and Holdco with any Tax authority prior
to the date hereof. All such Tax Returns are true, correct and complete in all material respects.<FONT STYLE="color: red"><B> </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>All
Taxes that Cambridge or Holdco are required by law to withhold or collect have been duly withheld or collected, and have been timely
paid over to the proper governmental authorities to the extent due and payable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
Cambridge nor Holdco has been delinquent in the payment of any material Tax that has not been accrued for in Cambridge&rsquo;s
or Holdco&rsquo;s books and records of account for the period for which such Tax relates nor is there any material Tax deficiency
outstanding, proposed or assessed against Cambridge or Holdco, nor has Cambridge or Holdco executed any unexpired waiver of any
statute of limitations on or extending the period for the assessment or collection of any Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
audit or other examination of any Tax Return of Cambridge or Holdco by any Tax authority is presently in progress, nor has Cambridge
been notified of any written request for such an audit or other examination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>No
adjustment relating to any Tax Returns filed by Cambridge or Holdco has been proposed in writing, formally or informally, by any
Tax authority to Cambridge or any representative thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
Cambridge nor Holdco has any liability for any material unpaid Taxes which have not been accrued for or reserved on Cambridge&rsquo;s
balance sheets included in the audited financial statements for the most recent fiscal year ended, whether asserted or unasserted,
contingent or otherwise, which is material to Cambridge, other than any liability for unpaid Taxes that may have accrued since
the end of the most recent fiscal year in connection with the operation of the business of Cambridge in the ordinary course of
business, none of which is material to the business, results of operations or financial condition of Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Environmental
Matters</U></B>. Except for such matters that, individually or in the aggregate, are not reasonably likely to have a Material Adverse
Effect and except for matters which have been resolved with no remaining obligations: (i) Cambridge and Holdco have complied with
all applicable Environmental Laws; (ii) to the knowledge of Cambridge, Cambridge and Holdco are not subject to liability for any
Hazardous Substance disposal or contamination on any third party property; (iii) Cambridge and Holdco have not been associated
with any release or threat of release of any Hazardous Substance; (iv) Cambridge and Holdco have not received any written notice,
demand, letter, claim or request for information from any Governmental Entity alleging that Cambridge or Holdco are in violation
of or liable under any Environmental Law; and (v) Cambridge and Holdco are not subject to any orders, decrees, injunctions or other
arrangements with any Governmental Entity or subject to any outstanding indemnity claim from any third party relating to liability
under any Environmental Law or relating to Hazardous Substances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Brokers</U></B>.
Except as set forth in <U>Schedule&nbsp;3.17</U>, neither Cambridge nor Holdco has incurred, nor will it incur, directly or indirectly,
any liability for brokerage or finders&rsquo; fees or agent&rsquo;s commissions or any similar charges in connection with this
Agreement or any transaction contemplated hereby.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Intellectual
Property</U></B>. Cambridge and Holdco do not own, license or otherwise have any right, title or interest in any material Intellectual
Property or Registered Intellectual Property except non-exclusive rights to the name &ldquo;Cambridge Capital.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Agreements,
Contracts and Commitments</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as set forth in the Cambridge SEC Reports filed prior to the date of this Agreement or as set forth in <U>Schedule 3.19</U>, other
than confidentiality and non-disclosure agreements, there are no contracts, agreements, leases, mortgages, indentures, notes, bonds,
liens, license, permit, franchise, purchase orders, sales orders or other understandings, commitments or obligations of any kind,
whether written or oral, to which Cambridge or Holdco is a party or by or to which any of the properties or assets of Cambridge
or Holdco may be bound, subject or affected, which either (a) creates or imposes a liability greater than $25,000 in the aggregate,
or (b) may not be cancelled by Cambridge or Holdco on less than 30 days&rsquo; or less prior notice (&ldquo;<U>Cambridge Contracts</U>&rdquo;).
All Cambridge Contracts are listed in <U>Schedule&nbsp;3.19</U> other than those that are exhibits to the Cambridge SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Except
as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect on Cambridge or Holdco
and except as set forth in <U>Schedule&nbsp;3.19(b)</U>: (i) each Cambridge Contract is in full force and effect and is valid and
binding upon and enforceable against each of the parties thereto, and (ii) neither Cambridge nor, to the Cambridge&rsquo;s knowledge,
any other party thereto is in breach of or in default under, any Cambridge Contract, and no party to any Cambridge Contract has
given any written notice of any claim of any such breach, default or event. True, correct and complete copies of all Cambridge
Contracts (or written summaries in the case of oral Cambridge Contracts) have been heretofore been made available to the Company
or Company counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Insurance</U></B>.
Except for directors&rsquo; and officers&rsquo; liability insurance, Cambridge and Holdco do not maintain any Insurance Policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Violation of FCPA and Related Matters</U></B>.<B><U> </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
Cambridge nor Holdco has not, to the knowledge of Cambridge, has any director, officer, agent, employee, Affiliate or other person
acting on behalf of Cambridge or Holdco, (i) used any corporate funds for any unlawful contribution, gift, entertainment or other
unlawful expense relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or domestic government
official or employee from corporate funds; or (iii) made any bribe, rebate, payoff, influence payment, kickback or other unlawful
payment. Neither Cambridge or Holdco nor, to the knowledge of Cambridge, any director, officer, agent, employee or affiliate or
other person acting on behalf of Cambridge or Holdco is aware of or has taken any action, directly or indirectly, that would result
in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder;
and each of Cambridge and Holdco and, to the knowledge of Cambridge, Cambridge&rsquo;s and Holdco&rsquo;s respective Affiliates
have instituted and maintain policies and procedures reasonably designed to ensure continued compliance therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
operations of Cambridge and Holdco have been conducted at all times in material compliance with all Money Laundering Laws and no
action, suit or proceeding by or before any court or Governmental Entity involving Cambridge or Holdco with respect to the Money
Laundering Laws is pending or, to the knowledge of Cambridge, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Neither
Cambridge or Holdco nor, to the knowledge of Cambridge, any director, officer, agent, employee or Affiliate of Cambridge or Holdco
is currently subject to any U.S. sanctions administered by OFAC, and neither Cambridge nor Holdco will directly or indirectly use
the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner
or other Person, for the purpose of financing the activities of any Person currently subject to any U.S. sanctions administered
by OFAC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>To
Cambridge&rsquo;s knowledge, no employee of Cambridge has provided or is providing information to any law enforcement agency regarding
the commission or possible commission of any crime or the violation or possible violation of any Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Interested
Party Transactions</U></B>. Except as set forth in the Cambridge SEC Reports filed prior to the date of this Agreement: (a) no
employee, officer, director or stockholder of Cambridge or a member of his or her immediate family is indebted for borrowed money
to Cambridge nor is Cambridge indebted for borrowed money (or committed to make loans or extend or guarantee credit) to any of
them, other than reimbursement for reasonable expenses incurred on behalf of Cambridge; (b) to Cambridge&rsquo;s knowledge, none
of such individuals has any direct or indirect ownership interest in any Person with whom Cambridge is affiliated or with whom
Cambridge has a material contractual relationship, or any Person that competes with Cambridge, except that each employee, stockholder,
officer or director of Cambridge and members of their respective immediate families may own less than 5% of the outstanding stock
in publicly traded companies that may compete with Cambridge; and (c) to Cambridge&rsquo;s knowledge, no officer, director or stockholder
or any member of their immediate families has an economic interest in any material contract with Cambridge (other than such contracts
as relate to any such individual ownership of capital stock or other securities of Cambridge).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Indebtedness</U></B>.
Except as set forth in the Cambridge SEC Reports filed prior to the date of this Agreement, neither Cambridge nor Holdco has any
indebtedness for borrowed money.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Listing
of Securities</U></B>. The Cambridge Units, Cambridge Common Stock and Cambridge Warrants are listed for trading on the Capital
Markets of Nasdaq. There is no action or proceeding pending or, to Cambridge's knowledge, threatened against Cambridge by Nasdaq
with respect to any intention by such entity to prohibit or terminate the listing of the Cambridge Units, Cambridge Common Stock
or Cambridge Warrants on the Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Board
Approval</U></B>. The Board of Directors of Cambridge (including any required committee or subgroup of the Board of Directors of
Cambridge) has, as of the date of this Agreement, unanimously (i) declared the advisability of the Transactions and approved this
Agreement and the transactions contemplated hereby, (ii) determined that the Transactions are in the best interests of the stockholders
of Cambridge, and (iii) determined that the fair market value of the Company is equal to at least 80% of the balance in the Trust
Fund (as defined in Section 3.25).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Trust
Fund</U></B>. Cambridge has as of the date hereof all funds necessary to consummate the Transactions and to perform its obligations
hereunder. As of the date hereof, and immediately prior to the Effective Time, Cambridge has and will have no less than $81,307,407
in a trust account at UBS Financial Services Inc., administered by Continental (the &ldquo;<U>Trust Fund</U>&rdquo;) invested in
United States &ldquo;government securities&rdquo; within the meaning of Section 2(a)(16) of the Investment Company Act of 1940,
as amended, having a maturity of 180 days or less, or in money market funds meeting certain conditions under Rule 2a-7 promulgated
under the Investment Company Act of 1940, as amended; provided that a portion of the Trust Fund shall be utilized in accordance
with Section 5.23. The Trust Fund Agreement, dated as of December 17, 2013 (the &ldquo;<U>Trust Fund Agreement</U>&rdquo;), by
and between Cambridge and Continental is valid and in full force and effect and enforceable in accordance with its terms and has
not been amended or modified. There are no separate agreements, side letters, or other agreements or understandings (whether written
or unwritten, express or implied) that would cause the description of the Trust Fund Agreement in the Cambridge SEC Reports to
be inaccurate in any respect and/or that would entitle any third party to any portion of the cash proceeds of the initial public
offering of Cambridge and private placements of its securities, substantially all of which proceeds have been deposited in the
Trust Fund for the benefit of Cambridge, certain of its stockholders and the underwriters of its initial public offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Governmental
Filings</U></B>. Except as set forth in <U>Schedule&nbsp;3.27</U>, each of Cambridge and Holdco is in possession of all Governmental
Actions/Filings necessary to the conduct by Cambridge and Holdco of its business (as presently conducted), and true, complete and
correct copies of which have heretofore been delivered to the Company. Each such Governmental Action/Filing is in full force and
effect and, except as disclosed in <U>Schedule&nbsp;3.27</U>, will not expire prior to December&nbsp;31, 2016, and each of Cambridge
and Holdco is in material compliance with all of its obligations with respect thereto. To the knowledge of Cambridge, no event
has occurred and is continuing which requires or permits, or after notice or lapse of time or both would require or permit, and
consummation of the transactions contemplated by this Agreement or any ancillary documents will not require or permit (with or
without notice or lapse of time, or both), any modification or termination of any such Governmental Actions/Filings except such
events which, either individually or in the aggregate, would not have a Material Adverse Effect upon Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Survival
of Representations and Warranties</U></B>. The representations and warranties of Cambridge and Holdco set forth in this Agreement
shall survive until the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
IV.</B></FONT><BR>
<B>CONDUCT PRIOR TO THE EFFECTIVE TIME&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Conduct
of Business by the Company and Cambridge</U></B>. Except as set forth in <U>Schedule 4.1</U> hereto, during the period from the
date of this Agreement and continuing until the earlier of the termination of this Agreement pursuant to its terms or the Closing,
each of the Company, its Subsidiaries and Cambridge shall, and, with respect to the Joint Venture, the Company shall cause the
Joint Venture to, except to the extent that the other party shall otherwise consent in writing, carry on its business in the usual,
regular and ordinary course consistent with past practices, in substantially the same manner as heretofore conducted and in compliance
with all Applicable Laws (except where noncompliance would not be reasonably expected to have a Material Adverse Effect on the
applicable party), pay its debts and taxes when due subject to good faith disputes over such debts or taxes, pay or perform other
material obligations when due, and use its commercially reasonable efforts consistent with past practices and policies to (i) preserve
substantially intact its present business organization, (ii) keep available the services of its present officers and employees
and (iii) preserve its relationships with customers, suppliers, distributors, licensors, licensees, and others with which it has
significant business dealings. In addition, except as required or permitted by the terms of this Agreement or set forth in <U>Schedule&nbsp;4.1</U>
hereto, without the prior written consent of the other party, during the period from the date of this Agreement and continuing
until the earlier of the termination of this Agreement pursuant to its terms or the Closing, each of the Company, its Subsidiaries
and Cambridge shall not (and the Company shall not cause the Joint Venture to) do any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>waive
any stock repurchase rights, accelerate, amend or change the period of exercisability of options or restricted stock, or reprice
options granted under any employee, consultant, director or other stock plans or authorize cash payments in exchange for any options
granted under any of such plans;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>grant
any severance or termination pay to any officer or employee outside the ordinary course of business except pursuant to Applicable
Law, written agreements outstanding, or company policies existing on the date hereof and as previously or concurrently disclosed
in writing or made available to the other party, or adopt any new severance plan, or amend or modify or alter in any manner any
severance plan, agreement or arrangement existing on the date hereof in any material respect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>transfer
or license to any person or otherwise extend, amend or modify any material rights to any material Intellectual Property or enter
into any written agreement to transfer or license to any Person future patent rights, other than in the ordinary course of business
consistent with past practices provided that in no event shall the Company, its Subsidiaries or Cambridge or Holdco license on
an exclusive basis or sell any material Intellectual Property of the Company, its Subsidiaries or Cambridge as or Holdco applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>declare,
set aside or pay any dividends on or make any other distributions (whether in cash, stock, equity securities or property) in respect
of any capital stock or split, combine or reclassify any capital stock or issue or authorize the issuance of any other securities
in respect of, in lieu of or in substitution for any capital stock, other than, in the case of the Company, payment of the Company
Dividend (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>purchase,
redeem or otherwise acquire, directly or indirectly, any shares of capital stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>issue,
deliver, sell, authorize, pledge or otherwise encumber, or agree to any of the foregoing with respect to, any shares of capital
stock or any securities convertible into or exchangeable for shares of capital stock, or subscriptions, rights, warrants or options
to acquire any shares of capital stock or any securities convertible into or exchangeable for shares of capital stock, or enter
into other agreements or commitments of any character obligating it to issue any such shares or convertible or exchangeable securities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>amend
its Charter Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>acquire
or agree to acquire by merging or consolidating with, or by purchasing any equity interest in or a portion of the assets of, or
by any other manner, any business or any corporation, partnership, association or other business organization or division thereof,
or otherwise acquire or agree to acquire any assets which are material, individually or in the aggregate, to its respective business,
or enter into any joint ventures, strategic partnerships or alliances or other arrangements that provide for exclusivity of territory
or otherwise restrict in any material respect such party&rsquo;s ability to compete or to offer or sell any products or services.
For purposes of this paragraph, &ldquo;material&rdquo; includes the requirement that, as a result of such transaction, financial
statements of the acquired, merged or consolidated entity be included in the Proxy Statement/Prospectus (as defined in Section&nbsp;5.1);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>sell,
lease, license, encumber or otherwise dispose of any properties or assets, except (A) sales of inventory and property, plant and
equipment in the ordinary course of business consistent with past practice, and (B) the sale, lease or disposition (other than
through licensing) of property or assets that are not material, individually or in the aggregate, to the business of such party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>incur
any indebtedness for borrowed money or guarantee any such indebtedness of another Person or Persons in an amount greater than $250,000,
issue or sell any debt securities or options, warrants, calls or other rights to acquire any debt securities, enter into any &ldquo;keep
well&rdquo; or other agreement to maintain any financial statement condition or enter into any arrangement having the economic
effect of any of the foregoing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>adopt
or amend any employee benefit plan, policy or arrangement, any employee stock purchase or employee stock option plan, or enter
into any collective bargaining agreement, pay any special bonus or special remuneration to any director or employee in an amount
greater than $100,000, or increase the salary or wage rate or fringe benefit (including rights to severance or indemnification)
of any of its directors, officers, employees or consultants in an amount greater than $100,000, in each case, except in the ordinary
course of business consistent with past practices or, in the case of salaries and wages, in a manner generally consistent with
market practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>pay,
discharge, settle or satisfy any claims, liabilities or obligations (absolute, accrued, asserted or unasserted, contingent or otherwise),
or litigation (whether or not commenced prior to the date of this Agreement) in an amount greater than $500,000, other than the
payment, discharge, settlement or satisfaction of claims, obligations or litigations in the ordinary course of business consistent
with past practices or in accordance with their terms, or liabilities recognized or disclosed in the Audited Financial Statements
or in the most recent financial statements included in the Cambridge SEC Reports filed prior to the date of this Agreement, as
applicable, or incurred since the date of such financial statements;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>waive
the benefits of, agree to modify in any material respect, terminate, release any person from any confidentiality or similar agreement
to which the Company or Cambridge or Holdco is a party or of which the Company or Cambridge or Holdco is a beneficiary, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>except
in the ordinary course of business consistent with past practices, modify or amend in any material respect or terminate any Material
Company Contract or Cambridge Contract, as applicable, or waive, release or assign any material rights or claims thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>except
as required by U.S. GAAP, revalue any of its assets or make any change in accounting methods, principles or practices;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>except
in the ordinary course of business consistent with past practices, incur or enter into any agreement, contract or commitment requiring
such party to pay in excess of $100,000 in any 12 month period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>settle
any material litigation where the consideration given is other than monetary or to which an Insider (as defined in Section 2.19(a))
is an opposing party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(r)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make
or rescind any Tax elections that, individually or in the aggregate, could be reasonably likely to adversely affect in any material
respect the Tax liability or Tax attributes of such party, settle or compromise any material income tax liability or, except as
required by Applicable Law, materially change any method of accounting for Tax purposes or prepare or file any Tax Return in a
manner inconsistent with past practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(s)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>form,
establish or acquire any Subsidiary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(t)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>permit
any Person to exercise any of its discretionary rights under any employee benefit plan to provide for the automatic acceleration
of any outstanding options, the termination of any outstanding repurchase rights or the termination of any cancellation rights
issued pursuant to such plans;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(u)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make
capital expenditures in excess of $100,000 in the aggregate other that in the ordinary course of business consistent with past
practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>make
or omit to take any action which would be reasonably expected to have a Material Adverse Effect on such party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(w)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>enter
into any transaction with or distribute or advance any assets or property to any of its officers, directors, partners, stockholders
or other Affiliates other than the payment of salary and benefits in the ordinary course of business consistent with prior practice
or, in the case of Cambridge, advancement or reimbursement of expenses in connection with Cambridge&rsquo;s search for a business
combination; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(x)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>agree
in writing or otherwise agree, commit or resolve to take any of the actions described in Section&nbsp;4.1(a) through (w) above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
V.</B></FONT><BR>
<B>ADDITIONAL AGREEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Proxy
Statement/Prospectus; Registration Statement; Special Meeting</U></B>.<B><U> </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
soon as is reasonably practicable after the execution of this Agreement, the Company and Cambridge shall prepare and file with
the SEC under the Securities Act, and with all other applicable regulatory bodies, a registration statement on Form S-4 with respect
to the Surviving Pubco Shares to be issued in connection with the Redomestication Merger (the &ldquo;<U>Registration Statement</U>&rdquo;),
which shall include proxy materials for the purpose of soliciting proxies from holders of Cambridge Common Stock to vote, at a
meeting of the holders of Cambridge Common Stock to be called for such purpose (the &ldquo;<U>Special Meeting</U>&rdquo;), in favor
of, among other matters, the adoption of this Agreement and the approval of the Transactions, including the approval of the Surviving
Pubco Plan (&ldquo;<U>Cambridge Stockholder Approval</U>&rdquo;). Such proxy materials shall be in the form of a proxy statement/prospectus
to be used for the purpose of soliciting proxies from holders of Cambridge Common Stock for the matters to be acted upon at the
Special Meeting and also for the purpose of issuing the Surviving Pubco Shares as contemplated hereby (the &ldquo;<U>Proxy Statement/Prospectus</U>&rdquo;).
Each of the Company and Cambridge shall furnish to the other all information concerning its respective company and business as
may reasonably be requested in connection with the preparation of the Registration Statement and Proxy Statement/Prospectus, including
providing the Company with periodic and prompt updates with respect to the tabulated vote counts received by Cambridge. Cambridge
shall cause the Proxy Statement/Prospectus and the Registration Statement to be filed as promptly as possible and (ii) October
1, 2015 (the &ldquo;<U>Filing Deadline</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
and the Company, with the assistance of their respective counsel, shall promptly respond to any SEC comments on such filings and
shall otherwise use reasonable best efforts to cause the Registration Statement to be declared effective by the SEC as promptly
as practicable, and keep the Registration Statement effective as long as is necessary to consummate the Transactions. Each of Cambridge
and the Company shall also take any and all actions required to satisfy the requirements of the Securities Act and the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
soon as practicable following the SEC declaring the Registration Statement effective, Cambridge shall distribute the Proxy Statement/Prospectus
to the holders of Cambridge Common Stock and Cambridge Warrants and, pursuant thereto, shall duly call, give notice of, convene
and hold the Special Meeting in accordance with the DGCL for a date no later than thirty (30) days following the SEC declaring
the Registration Statement effective and, subject to the other provisions of this Agreement, solicit proxies from the holders of
Cambridge Common Stock to vote in favor of the adoption of this Agreement and the approval of the Transactions and the other matters
presented to the stockholders of Cambridge for approval or adoption at the Special Meeting, including the matters described in
Section&nbsp;5.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company and Cambridge shall, and shall use commercially reasonable efforts to ensure that the Registration Statement and the Proxy
Statement/Prospectus, comply with all applicable provisions of and rules under the Exchange Act and all applicable provisions of
the DGCL in the preparation, filing and distribution of the Proxy Statement/Prospectus, the solicitation of proxies thereunder,
and the calling and holding of the Special Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company and Cambridge shall make all necessary filings with respect to the Transactions and the transactions contemplated hereby
under the Securities Act and the Exchange Act and applicable Blue Sky Laws and the rules and regulations thereunder. Cambridge
will advise the Company, promptly after it receives notice thereof, of the time when the Registration Statement has become effective
or any supplement or amendment has been filed, the issuance of any stop order, or any request by the SEC for amendment of the Proxy
Statement/Prospectus or the Registration Statement or comments thereon and responses thereto or requests by the SEC for additional
information. No amendment or supplement to the Proxy Statement/Prospectus or the Registration Statement shall be filed without
the approval of both the Company and Cambridge, which approval shall not be unreasonably withheld or delayed. If, at any time prior
to the Effective Time, any information relating to the Company or Cambridge, or any of their respective Affiliates, officers or
directors should be discovered by the Company or Cambridge that should be set forth in an amendment or supplement to the Registration
Statement or the Proxy Statement/Prospectus so that such documents would not include any misstatement of a material fact or omit
to state any material fact necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading, the party hereto that discovers such information shall promptly notify the other parties hereto and an appropriate
amendment or supplement describing such information shall be promptly filed with the SEC and, to the extent required by Applicable
Law, disseminated to the stockholders of the Company and Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge,
acting through its board of directors, shall include in the Proxy Statement/Prospectus the recommendation of its board of directors
that the holders of Cambridge Common Stock vote in favor of the adoption of this Agreement and the approval of the Transactions,
and shall otherwise use best efforts to obtain the Cambridge Stockholder Approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Directors
and Officers of Surviving Pubco After Merger; Further Actions</U></B>.<B><U> </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
shall take all such action as may be necessary (i) to cause the number of directors comprising the Surviving Pubco Board as of
the Effective Time to be increased to seven, (ii) to cause the five individuals designated by the Company (the &ldquo;<U>Company
Designated Directors</U>&rdquo;) to be appointed to the Surviving Pubco Board as of the Effective Time to the classes indicated,
to serve until the next annual election of directors of Surviving Pubco within such class; <U>provided</U>, <U>however</U>, that
three of such Company Designated Directors shall be reasonably acceptable to Cambridge (which acceptance may not be unreasonably
withheld or delayed) and (iii) to cause the two individuals designated by Cambridge to be appointed to the Surviving Pubco Board
as of the Effective Time, to serve until the next annual election of directors of Surviving Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
parties shall take all necessary action so that the Persons listed in <U>Schedule 5.2(b)</U> are elected to the positions of officers
of Surviving Pubco, as set forth therein, to serve in such positions effective immediately after the Closing. If any Person listed
in <U>Schedule 5.2(b)</U> becomes unable to serve prior to the Closing Date, the party appointing such Person shall designate a
successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Following
the Closing, the board of directors of Surviving Pubco shall evaluate possible redomestication from the Cayman Islands to a more
tax efficient jurisdiction for its stockholders; provided that no such shareholders are negatively affected by any such redomestication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company Designated Directors shall have the exclusive right to determine (i) the call of any outstanding warrants of Surviving
Pubco and (ii) whether to require the cashless exercise of any warrants called by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Repayment
to Indebtedness</U></B>. Prior to the Closing, Alan Ltd., an Israeli company wholly-owned by Anatoly Hurgin, will repay to the
Company the loan in the amount of US$760,000, as set forth in the Financial Statements, and there shall exist no other indebtedness
between the Company and any Insider, Company Designated Director, Joint Venture Partner or any Affiliate of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Other
Actions</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
promptly as practicable after execution of this Agreement, Cambridge will prepare and file a Current Report on Form 8-K pursuant
to the Exchange Act to report the execution of this Agreement (&ldquo;<U>Signing Form 8-K</U>&rdquo;). Promptly after the execution
of this Agreement, Cambridge and the Company shall also issue a mutually agreeable press release announcing the execution of this
Agreement (the &ldquo;<U>Signing Press Release</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>At
least five days prior to Closing, Cambridge shall prepare a Current Report on Form 8-K in connection with and announcing the Closing,
together with, or incorporating by reference, the financial statements prepared by the Company and its accountant, and such other
information that may be required to be disclosed with respect to the Transactions in any report or form to be filed with the SEC
(the &ldquo;<U>Closing Form 8-K</U>&rdquo;). Prior to Closing, Cambridge and the Company shall prepare a mutually agreeable press
release announcing the consummation of the Transactions hereunder (&ldquo;<U>Closing Press Release</U>&rdquo;). Concurrently with
the Closing, the Company shall distribute the Closing Press Release. Concurrently with the Closing, or as soon as practicable thereafter,
Cambridge shall file the Closing Form 8-K with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any
language included in a Reviewable Document (as defined herein) that reflects the comments of the reviewing party, as well as any
text as to which the reviewing party has not commented upon after being given a reasonable opportunity to comment, shall be deemed
to have been approved by the reviewing party and may henceforth be used by the other party in such Reviewable Documents without
further review or consent of the reviewing party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Required
Information</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>In
connection with the preparation of the Signing Form 8-K, the Signing Press Release, the Registration Statement, the Proxy Statement/Prospectus,
the Closing Form 8-K and the Closing Press Release, or any other statement, filing, notice, release or application made by or on
behalf of Cambridge and/or the Company to any Government Entity in connection with Transactions and the other transactions contemplated
hereby (each, a &ldquo;<U>Reviewable Document</U>&rdquo;), and for such other reasonable purposes, the Company and Cambridge each
shall, upon request by the other, promptly furnish the other with all information concerning themselves, their respective directors,
officers, stockholders and Affiliates (including the directors of Surviving Pubco to be elected effective as of the Closing pursuant
to Section&nbsp;5.2 hereof) and such other matters as may be reasonably necessary or advisable in connection with the Transactions
and the preparation of such document. Each party warrants and represents to the other party that all such information shall be
true and correct in all material respects as of the date of filing, issuance or other submission or public disclosure of such document
and the Closing Date and will not contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements contained therein, in light of the circumstances under which they were made,
not misleading (provided, that each party shall not be responsible for the accuracy or completeness of any information relating
to the other party or any other information furnished by the other party for inclusion in any such document).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>At
a reasonable time prior to the filing, issuance or other submission or public disclosure of a Reviewable Document by any of Cambridge
or the Company, the other party shall be given an opportunity to review and comment upon such Reviewable Document and give its
consent to the form thereof, such consent not to be unreasonably withheld, and each party shall accept and incorporate all reasonable
comments from the other party to any such Reviewable Document prior to filing, issuance, submission or disclosure thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Prior
to the Effective Time (i)&nbsp;the Company and Cambridge shall notify each other as promptly as reasonably practicable upon becoming
aware of any event or circumstance which should be described in an amendment of, or supplement to, a Reviewable Document that has
been filed with the SEC, and (ii)&nbsp;the Company and Cambridge shall each notify the other as promptly as practicable after the
receipt by it of any written or oral comments of the SEC on, or of any written or oral request by the SEC for amendments or supplements
to, any such Reviewable Document, and shall promptly supply the other with copies of all correspondence between it or any of its
representatives and the SEC with respect to any of the foregoing filings. Cambridge and the Company shall use their respective
commercially reasonable efforts, after consultation with each other, to resolve all such requests or comments with respect to the
any Reviewable Document as promptly as reasonably practicable after receipt of any comments of the SEC. All correspondence and
communications to the SEC made by Cambridge with respect to the transactions contemplated by this Agreement or any agreement ancillary
hereto shall be considered to be Reviewable Documents subject to the provisions of this Section 5.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Confidentiality;
Access to Information</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Confidentiality</U></B>.
All information obtained by the parties pursuant to this Section&nbsp;5.6 shall be kept confidential in accordance with the confidentiality
agreement, dated March 22, 2015 (the &ldquo;<U>Confidentiality Agreement</U>&rdquo;), between Cambridge and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Access
to Information</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Company will afford Cambridge and its financial advisors, accountants, counsel and other representatives reasonable access during
normal business hours, upon reasonable notice, to the properties, books, records and personnel of the Company during the period
prior to the Closing to obtain all information concerning the business, including the status of business development efforts, properties,
results of operations and personnel of the Company, as Cambridge may reasonably request. No information or knowledge obtained by
Cambridge in any investigation pursuant to this Section&nbsp;5.6 will affect or be deemed to modify or create any representation
or warranty contained herein or the conditions to the obligations of the parties to consummate the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
will afford the Company and its financial advisors, underwriters, accountants, counsel and other representatives reasonable access
during normal business hours, upon reasonable notice, to the properties, books, records and personnel of Cambridge a during the
period prior to the Closing to obtain all information concerning the business, including properties, results of operations and
personnel of Cambridge, as the Company may reasonably request. No information or knowledge obtained by the Company in any investigation
pursuant to this Section&nbsp;5.6 will affect or be deemed to modify or create any representation or warranty contained herein
or the conditions to the obligations of the parties to consummate the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Commercially
Reasonable Efforts</U></B>. Upon the terms and subject to the conditions set forth in this Agreement, each of Cambridge and the
Company agrees to use its commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be
done, and to assist and cooperate with the other parties hereto in doing, all things necessary, proper or advisable to consummate
and make effective, in the most expeditious manner practicable, the Transactions and the other transactions contemplated by this
Agreement, including using commercially reasonable efforts to accomplish the following: (i) the taking of all reasonable acts necessary
to cause the conditions precedent set forth in Article&nbsp;VI to be satisfied, (ii) the obtaining of all necessary actions, waivers,
consents, approvals, orders and authorizations from Governmental Entities and the making of all necessary registrations, declarations
and filings (including registrations, declarations and filings with Governmental Entities, if any) and the taking of all reasonable
steps as may be necessary to avoid any suit, claim, action, investigation or proceeding by any Governmental Entity, (iii) the obtaining
of all consents, approvals or waivers from third parties required as a result of the transactions contemplated in this Agreement,
including the consents referred to in <U>Schedule&nbsp;2.5</U> of the Company Schedule, (iv) providing suitably knowledgeable directors,
officers, employees and other Persons to attend &ldquo;road shows&rdquo; that are to be presented to existing and prospective Cambridge
security holders; (v) the defending of any suits, claims, actions, investigations or proceedings, whether judicial or administrative,
challenging this Agreement or the consummation of the transactions contemplated hereby, including seeking to have any stay or temporary
restraining order entered by any court or other Governmental Entity vacated or reversed and (vi) the execution or delivery of any
additional instruments reasonably necessary to consummate the transactions contemplated by, and to fully carry out the purposes
of, this Agreement; provided the Company&rsquo;s compliance with the foregoing shall not require it or its employees to unreasonably
disrupt the ordinary course operations of the Company. In connection with and without limiting the generality of the foregoing,
the Cambridge Board, the Company and the Company Board shall, if any state takeover statute or similar statute or regulation is
or becomes applicable to the Transactions, this Agreement or any of the transactions contemplated by this Agreement, use its commercially
reasonable efforts to enable the Transactions and the other transactions contemplated by this Agreement to be consummated as promptly
as practicable on the terms contemplated by this Agreement. Notwithstanding anything herein to the contrary, nothing in this Agreement
shall be deemed to require Cambridge, the Company or any Stockholder to agree to any divestiture by itself or any of its Affiliates
of shares of capital stock or of any business, assets or property, or the imposition of any material limitation on the ability
of any of them to conduct their business or to own or exercise control of such assets, properties and stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Surviving
Pubco Listing</U></B>. Cambridge shall promptly prepare and submit to the Nasdaq a listing application covering the shares of Surviving
Pubco Common Stock to be issued in the Reorganization Merger, and shall use its, and Surviving Pubco and the Company shall use
their, reasonable best efforts to obtain, prior to the Effective Time, approval for the listing for trading of the Surviving Pubco
Common Stock on Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Reserved</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Treatment
as a Reorganization</U></B>. This Agreement is intended to constitute a &ldquo;plan of reorganization&rdquo; within the meaning
of section 1.368-2(g) of the income tax regulations promulgated under the Code. From and after the date of this Agreement and until
the Effective Time, each party hereto shall use its commercially reasonable efforts to cause the Transactions to qualify, and will
not knowingly take any action, cause any action to be taken, fail to take any action or cause any action to fail to be taken which
action or failure to act could reasonably be expected to cause the Transactions to fail to qualify as a &ldquo;reorganization&rdquo;
within the meaning of Section&nbsp;368(a) of the Code and the regulations thereunder. Moreover, this Agreement is intended to comply
with Section 103[t] of the Income Tax Ordinance (New Version), 5721-1961 of the laws of the State of Israel (&ldquo;<U>Israel Tax
Ordinance</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Cambridge Securities Transactions</U></B>. Neither the Company, the Stockholders nor any of their respective Affiliates, directly
or indirectly, shall engage in any transactions involving the sale or purchase of securities of Cambridge prior to the time of
the making of a public announcement of the transactions contemplated by this Agreement. The Company shall use commercially reasonable
efforts to require each of its officers, directors, employees, agents, advisors, contractors, associates, clients, customers and
representatives, to comply with the foregoing requirement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Claim Against Trust Fund</U></B>. Notwithstanding anything else in this Agreement, the Company and the Stockholders acknowledge
that they have read Cambridge&rsquo;s final prospectus dated December 17, 2013 (&ldquo;<U>Final Prospectus</U>&rdquo;) and understand
that Cambridge has established the Trust Fund for the benefit of Cambridge&rsquo;s public stockholders and that, except for interest
earned on the amounts held in the Trust Fund, Cambridge may disburse monies from the Trust Fund only (i) to Cambridge&rsquo;s public
stockholders in the event they elect to convert their shares into cash in accordance with Cambridge&rsquo;s Charter Documents (x)
upon consummation of a business combination, (y) amendment to Cambridge&rsquo;s Charter Documents relating to pre-business combination
activity, or (z) the liquidation of Cambridge in the event that Cambridge is unable to consummate a business combination within
the required time period, (ii) to Cambridge after, or concurrently with, the consummation of a business combination, and (iii)
to Cambridge in limited amounts for its working capital requirements and tax obligations. The Company and the Stockholders further
acknowledge that, if Cambridge does not consummate a business combination by December 23, 2015, Cambridge will be obligated to
return to its stockholders the amounts being held in the Trust Fund. Accordingly, the Company, for itself and its affiliated entities,
directors, officers, employees, stockholders, representatives, advisors and all other associates and Affiliates, and the Stockholders,
for themselves (collectively, the &ldquo;<U>Company and Stockholder Releasors</U>&rdquo;), hereby waive all rights, title, interest
or claim of any kind against any monies in the Trust Fund for any monies that may be owed to the Company and Stockholder Releasors
by Cambridge for any reason whatsoever, including but not limited to a breach of this Agreement by Cambridge or any negotiations,
agreements or understandings with Cambridge (whether in the past, present or future), and the Company and Stockholder Releasors
will not seek recourse against the Trust Fund at any time for any reason whatsoever. This paragraph will survive the termination
of this Agreement for any reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Disclosure
of Certain Matters</U></B>. Each of Cambridge, Holdco, the Company and the Stockholders will provide the others with prompt written
notice of any event, development or condition that (i) would cause any of such party&rsquo;s representations and warranties to
become untrue or misleading or which may affect its ability to consummate the transactions contemplated by this Agreement, (ii)
had it existed or been known on the date hereof would have been required to be disclosed under this Agreement, (iii) gives such
party any reason to believe that any of the conditions set forth in Article&nbsp;VI will not be satisfied, (iv) is of a nature
that is or may be materially adverse to the operations or condition (financial or otherwise) of the Company, or (v) would require
any amendment or supplement to the Proxy Statement/Prospectus. The parties shall have the obligation to supplement or amend the
Company Schedules and Cambridge Schedules, as applicable (collectively, the &ldquo;<U>Disclosure Schedules</U>&rdquo;), being delivered
concurrently with the execution of this Agreement with respect to any material matter hereafter arising or discovered which, if
existing or known at the date of this Agreement, would have been required to be set forth or described in the Disclosure Schedules.
The obligations of the parties to amend or supplement the Disclosure Schedules being delivered herewith shall terminate on the
Closing Date. Notwithstanding any such amendment or supplementation, for purposes of Sections 6.2(a), 6.3(a), 7.1(a)(i), 8.1(d)
and 8.1(e), the representations and warranties of the parties shall be made with reference to the Disclosure Schedules as they
exist at the time of execution of this Agreement, subject to such anticipated changes as are set forth in <U>Schedule&nbsp;4.1</U>,
as are permitted by Section 4.1 or otherwise expressly contemplated by this Agreement or that are set forth in the Disclosure Schedules
as they exist on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Further
Actions</U></B>. The parties hereto shall use their best efforts to take such actions as are necessary to fulfill their respective
obligations under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Solicitation</U></B>. Upon the terms and subject to the conditions set forth in this Agreement, each of Cambridge and the Company
agrees to use its commercially reasonable efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and
to assist and cooperate with the other parties hereto in doing, all things necessary, proper or advisable to consummate and make
effective, in the most expeditious manner practicable, the Transactions and the other transactions contemplated by this Agreement.
In furtherance of the foregoing, none of Cambridge, Holdco, the Company or the Stockholders will, and each of the foregoing will
cause its Affiliates and employees not to, directly or indirectly, (i)&nbsp;solicit or enter into discussions or transactions with,
or encourage, or provide any information to, any Person (other than the other parties hereto and their designees) concerning any
merger, acquisition of ownership interests and/or assets of any Person, recapitalization or similar transaction (an &ldquo;<U>Alternative
Transaction Proposal</U>&rdquo;), (ii)&nbsp;approve or recommend, or propose to approve or recommend, any Alternative Transaction
Proposal, (iii)&nbsp;approve or recommend, or propose to approve or recommend, or execute or enter into, any letter of intent,
agreement in principle, memorandum of understanding, merger agreement, asset or share purchase or share exchange agreement, option
agreement or other similar agreement related to any Alternative Transaction Proposal, (iv)&nbsp;enter into any agreement or agreement
in principle requiring the Cambridge, Holdco, the Company or the Stockholders to abandon, terminate or fail to consummate the Transactions
or breach their respective obligations hereunder, or (v)&nbsp;propose or agree to do any of the foregoing. Notwithstanding the
foregoing, nothing in this Agreement shall be deemed to prohibit BG Strategic Advisors LLC or Cambridge Capital LLC from conducting
their normal operations and activities so long as such operations and activities conducted on behalf of Cambridge and Holdco do
not violate this Section 5.15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Ancillary
Agreements</U></B>. Each party shall use its reasonable best efforts to cause each other party to any ancillary agreement to which
it a party to (i)&nbsp;perform and comply in all material respects with all obligations required of each such other party thereunder
and (ii)&nbsp;consummate the Transactions in accordance with the terms thereof (including by taking enforcement action to cause
such performance, compliance and consummation). Notwithstanding anything to the contrary contained herein, no party shall agree
to amend any ancillary agreement to which it is a party, or terminate, or waive, release or assign any material right or claim
under, any such ancillary agreement, in either case, in a manner adverse to the other party without the other party&rsquo;s prior
written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Public
Announcements</U></B>. Except as otherwise set forth in Section 5.4 and elsewhere in this Agreement, no party hereto shall make,
or cause to be made, any press release or public announcement in respect of this Agreement or the transactions contemplated hereby
or otherwise communicate with any news media without the prior written consent of the other parties, and the parties hereto shall
cooperate as to the timing and contents of any such press release, public announcement or communication.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Liability
Insurance</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>For
six (6) years after the Effective Time, Surviving Pubco agrees that it will (i) indemnify and hold harmless, to the extent Cambridge
is obligated to indemnify and hold harmless such Persons as of the date of this Agreement to the fullest extent permitted by Applicable
Law (and the Surviving Pubco shall also advance expenses as incurred to the extent Cambridge is obligated to advance such expenses
as of the date of this Agreement, provided that the Person to whom expenses are advanced provides an undertaking to repay such
advances if it is ultimately determined that such Person is not entitled to indemnification), each present and former director
and officer of Cambridge (in each case, when acting in such capacity) (the &ldquo;<U>Indemnified Parties</U>&rdquo;), against any
costs or expenses (including reasonable attorneys&rsquo; fees), judgments, fines, settlements, losses, claims, damages or liabilities
(collectively, &ldquo;<U>Costs</U>&rdquo;) incurred in connection with any threatened, pending or completed action, suit or proceeding,
whether civil, criminal, administrative or investigative, arising out of matters existing or occurring at or prior to the Effective
Time, whether asserted or claimed prior to, at or after the Effective Time, including the Transactions and (ii) include and cause
to be maintained in effect in the Surviving Pubco&rsquo;s (or any successor&rsquo;s) constitutional documents after the Effective
Time provisions regarding the elimination of liability of the Surviving Pubco&rsquo;s directors and officers and the indemnification
of the Indemnified Parties that are no less advantageous to the intended beneficiaries than the corresponding provisions contained
in the current Charter Documents of Cambridge. Notwithstanding anything to the contrary contained herein, the Surviving Pubco shall
not be obligated pursuant to this Section&nbsp;5.18(a) to pay the fees and disbursements of more than one counsel for all Indemnified
Parties in any single action, suit or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
Surviving Pubco agrees to maintain in effect for a period of six (6) years from and after the Effective Time any insurance policy
purchased by Cambridge prior to the Effective Time providing tail coverage with respect to events occurring prior to the Effective
Time, continuing the Cambridge&rsquo;s existing director and officer insurance coverage. The premium for such tail coverage for
such six year period (not to exceed the amount specified on <U>Schedule 5.23</U>) shall be paid at or prior to Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Surviving Pubco or any of its successors or assigns (i) consolidates with or merges into any other Person and shall not be
the continuing or surviving entity of such consolidation or merger, or (ii) transfers or conveys all or substantially all of its
properties and assets to any Person, then, in each such case, to the extent necessary, proper provision shall be made so that the
successors and assigns of the Surviving Pubco assume the obligations set forth in this Section&nbsp;5.18.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
provisions of this Section&nbsp;5.18 are intended to be for the benefit of, and shall be enforceable by, each Person who will have
been a director or officer of Cambridge for all periods ending on or before the Closing Date and may not be changed without the
consent of the Cambridge Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
rights of the Indemnified Parties under this Section 5.18 shall be in addition to any rights such Indemnified Parties may have
under the Charter Documents of Cambridge, or under any applicable contracts or Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Certain
Financial Information</U>.</B> Within twenty (20) Business Days after the end of each month between the date hereof and the earlier
of the Closing Date and the date on which this Agreement is terminated, the Company shall deliver to Cambridge management reports,
prepared on a cash basis, of the Company for such month, prepared on a cash basis consistent with past practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Access
to Financial Information</U>.</B> The Company will, and will cause its auditors to, during normal business hours and upon reasonable
notice, (a) continue to provide Cambridge and its advisors full access to all of the Company&rsquo;s financial information used
in the preparation of its Audited Financial Statements and the financial information furnished pursuant to Section&nbsp;5.18 hereof
and (b) cooperate fully with any reviews performed by Cambridge or its advisors of any such financial statements or information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Insider
Loans; Equity Ownership in Subsidiaries</U></B>. The Stockholders, at or prior to Closing, shall (i) repay to the Company any loan
by the Company to such Stockholders and any other amount owed by the Stockholders to the Company; (ii) cause any guaranty or similar
arrangement pursuant to which the Company has guaranteed the payment or performance of any obligations of such Stockholders to
a third party to be terminated; and (iii) cease to own any direct equity interests in any Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Cambridge
Borrowings</U></B>. Through the Closing, Cambridge shall be allowed to borrow funds from its directors, officers, stockholders
or their respective affiliates to meet its reasonable capital requirements, with any such loans to be made only as reasonably required
by the operation of Cambridge in due course on a non-interest bearing basis and repayable at Closing (or convertible into securities
of Cambridge in accordance with the terms of the promissory notes issued to evidence the borrowing, which such terms have been
set in the Final Prospectus).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Trust
Fund Disbursement</U></B>. Cambridge shall cause the Trust Fund, which shall consist of no less than $40,000,000 at Closing (after
giving effect to the amounts paid or to be paid in accordance with the next sentence), to be disbursed to the Company and as otherwise
contemplated by this Agreement immediately upon the Closing. All liabilities and obligations of Cambridge (and, in the case of
subsection (iv)(y) below, of the Company) due and owing or incurred at or prior to the Effective Time, all of which are set forth
on <U>Schedule 5.23</U>, shall be paid as and when due from the Trust Fund, including all amounts payable (i) to stockholders who
elect to have their shares of Cambridge Common Stock converted to cash in accordance with the provisions of Cambridge&rsquo;s Charter
Documents, (ii) for income tax or other tax obligations of Cambridge prior to Closing, (iii) as repayment of loans and reimbursement
of expenses to directors, officers and founding stockholders of Cambridge, (iv) to third parties (e.g., professionals, printers,
cash finders fees due on Closing, underwriters, etc.) who have rendered services to (x) Cambridge in connection with its operations
and efforts to effect a business combination, including the Transactions and the other transactions contemplated by this Agreement,
and (y) the Company in connection with its efforts to effect the Transactions and the other transactions contemplated by this Agreement,
and (v) payment to the representative of the underwriters in Cambridge&rsquo;s initial public offering of a merger/acquisition
fee as described in the Final Prospectus. For purposes of clarity, it is acknowledged and agreed (i) that the Cash Consideration
shall be paid from the Trust Fund and (ii) any payments with respect to Taxes reimbursed or paid on behalf of any third party,
including value added taxes, shall not be deducted in the calculation of amounts contained in the Trust Fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Pre-Closing
Confirmation and Certification</U></B>. Not later than 48 hours prior to the Closing, Cambridge shall give Continental advance
notice of the Effective Time. At the Closing, Cambridge shall deliver, or cause to be delivered, to Continental written notification
that the Closing has occurred and irrevocable written instructions with respect to the funds in the Trust Account to deliver such
funds with respect to the payments referred to in Section&nbsp;5.23.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Section
16 Matters</U></B>. Prior to the Effective Time, Cambridge shall take all reasonable steps as may be required or permitted to cause
any dispositions of the Cambridge Shares and Cambridge Warrants that occur or are deemed to occur by reason of or pursuant to the
Transactions by each individual who is or will be subject to the reporting requirements of Section 16(a) of the Exchange Act with
respect to Cambridge to be exempt under Rule 16b-3 promulgated under the Exchange Act, including by taking steps in accordance
with the No-Action Letter, dated January 12, 1999, issued by the SEC regarding such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Surviving
Pubco Plan</U></B>. As soon as practicable following Closing, Surviving Pubco shall create an incentive stock plan created under
the laws of Israel and administered by the Board of Surviving Pubco or a committee thereof (the &ldquo;<U>Surviving Pubco Plan</U>&rdquo;)
that provides that an aggregate of no more than 8% of the Surviving Pubco Shares to be outstanding immediately after the Effective
Time shall be reserved for issuance pursuant to the Surviving Pubco Plan; provided, that (i) the Surviving Pubco Plan shall require
all issuances shall be made at fair market value on the date of grant and (ii) provided further that such Surviving Pubco Plan
shall not provide for any grants to the Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Company
Dividend</U></B>. At or prior to the Closing, the Company shall, and shall be permitted hereunder to, declare and pay a cash dividend
to the holders of shares of Company Common Stock of Eleven Million US Dollars (US$11,000,000) (the &ldquo;<U>Company Dividend</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Joint
Venture Acquisition Agreement</U></B>. As of the date of this Agreement, the Company, Cambridge, the Stockholders, Eyal Tzur and
the Joint Venture Partner shall enter into that certain Share Purchase Agreement (the &ldquo;<U>Joint Venture Acquisition Agreement</U>&rdquo;)
in the form attached hereto as <U>Exhibit E</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Stockholder
Right to Veto Private Placements</U>. </B> From the Closing until the second anniversary thereof, each Stockholder has the right
to prohibit Surviving Pubco from closing on any private placement of Surviving Pubco Shares (a) being sold to any Persons who were
holders of Cambridge capital stock at the Closing Date or (b) that would be contrary to Sections 103C(8) and 103(C)(9) of the Israel
Tax Ordinance, except if any of the foregoing private placement types are then allowable under the tax rulings issued under the
ITA in connection with the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Conversion
of Early Bird Capital Warrants</U></B>. At Closing, those warrants of Cambridge held by Early Bird Capital shall be converted into
150,000 Surviving Pubco Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Escrows</U></B>.
At Closing, the parties shall deliver or cause to be delivered the escrow agreements prescribed by <U>Schedule 5.31</U> attached
hereto, including the Continental Escrow Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
VI.</B></FONT><BR>
<B>CONDITIONS TO THE TRANSACTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Conditions
to Obligations of Each Party to Effect the Transactions</U></B>. The respective obligations of each party to this Agreement to
effect the Transactions shall be subject to the satisfaction or waiver (where permissible) at or prior to the Closing Date of the
following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Registration
Statement</U></B>. The Registration Statement shall have become effective under the Securities Act and shall not be the subject
of any stop order suspending the effectiveness of the Registration Statement nor shall proceedings for that purpose shall have
been threatened or initiated by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Cambridge
Stockholder Approval</U></B>. This Agreement and the Transactions shall have been duly approved and adopted by the stockholders
of Cambridge by the requisite vote under the laws of the State of Delaware and the Cambridge Charter Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Cambridge
Net Tangible Assets</U></B>. Cambridge shall have at least $5 million of net tangible assets following the exercise by holders
of Cambridge Common Stock issued in Cambridge&rsquo;s initial public offering of securities and outstanding immediately before
the Closing of their right to convert their shares into a pro rata share of the Trust Fund in accordance with Cambridge&rsquo;s
Charter Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Cambridge
Common Stock</U></B>. The time period for the valid exercise of conversion rights shall have terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Nasdaq</U></B>.
The shares of Surviving Pubco Shares to be issued in the Redomestication Merger shall have been authorized for listing on the Nasdaq,
subject to official notice of issuance; <U>provided</U>, <U>however</U>, that any certification of compliance with Nasdaq&rsquo;s
minimum number of beneficial holders requirement shall not occur until after Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Additional
Conditions to Obligations of the Company</U></B>. The obligations of the Company and the Stockholders to consummate and effect
the Transactions shall be subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any
of which may be waived, in writing, exclusively by the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Representations
and Warranties</U></B>. Each representation and warranty of Cambridge and Holdco contained in this Agreement shall have been true
and correct (without regard to any materiality or Material Adverse Effect qualifier contained therein) (A) as of the date of this
Agreement and (B) on and as of the Closing Date (except for any representations and warranties made as of an earlier date, which
shall be true and correct as of the specified date) with the same force and effect as if made on the Closing Date, except (i) where
the failure of such representations and warranties to be true and correct would not have a Material Adverse Effect on Cambridge
or Holdco and (ii) that the representation set forth in Sections 3.9(ii) shall be true and correct in all respects as of the date
of this Agreement and as of the Closing Date as though made as of the Closing Date. The Company shall have received a certificate
with respect to the foregoing signed on behalf of Cambridge and Holdco by an authorized officer of Cambridge and Holdco (&ldquo;<U>Cambridge
Closing Certificate</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Agreements
and Covenants</U></B>. Cambridge and Holdco shall have performed or complied with all agreements and covenants required by this
Agreement to be performed or complied with by them on or prior to the Closing Date, in each case in all material respects, and
the Cambridge Closing Certificate shall include a provision to such effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Litigation</U></B>. No action, suit or proceeding shall be pending or threatened which is reasonably likely to (i) prevent consummation
of any of the transactions contemplated by this Agreement, (ii) cause any of the transactions contemplated by this Agreement to
be rescinded following consummation or (iii) affect materially and adversely the right of Cambridge or the Company to own, operate
or control any of the assets and operations of Surviving Pubco following the Transactions and no order, judgment, decree, stipulation
or injunction to any such effect shall be in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Consents</U></B>.
Cambridge and Holdco shall have obtained all consents, waivers and approvals required to be obtained in connection with the consummation
of the transactions contemplated hereby, other than consents, waivers and approvals the absence of which, either alone or in the
aggregate, would not reasonably be expected to have a Material Adverse Effect on Cambridge or Holdco and the Cambridge Closing
Certificate shall include a provision to such effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Material
Adverse Effect</U></B>. No Material Adverse Effect with respect to Cambridge or Holdco shall have occurred since the date of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>SEC
Compliance</U></B>. Immediately prior to Closing, Cambridge shall be in compliance with the reporting requirements under the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Lock-Up
Agreements</U></B>. The applicable Lock-Up Agreements shall be executed by each of the Persons (other than the Stockholders) set
forth on <U>Schedule 1.14(i)</U> and <U>1.14(ii)</U> and delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Reserved.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Reserved</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Evidence
of Repayments</U></B>. Cambridge shall have received reasonably satisfactory evidence that the repayments and conditions required
under Section 5.3 have been made and satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>&nbsp;Directors
Comprising the Surviving Pubco Board</U></B>. The provisions of Section 5.2(a) herein shall have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Other
Deliveries</U></B>. At or prior to Closing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
shall have delivered to the Company (a) copies of resolutions and actions taken by the respective board of directors and stockholders
of Cambridge and Holdco in connection with the approval of this Agreement and the transactions contemplated hereunder, and (b)
such other documents or certificates as shall reasonably be required by the Company and its counsel in order to consummate the
transactions contemplated hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Cambridge
shall have delivered or issued, as applicable, to the Stockholders pro rata with their ownership of Company Common Shares (a) the
Cash Consideration by wire transfer of immediately available funds to an account designated in writing to the Cambridge Representative,
and (b) the Closing Date Share Consideration to the Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Trust
Fund</U></B>. Cambridge shall have caused the Trust Fund, which shall consist of no less than $40,000,000 at Closing after giving
effect to the amounts paid and to be paid pursuant to Section 5.23, to be disbursed to the Company upon the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Opinion
of Cambridge Counsel</U></B>. The Company shall have received from Graubard Miller, counsel to Cambridge, the opinion of counsel
in substantially the form of <U>Exhibit F</U> annexed hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Additional
Conditions to the Obligations of Cambridge and Holdco</U></B>. The obligations of Cambridge and Holdco to consummate and effect
the Transactions shall be subject to the satisfaction at or prior to the Closing Date of each of the following conditions, any
of which may be waived, in writing, exclusively by Cambridge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Representations
and Warranties</U></B>. Each representation and warranty of the Company and the Stockholder contained in this Agreement shall have
been true and correct (without regard to any materiality or Material Adverse Effect qualifier contained therein) (A) as of the
date of this Agreement and (B) on and as of the Closing Date (except for any representations and warranties made as of an earlier
date, which shall be true and correct as of the specified date) with the same force and effect as if made on the Closing Date,
except (i) where the failure of such representations and warranties to be true and correct would not have a Material Adverse Effect
on the Company and (ii) that the representation set forth in Section 2.9(ii) shall be true and correct in all respects as of the
date of this Agreement and as of the Closing Date as though made as of the Closing Date. Cambridge shall have received a certificate
with respect to the foregoing signed on behalf of the Company by an authorized officer of the Company (&ldquo;<U>Company Closing
Certificate</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Agreements
and Covenants</U></B>. The Company and the Stockholder shall have performed or complied with all agreements and covenants required
by this Agreement to be performed or complied with by them at or prior to the Closing Date except to the extent that any failure
to perform or comply (other than a willful failure to perform or comply or failure to perform or comply with an agreement or covenant
reasonably within the control of the Company) does not, or will not, constitute a Material Adverse Effect on the Company, and the
Company Closing Certificate shall include a provision to such effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Litigation</U></B>. No action, suit or proceeding shall be pending or threatened before any Governmental Entity which is reasonably
likely to (i) prevent consummation of any of the transactions contemplated by this Agreement, (ii) cause any of the transactions
contemplated by this Agreement to be rescinded following consummation or (iii) affect materially and adversely the right of Cambridge
or the Company to own, operate or control any of the assets and operations of Surviving Pubco or the Company following the Transactions
and no order, judgment, decree, stipulation or injunction to any such effect shall be in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Consents</U></B>.
The Company shall have obtained all consents, waivers, permits and approvals required to be obtained by the Company in connection
with the consummation of the transactions contemplated hereby, other than consents, waivers and approvals the absence of which,
either alone or in the aggregate, could not reasonably be expected to have a Material Adverse Effect on the Company and the Company
Closing Certificate shall include a provision to such effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Material
Adverse Effect</U></B>. No Material Adverse Effect with respect to the Company shall have occurred since the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Lock-Up
Agreements</U></B>. The applicable Lock-Up Agreements shall be executed by each of the Stockholders and delivered to Cambridge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Reserved</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Reserved</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Opinions
of Company Counsel</U></B>. Cambridge shall have received (i) from Blank Rome LLP, US counsel to the Company, or such other counsel
that is reasonably acceptable to Cambridge, an opinion of counsel in substantially the form of <U>Exhibit H</U> annexed hereto;
(ii) from Levin-Fisher, law offices, Israeli counsel to the Company, or such other counsel that is reasonably acceptable to Cambridge,
an opinion of counsel with respect to Israeli matters relating to the Company (but other than regulation relating to security export
controls) in substantially the form of <U>Exhibit I</U> annexed hereto; and (iii) from the law offices of Jonathan Aronson, Israeli
counsel to the Company, or such other counsel that is reasonably acceptable to Cambridge, an opinion of counsel with respect to
Israeli security export controls regulations, in substantially the form of <U>Exhibit J</U> annexed hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Other
Deliveries</U></B>. At or prior to Closing, the Company shall have delivered to Cambridge: (i) copies of resolutions and actions
taken by the Company&rsquo;s board of directors and stockholders in connection with the approval of this Agreement and the transactions
contemplated hereunder, and (ii) such other documents or certificates as shall reasonably be required by Cambridge and its counsel
in order to consummate the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Insider
Loans; Equity Ownership in Subsidiaries</U></B>. (i) All outstanding indebtedness owed by Insiders to the Company shall have been
repaid in full, including the indebtedness and other obligations described on <U>Schedule&nbsp;2.23</U>; (ii) all outstanding guaranties
and similar arrangements pursuant to which the Company has guaranteed the payment or performance of any obligations of any Insider
to a third party shall have been terminated; and (iii) no Insider shall own any direct equity interests in any Subsidiary of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Employment
Agreements</U></B>. The Company shall have entered into employment agreements in the forms of <U>Exhibit K-1</U> and <U>Exhibit
K-2</U> annexed hereto with each of the Stockholders, which employment agreements shall be effective as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
VII.</B></FONT><BR>
<B>INDEMNIFICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Indemnification
of Surviving Pubco by the Stockholders</U></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Effective
at and after the Closing, subject to the terms and conditions of this Article&nbsp;VII (including the limitations set forth in
Section&nbsp;7.4), the Surviving Pubco and its representatives, successors and permitted assigns (the &ldquo;<U>Indemnified Parties</U>&rdquo;)
shall be indemnified, defended and held harmless, through the availability of the Escrow Shares and solely to the extent of the
Escrow Shares, from and against all Losses asserted against, resulting to, imposed upon, or incurred by any Indemnified Party by
reason of, arising out of or resulting from:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
inaccuracy or breach of any representation or warranty of the Company contained in or made pursuant to this Agreement, including
any Schedule&nbsp;or ancillary agreement hereto, or contained in any certificate delivered by the Company to Cambridge pursuant
to this Agreement with respect hereto or thereto in connection with the Closing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
non-fulfillment or breach of any covenant or agreement of the Company contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify">Notwithstanding anything contained
in this Section 7.1, the matter set forth on Schedule 2.10 shall not be subject to this Article VII, and no indemnification obligations
shall apply hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>As
used in this Article&nbsp;VII, the term &ldquo;<U>Losses</U>&rdquo; shall include on a dollar for dollar basis all losses, liabilities,
damages, judgments, awards, orders, penalties, settlements, costs and expenses (including interest, penalties, court costs and
reasonable legal fees and expenses) including those arising from any demands, claims, suits, actions, costs of investigation, notices
of violation or noncompliance, causes of action, proceedings and assessments whether or not made by third parties or whether or
not ultimately determined to be valid; provided that in no event will Losses include any indirect, incidental, remote, exemplary,
special, consequential, diminution of value, failure to realize savings or benefits, punitive, lost profits, loss of use, or other
multiple-based losses, liabilities, damages, judgments, awards, orders, penalties, settlements, costs or expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Solely
for the purpose of determining the amount of any Losses (and not for determining whether a representation or warranty or covenant
has been breached or is inaccurate) for which the Indemnified Parties may be entitled to indemnification pursuant to Article&nbsp;VII,
any representation or warranty contained in this Agreement that is qualified by a term or terms such as &ldquo;material,&rdquo;
&ldquo;materially,&rdquo; or &ldquo;Material Adverse Effect&rdquo; shall be deemed made or given without such qualification and
without giving effect to such words.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any
payment for an Indemnifiable Loss pursuant to this Section&nbsp;7.1 shall be made out of the Escrow Shares by transferring to the
Surviving Pubco that number of Escrow Shares that is equal to the amount of the Indemnifiable Loss as determined by the terms of
the Continental Escrow Agreement, subject to <U>Section&nbsp;7.4</U>. As used in this <U>Article VII</U>, the term &ldquo;<U>Indemnifiable
Loss</U>&rdquo; means an amount equal to (A)&nbsp;the amount of any Loss <I>multiplied</I> by the number that is (B) equal to one
<I>minus</I> the quotient of (1)&nbsp;the total number of shares representing the Closing Date Share Consideration, including the
Escrow Shares, <I>divided</I> by (2)&nbsp;the total number of shares of Surviving Pubco Shares issued and outstanding immediately
after giving effect to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Indemnification
of Third Party Claims</U></B>. The indemnification obligations and liabilities under this <U>Article&nbsp;VII</U> with respect
to actions, proceedings, lawsuits, investigations, demands or other claims brought against a party under an obligation to indemnify
pursuant to Sections 7.1 other than the Indemnified Parties (a &ldquo;<U>Third Party Claim</U>&rdquo;) shall be subject to the
following terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Notice
of Claim</U></B>. The Indemnified Parties will give the Stockholders prompt written notice after receiving written notice of any
Third Party Claim or discovering the liability, obligation or facts giving rise to such Third Party Claim (a &ldquo;<U>Notice of
Claim</U>&rdquo;) which Notice of Third Party Claim shall set forth (i) a brief description of the nature of the Third Party Claim,
(ii) the underlying representation, warranty or covenant alleged to have been breached and the facts then known on which such alleged
breach is based, (iii) the total amount of the actual out-of-pocket Loss or the anticipated potential Loss (including any costs
or expenses which have been or may be reasonably incurred in connection therewith), and (iv) whether such Loss may be covered (in
whole or in part) under any insurance and the estimated amount of such Loss which may be covered under such insurance, and the
Stockholders shall be entitled to participate in the defense of Third Party Claim at their expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Defense</U></B>.
The Stockholders shall have the right, at their option (subject to the limitations set forth in subsection 7.2(c) below) and at
their own expense, by written notice to the Indemnified Parties, to assume the entire control of, subject to the right of the Indemnified
Parties to participate (at their expense and with counsel of their choice) in, the defense, compromise or settlement of the Third
Party Claim as to which such Notice of Claim has been given, and shall be entitled to appoint a recognized and reputable counsel
to be the lead counsel in connection with such defense; provided that the Stockholders&rsquo; assumption of the defense of a Third
Party Claim will not, vis-&agrave;-vis the Indemnified Parties, constitute acceptance of liability to the Indemnified Parties under
this Article VII. So long as the Stockholders are contesting any such claim in good faith, the Indemnified Parties shall not pay
or settle any such claim; <U>provided</U>, <U>however</U>, that notwithstanding the foregoing, the Indemnified Parties shall have
the right to pay or settle any such claim at any time, provided that in such event, the Indemnified Parties shall waive any right
of indemnification therefor under this Article VII. If the Stockholders elect to assume the defense of a Third Party Claim:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Stockholders shall diligently and in good faith defend such Third Party Claim and shall keep the Indemnified Parties reasonably
informed of the status of such defense and shall have full control of such defense and proceedings, including any compromise or
settlement thereof; provided, however, that the Stockholders shall obtain the prior written consent of the applicable Indemnified
Party before entering into any compromise or settlement of such Third Party Claim, which consent shall not be unreasonably withheld,
delayed or conditioned; provided further<I>,</I> that no such consent shall be required for any such compromise or settlement that:
(A) is exclusively monetary and will be paid in full out of the Escrow Shares (rather than by the applicable Indemnified Party);
(B) does not contain an admission of liability on the part of any Indemnified Party; and (C) unconditionally and fully releases
the applicable Indemnified Party with respect to such Third Party Claim; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
Indemnified Parties shall cooperate fully in all respects with the Stockholders in any such defense, compromise or settlement thereof,
including the selection of counsel and in making any related counterclaim against the Person asserting the Third Party Claim or
any cross-complaint against any Person, and the Indemnified Parties shall make available to the Stockholders all pertinent information
and documents under its control, including by providing the Stockholders with reasonable access during normal business hours of
the applicable Indemnified Party to books, records and personnel of the applicable Indemnified Party (but only to the extent relevant
to such Third Party Claim).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Limitations
of Right to Assume Defense</U></B>. The Stockholders shall not be entitled to assume control of such defense if (i) the Third Party
Claim relates to or arises in connection with any criminal proceeding, action, indictment, allegation or investigation; (ii) the
Third Party Claim seeks an injunction or equitable relief against the Stockholders which is not merely incidental to a primary
damage claim or claims for monetary damages; or (iii) there is a reasonable probability that a Third Party Claim would result in
a Material Adverse Effect of Surviving Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Other
Limitations</U></B>. Failure to give prompt Notice of Claim or to provide copies of relevant available documents or to furnish
relevant available data shall not constitute a defense (in whole or in part) to any Third Party Claim by the Indemnified Parties
against the Indemnifying Parties and shall not affect the Indemnifying Parties&rsquo; duties or obligations under this Article&nbsp;VII,
except to the extent (and only to the extent that) such failure shall have (i) adversely affected the ability of the Stockholders
to defend against or reduce the Indemnifiable Losses or (ii) caused or increased such Indemnifiable Losses or otherwise caused
the Indemnifiable Losses to be greater than such Indemnifiable Losses would have been had the Indemnified Parties given the Stockholders
prompt notice hereunder. So long as the Stockholders are defending any such action actively and in good faith, the Indemnified
Parties shall not settle such action. The Indemnified Parties shall make available to the Stockholders all relevant records and
other relevant materials required by them and in the possession or under the control of the Indemnified Parties, for the use of
the Stockholders and their representatives in defending any such action, and shall in other respects give reasonable cooperation
in such defense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Failure
to Defend</U></B>. If the Stockholders, promptly after receiving a Notice of Claim, fail to defend such Third Party Claim in good
faith, the Indemnified Parties, at their own cost and expense, will (upon further written notice) have the right to undertake the
defense, compromise or settlement of such Third Party Claim as they may determine in their reasonable discretion, provided that
the Stockholders shall have the right to approve any settlement, which approval will not be unreasonably withheld, delayed or conditioned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Indemnifying
Parties Consent</U></B>. Unless the Stockholders have consented to a settlement of a Third Party Claim, the amount of the settlement
shall not be a binding determination of the amount of the Loss and such amount shall be determined in accordance with the provisions
of the Continental Escrow Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Advancement
of Defense Costs</U></B>. Notwithstanding anything to the contrary contained herein, the Surviving Pubco shall advance to or pay
on behalf of the Stockholders the reasonable out-of-pocket costs and expenses incurred by the Stockholders in connection with the
defense of any alleged Indemnifiable Matter asserted by the Surviving Pubco, including reasonable attorneys&rsquo; fees; provided,
however, if it is finally determined by a court of competent jurisdiction that the Indemnifiable Losses related to any such indemnifiable
matter shall be satisfied through the availability of the Escrow Shares, the advances to or payments made on behalf of the Stockholders
shall count towards the aggregate Indemnifiable Losses incurred by the Surviving Pubco in connection with such indemnifiable matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Insurance
Effect</U></B>. To the extent that any Losses that are subject to indemnification pursuant to this Article&nbsp;VII are covered
by insurance paid for by the Surviving Pubco or the Company prior to or after the Closing, the Surviving Pubco and the Company
shall use commercially reasonable efforts to obtain the maximum recovery under such insurance; provided that the Indemnified Parties
shall nevertheless be entitled to bring a claim for indemnification under this Article&nbsp;VII in respect of such Losses and the
time limitations set forth in Section&nbsp;7.4 hereof for bringing a claim of indemnification under this Agreement shall be tolled
during the pendency of such insurance claim. The existence of a claim by the Indemnified Parties for monies from an insurer or
against a third party in respect of any Loss shall not, however, delay any payment pursuant to the indemnification provisions contained
herein and otherwise determined to be due and owing from the Escrow Shares. If the Surviving Pubco has received the payment required
by this Agreement from the Escrow Shares in respect of any Loss and later receives proceeds from insurance or other amounts in
respect of such Loss, then it shall hold such proceeds or other amounts in trust for the benefit of the Stockholders and shall
return to escrow the Escrow Shares released to the Indemnified Parties or in the event of a subsequent sale thereof, as promptly
as practicable after receipt, a sum equal to the amount of such proceeds or other amount realized by the Indemnified Parties upon
such sale. Notwithstanding any other provisions of this Agreement, it is the intention of the parties that no insurer or any other
third party shall be (i) entitled to a benefit it would not be entitled to receive in the absence of the foregoing indemnification
provisions, or (ii) relieved of the responsibility to pay any claims for which it is obligated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Limitations
on Indemnification</U></B>. Notwithstanding anything to the contrary in this Article VII or elsewhere in this Agreement, the following
terms will apply to any claim arising out of this Agreement or related to the transactions contemplated hereby:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Survival:
Time Limitation</U></B>. The representations and warranties of the parties under this Agreement will survive the execution and
delivery of this Agreement until the first anniversary of the Closing Date, at which time such representations and warranties will
expire (the &ldquo;<U>Basic Survival Period</U>&rdquo;) except that the right of the Indemnified Parties to bring (i) Additional
Indemnity Claims shall survive the Closing for the period that ends on the Additional Indemnity Escrow Termination Date (the &ldquo;<U>Additional
Indemnity Survival Period</U>&rdquo;), (ii) Claims for the breach of the representations and warranties in Sections 2.1(a) and
(b) and 2.4, 1.12(b)(i) and 1.12(b)(ii) shall survive without limitation as to time, and (iii) Claims for the breach of the representations
and warranties in Sections 3.1 and 3.4 shall survive without limitation as to time. The covenants and agreements of the parties
hereto contained in this Agreement or in any certificate or other writing delivered pursuant hereto or thereto or in connection
herewith shall survive the Closing indefinitely or for the shorter period explicitly specified therein, except that for such covenants
and agreements that survive for such shorter period, breaches thereof shall survive indefinitely or until the latest date permitted
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Any
indemnification claim made by the Indemnified Parties prior to the termination of the Basic Survival Period or the Additional Indemnity
Survival Period (each a &ldquo;<U>Survival Period</U>&rdquo;), as the case may be, in accordance with the requirements of this
Agreement shall be preserved despite the subsequent termination of such Survival Period and any claim set forth in a Notice of
Claim sent prior to the expiration of such Survival Period shall survive until final resolution thereof. Except as set forth in
the immediately preceding sentence, no claim for indemnification under this Article&nbsp;VII shall be brought after the end of
the Survival Period or the Additional Indemnity Survival Period, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Deductible</U></B>.
No amount shall be payable under Article&nbsp;VII unless and until the aggregate amount of all Indemnifiable Losses otherwise payable
exceeds $1,500,000 (the &ldquo;<U>Deductible</U>&rdquo;), in which event all Indemnifiable Losses so due in excess of the Deductible
shall be paid out of the Escrow Shares. Notwithstanding anything to the contrary contained herein, the Deductible shall not apply
to any claims for Indemnifiable Losses for the breach of the representations and warranties contained in Section 2.6 (Compliance).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Aggregate
Amount Limitations</U></B>. The aggregate liability for Losses pursuant to Section&nbsp;7.1 shall not in any event exceed the Escrow
Shares in the case of Basic Indemnity Claims or the Additional Indemnity Shares in the case of Additional Indemnity Claims, and
Surviving Pubco shall have no claim against the Stockholders other than for any of such Escrow Shares (and any non-cash dividends
declared and actually paid with respect to the Escrow Shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Double Recovery</U></B>. In the event that any Losses for which indemnification is provided under this Article VII are recoverable
under more than one provision of this Agreement, the Indemnified Parties will only be permitted to recover with respect to any
particular Losses suffered by it one time as it is the parties&rsquo; intention that once any particular Losses have been recovered
by the Indemnified Parties under one provision, such Losses no longer exist and, therefore, recovery by the Indemnified Parties
for such same Losses under another provision would constitute an unintended and prohibited &ldquo;double&rdquo; recovery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Miscellaneous
Limitations</U></B>. Notwithstanding anything to the contrary contained in this Agreement or otherwise, the Indemnified Parties
will not be entitled to indemnification pursuant to Section 7.1 for any Loss underlying such indemnification claim to the extent
that: (i) the Indemnified Parties could have, with commercially reasonable efforts, mitigated or prevented such Loss (or any part
thereof); (ii) such Loss (or any part thereof) results from or is increased by the action or inaction of any Indemnified Parties
or any Affiliate thereof; (iii) such Loss (or any part thereof) arises, or is increased, as a result of a change after the Closing
in any accounting principle, method or policy, or (iv)&nbsp;Cambridge had, prior to the Closing Date, actual knowledge of a breach
of the applicable representation, warranty or covenant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>EXCLUSIVE
REMEDY</U></B>. HOLDCO (WHICH SHALL SURVIVE THE REDOMESTICATION MERGER TO BECOME SURVIVING PUBCO, ON BEHALF OF ITSELF AND THE OTHER
INDEMNIFIED PARTIES, HEREBY ACKNOWLEDGES AND AGREES THAT, FROM AND AFTER THE CLOSING, THE SOLE AND EXCLUSIVE REMEDY OF THE INDEMNIFIED
PARTIES WITH RESPECT TO ANY AND ALL CLAIMS FOR LOSSES ARISING OUT OF OR RELATING TO THIS AGREEMENT SHALL BE PURSUANT AND SUBJECT
TO THE REQUIREMENTS OF THE INDEMNIFICATION PROVISIONS SET FORTH IN THIS ARTICLE&nbsp;VII. ACCORDINGLY, EACH OF THE PARTIES TO THIS
AGREEMENT EXPRESSLY WAIVES AND RELEASES ANY REMEDY, LIABILITY AND ANY RIGHTS IT MAY HAVE PURSUANT TO LAW OR EQUITY OTHER THAN THE
REMEDIES EXPRESSLY PROVIDED UNDER THIS ARTICLE VII. FURTHERMORE, EACH PARTY TO THIS AGREEMENT COVENANTS NOT TO SUE OR OTHERWISE
THREATEN ANY CLAIM THAT INCLUDES ANY REMEDY WAIVED BY THE PRECEDING SENTENCE, AND SUCH PARTIES AGREE THAT, TO THE EXTENT REQUIRED
BY APPLICABLE LAW TO BE EFFECTIVE, THE AGREEMENT, WAIVERS AND RELEASES CONTAINED IN THIS SECTION 7.5 ARE CONSPICUOUS. NOTWITHSTANDING
ANY OF THE FOREGOING, NOTHING CONTAINED IN THIS ARTICLE&nbsp;VII SHALL IN ANY WAY IMPAIR, MODIFY OR OTHERWISE LIMIT THE INDEMNIFIED
PARTIES&rsquo; RIGHT TO BRING ANY CLAIM, DEMAND OR SUIT AGAINST THE OTHER PARTY BASED UPON SUCH OTHER PARTY&rsquo;S ACTUAL FRAUD
OR INTENTIONAL OR WILLFUL MISREPRESENTATION OR OMISSION, IT BEING UNDERSTOOD THAT A MERE BREACH OF A REPRESENTATION AND WARRANTY,
WITHOUT INTENTIONAL OR WILLFUL MISREPRESENTATION OR OMISSION, DOES NOT CONSTITUTE FRAUD. NOTWITHSTANDING ANY OF THE FOREGOING,
AND FOR PURPOSE OF FURTHER CLARITY, NOTHING IN THIS AGREEMENT, INCLUDING THIS SECTION 7.5, SHALL SERVE TO LIMIT OR ELIMINATE ANY
REMEDY AVAILABLE TO CAMBRIDGE OR THE SURVIVING PUBCO AT LAW OR EQUITY UNDER THE JOINT VENTURE ACQUISITION AGREEMENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Adjustment
to Merger Consideration</U></B>. Amounts paid for indemnification under Article&nbsp;VII shall be deemed to be an adjustment to
the value of the Surviving Pubco Shares issued by Surviving Pubco as a result of the Transactions, except as otherwise required
by Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Representative
Capacities; Application of Escrow Shares</U></B>. The parties acknowledge that the Cambridge Representative&rsquo;s obligations
under this Article&nbsp;VII are solely as a representative of the stockholders of Cambridge immediately prior to the Effective
Time in the manner set forth in the Continental Escrow Agreement with respect to the obligations to indemnify the Surviving Pubco
under this Article&nbsp;VIII and that the Cambridge Representative shall have no personal responsibility for any expenses incurred
by him in such capacity and that all payments to the Surviving Pubco as a result of such indemnification obligations shall be made
solely from, and to the extent of, the Escrow Shares. Reasonable and actual out-of-pocket expenses of the Cambridge Representative
for attorneys&rsquo; fees and other costs shall be borne in the first instance by the Surviving Pubco, which may make a claim for
reimbursement thereof as part of the Indemnifiable Losses against the Escrow Shares upon the claim with respect to which such expenses
are incurred becoming an Established Claim (as defined in the Continental Escrow Agreement). The Continental Escrow Agent, pursuant
to the Continental Escrow Agreement after the Closing, may apply all or a portion of the Escrow Shares to satisfy any claim for
indemnification pursuant to this Article&nbsp;VII. The value of the Escrow Shares shall be determined in accordance with this Agreement
and the Continental Escrow Agreement. The Continental Escrow Agent will hold the remaining portion of the Escrow Shares until final
resolution of all claims for indemnification or disputes relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Tax
Benefits</U></B>. The amount of any Losses for which indemnification is provided shall be reduced by any net Tax benefit to such
Indemnified Party and its Affiliates, to the extent realized by such party as a result of such Losses, including the present value
(determined by discounting at 8%) of the benefit arising from an increase in the Tax basis of assets, net of any Tax costs incurred
by the Indemnified Party as a result of the receipt of the indemnification payments hereunder. In calculating the amount of net
Tax benefit, the Indemnified Party and its Affiliates shall be presumed to pay Taxes at a forty percent (40%) Tax rate. The Indemnified
Party shall provide the Indemnifying Party with such documentation as may be reasonably requested in order to ascertain or confirm
the amount of any net Tax benefit or net Tax cost referred to herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Mitigation</U></B>.
A Indemnified Party shall use commercially reasonable efforts to mitigate Losses suffered, incurred or sustained by it arising
out of any matter for which it is entitled to indemnification hereunder; provided that no Indemnified Party shall be required to
(i) take any action or refrain from taking any action that is contrary to any applicable Contract, order or law binding on it or
any Affiliate thereof or (ii) incur any out-of-pocket expense in connection with such mitigation (other than de minimis incidental
expenses).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>NO
RELIANCE</U></B>. AS MODIFIED BY THE APPLICABLE DISCLOSURE SCHEDULES, THE REPRESENTATIONS AND WARRANTIES OF THE COMPANY CONTAINED
IN ARTICLE II AND CAMBRIDGE AND HOLDCO IN ARTICLE III, CONSTITUTE THE SOLE AND EXCLUSIVE REPRESENTATIONS AND WARRANTIES OF THE
PARTIES TO THIS AGREEMENT AND IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT OR ANY ANCILLARY AGREEMENT HERETO.
EXCEPT FOR SUCH REPRESENTATIONS AND WARRANTIES, NO PARTY TO THIS AGREEMENT MAKES ANY OTHER EXPRESS OR IMPLIED REPRESENTATION OR
WARRANTY OF ANY NATURE. EACH PARTY CONFIRMS THAT IT IS NOT RELYING ON ANY REPRESENTATION OR WARRANTY OTHER THAN AS SET FORTH IN
THIS AGREEMENT AND EACH PARTY ACKNOWLEDGES THAT THIS NO RELIANCE CONFIRMATION IS A MATERIAL INDUCEMENT TO THE OTHER PARTY&rsquo;S
WILLINGNESS TO ENTER INTO THIS AGREEMENT AND CONSUMMATE THE TRANSACTIONS CONTEMPLATED HEREBY AND BY ANY ANCILLARY AGREEMENT HERETO.
WITHOUT LIMITING THE FOREGOING, THE PARTIES ACKNOWLEDGE AND AGREE THAT, EXCEPT AS EXPRESSLY SET FORTH IN ARTICLE II, THE COMPANY
IS NOT MAKING AND HAS NOT MADE ANY REPRESENTATION OR WARRANTY WITH RESPECT TO MATERIALS FURNISHED TO CAMBRIDGE OR ITS REPRESENTATIVES
DURING THE DILIGENCE PROCESS OR OTHERWISE (INCLUDING FINANCIAL OR OPERATIONAL FORECASTS) OR MATTERS THAT WERE DISCUSSED ORALLY
OR IN WRITING ON OR PRIOR TO THE DATE HEREOF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
VIII.</B></FONT><BR>
<B>TERMINATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Termination</U></B>.
This Agreement may be terminated at any time prior to the Closing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
mutual written agreement of Cambridge and the Company at any time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
either Cambridge or the Company if the Transactions shall not have been consummated by December 23, 2015 (the &ldquo;<U>Termination
Date</U>&rdquo;) for any reason; provided, however, that the right to terminate this Agreement under this Section&nbsp;8.1(b) shall
not be available to any party whose action or failure to act has been a principal cause of or resulted in the failure of the Transactions
to occur on or before such date and such action or failure to act constitutes a breach of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
either Cambridge or the Company if a Governmental Entity shall have issued an order, decree, judgment or ruling or taken any other
action, in any case having the effect of permanently restraining, enjoining or otherwise prohibiting the Transactions, which order,
decree, ruling or other action is final and nonappealable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
the Company, upon a material breach of any representation, warranty, covenant or agreement on the part of Cambridge set forth in
this Agreement, or if any representation or warranty of Cambridge shall have become untrue, in either case such that the conditions
set forth in Article&nbsp;VI would not be satisfied as of the time of such breach or as of the time such representation or warranty
shall have become untrue, provided, that if such breach by Cambridge is curable by Cambridge prior to the Closing Date, then the
Company may not terminate this Agreement under this Section&nbsp;8.1(d) for ten (10) days after delivery of written notice from
the Company to Cambridge of such breach (or if the Termination Date is less than ten (10) days from notice by the Company, is not
cured, or by its nature or timing cannot be cured, by the Company by the Termination Date), provided Cambridge continues to exercise
commercially reasonable efforts to cure such breach (it being understood that the Company may not terminate this Agreement pursuant
to this Section&nbsp;8.1(d) if it shall have materially breached this Agreement or if such breach by Cambridge is cured during
such ten (10)-day period);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
Cambridge, upon a material breach of any representation, warranty, covenant or agreement on the part of the Company set forth in
this Agreement, or if any representation or warranty of the Company shall have become untrue, in either case such that the conditions
set forth in Article&nbsp;VI would not be satisfied as of the time of such breach or as of the time such representation or warranty
shall have become untrue, provided, that if such breach is curable by the Company prior to the Closing Date, then Cambridge may
not terminate this Agreement under this Section&nbsp;8.1(e) for ten (10) days after delivery of written notice from Cambridge to
the Company of such breach (or if the Termination Date is less than ten (10) days from notice by Cambridge, is not cured, or by
its nature or timing cannot be cured, by Cambridge by the Termination Date), provided the Company continues to exercise commercially
reasonable efforts to cure such breach (it being understood that Cambridge may not terminate this Agreement pursuant to this Section&nbsp;8.1(e)
if it shall have materially breached this Agreement or if such breach by the Company is cured during such ten (10)-day period);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
either Cambridge or the Company, if, at the Special Meeting (including any adjournments thereof), this Agreement and the transactions
contemplated thereby shall fail to be approved and adopted by the affirmative vote of the holders of Cambridge Common Stock required
under Cambridge&rsquo;s Charter Documents, or Cambridge will have less than $5 million of net tangible assets following the exercise
by the holders of shares of Cambridge Common Stock issued in Cambridge&rsquo;s initial public offering of their rights to convert
the Cambridge Common Stock held by them into cash in accordance with Cambridge&rsquo;s Charter Documents;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
the Company, if immediately prior to the Transactions, Cambridge does not have cash on hand (or in Cambridge&rsquo;s Trust Fund)
of at least $40,000,000, after giving effect to the amounts paid or to be paid in accordance with Section 5.23;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
the Company, if the Registration Statement and the Proxy Statement/Prospectus are not filed with the SEC on or prior to the Filing
Deadline; <U>provided</U> that such failure to file is not due to the Company&rsquo;s failure to furnish to Cambridge all information
concerning its company and business in a timely fashion and as has been reasonably requested in connection with the preparation
of the Registration Statement and Proxy Statement/Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
Cambridge, if the Registration Statement and the Proxy Statement/Prospectus are not filed with the SEC on or prior to the Filing
Deadline and such failure to file is due to the Company&rsquo;s failure to furnish to Cambridge all information concerning its
company and business in a timely fashion and as has been reasonably requested in connection with the preparation of the Registration
Statement and Proxy Statement/Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
Cambridge if the relevant Israeli tax authorities issue any ruling or decision prior to Closing that serves to lockup or restrict
transfers by any person holding Cambridge Common Stock prior to the consummation of the transactions contemplated hereby, other
than any pre-Closing director or officer of Cambridge holding 5% or more of the outstanding Cambridge Common Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
the Company if the relevant tax authorities issue any ruling or decision (the &ldquo;<U>ITA Ruling</U>&rdquo;) prior to Closing
that does not provide for the tax treatment to the Stockholders under Section 103[t] of Israel Tax Ordinance contemplated by their
application to the ITA to be filed (a copy to be promptly provided to Cambridge (&ldquo;<U>ITA Application</U>&rdquo;)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>by
Cambridge if either ASM or the ASM Stockholder has materially breached any representation or covenant contained in the Joint Venture
Agreement; unless the business and operations of ASM can be otherwise transferred to Surviving Pubco without liabilities to Surviving
Pubco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Notice
of Termination; Effect of Termination</U></B>. Any termination of this Agreement under Section&nbsp;8.1 above will be effective
immediately upon (or, if the termination is pursuant to Section&nbsp;8.1(d) or Section&nbsp;8.1(e) and the proviso therein is applicable,
thirty (30) days after) the delivery of written notice of the terminating party to the other parties hereto. In the event of the
termination of this Agreement as provided in Section&nbsp;8.1, this Agreement shall be of no further force or effect and the Transactions
shall be abandoned, except for and subject to the following: (i) Sections 5.6(a), 5.12, 8.2 and 8.3 and Article&nbsp;X (General
Provisions) shall survive the termination of this Agreement, and (ii) nothing herein shall relieve any party from liability for
any breach of this Agreement, including a breach by a party electing to terminate this Agreement pursuant to Section&nbsp;8.1(b)
caused by the action or failure to act of such party constituting a principal cause of or resulting in the failure of the Transactions
to occur on or before the date stated therein; provided however, the liabilities hereunder shall not include any consequential,
special, indirect or punitive damages (except to the extent any such consequential, special, incidental, indirect or punitive damages
are paid to a third party in a third party claim).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Fees
and Expenses</U></B>. Except as otherwise specifically provided in this Agreement, all fees and expenses incurred in connection
with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such expenses whether or not
the transactions contemplated hereby are effected and consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
IX.</B></FONT><BR>
<B>DEFINED TERMS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Terms defined in this Agreement
are organized alphabetically as follows, together with the Section and, where applicable, paragraph, number in which definition
of each such term is located:<FONT STYLE="font: 10pt Times New Roman, Times, Serif"><SUP>[1]</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ARTICLE
X.</B></FONT><BR>
<B>GENERAL PROVISIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Notices</U></B>.
All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally or by commercial
delivery service, or sent via email or telecopy to the parties at the following addresses or telecopy numbers (or at such other
address or telecopy numbers for a party as shall be specified by like notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif">if
    to Cambridge or Holdco to:</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Cambridge
    Capital Acquisition Corporation</FONT></TD>
</TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">525 South
    Flagler Drive, Suite 201</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">West Palm
    Beach, Florida 33401</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention:&nbsp;&nbsp;Benjamin
    Gordon</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telephone:&nbsp;&nbsp;(561)
    932-1600</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telecopy:&nbsp;&nbsp;&nbsp;&nbsp;(561)
    655-6232</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail:&nbsp;&nbsp;ben@cambridgecapital.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">with a copy
    to:</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Graubard
    Miller</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">405 Lexington
    Avenue</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">New York,
    New York 10174-1901</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention:
    David Alan Miller, Esq.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telephone:&nbsp;&nbsp;212-818-8880</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telecopy:&nbsp;&nbsp;&nbsp;&nbsp;212-818-8881</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Email: <U>dmiller@graubard.com</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">if to the
    Company or</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders,
    to:</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ability
    Computer &amp; Software Industries Ltd.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Yad Harutzim
    14</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tel Aviv,
    Israel, 6770007</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Attention:
    Anatoly Hurgin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telephone:
                                         972-3-6879777</FONT></P>


</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Telecopy:
                                         972-3-5376483</FONT></P>


</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">E-mail:
                                         ability@ability.co.il</FONT></P>


</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in"><SUP>1</SUP> Note:
To be inserted once agreement is fully negotiated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; width: 0.5in">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; width: 25%; text-indent: 0">with a copy to:</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Blank Rome LLP</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">405 Lexington Avenue</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">New York, NY 10174</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Attention: Robert J. Mittman</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Telephone: 212-885-5555</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Telecopy: 212-885-5001</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">E-mail: <U>rmittman@blankrome.com</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Maples &amp; Calder LLP</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">PO Box 309</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Ugland House</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Grand Cayman KY1-1104</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Attention: Michael Johns</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Telephone: 345-814-5264</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Telecopy:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">E-mail: <U>michael.johns@maplesandcalder.com</U></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-align: left; text-indent: -2in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Interpretation</U></B>.
The definitions of the terms herein shall apply equally to the singular and plural forms of the terms defined. Whenever the context
shall require, any pronoun shall include the corresponding masculine, feminine and neuter forms. When a reference is made in this
Agreement to an Exhibit or Schedule, such reference shall be to an Exhibit or Schedule&nbsp;to this Agreement unless otherwise
indicated. When a reference is made in this Agreement to Sections or subsections, such reference shall be to a Section or subsection
of this Agreement. Unless otherwise indicated the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; and &ldquo;including&rdquo;
when used herein shall be deemed in each case to be followed by the words &ldquo;without limitation.&rdquo; The table of contents
and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
of this Agreement. When reference is made herein to &ldquo;the business of&rdquo; an entity, such reference shall be deemed to
include the business of all direct and indirect Subsidiaries of such entity. Reference to the Subsidiaries of an entity shall be
deemed to include all direct and indirect Subsidiaries of such entity. For purposes of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Affiliate</U>&rdquo; means, as applied to any Person, any other Person directly or indirectly controlling, controlled
by or under direct or indirect common control with, such Person. For purposes of this definition, &ldquo;control&rdquo; (including
with correlative meanings, the terms &ldquo;controlling,&rdquo; &ldquo;controlled by&rdquo; and &ldquo;under common control with&rdquo;),
as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management
and policies of such Person, whether through the ownership of voting securities, by contract or otherwise;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Business Day</U>&rdquo; means a day, other than Saturday, Sunday or other day on which commercial banks in New York,
New York are authorized or required by Applicable Law to close;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>knowledge</U>&rdquo; means actual knowledge or awareness as to a specified fact or event and, with respect to the
Company or Cambridge of each of the persons listed on <U>Schedule 10.2(c)</U>, without the requirement of any independent verification
or investigation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Legal Requirements</U>&rdquo; means any federal, state, local, municipal, foreign or other law, statute, constitution,
principle of common law, resolution, ordinance, code, edict, decree, rule, regulation, ruling or requirement issued, enacted, adopted,
promulgated, implemented or otherwise put into effect by or under the authority of any Governmental Entity which are applicable
to a Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Lien</U>&rdquo; means any mortgage, pledge, security interest, encumbrance, lien, restriction or charge of any kind
(including any conditional sale or other title retention agreement or lease in the nature thereof, any sale with recourse against
the Company or any Affiliate of the Company, or any agreement to give any security interest);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Material Adverse Effect</U>&rdquo; when used in connection with an entity means any change, event, or circumstance
or effect, individually or when aggregated with other changes, events, circumstances or effects, which has had a material adverse
effect on the business, assets (including intangible assets), revenues, financial condition, or results of operations of such entity
and its Subsidiaries, taken as a whole, it being understood that none of the following alone or in combination shall be deemed,
in and of itself, to constitute a Material Adverse Effect: (i) any outbreak or any development, change, worsening or escalation
of hostilities (whether or not armed), acts of war (whether or not declared), sabotage or terrorism, (ii) any act of God, hurricane,
tornado, flood, volcano, earthquake or other natural or man-made disaster (except to the extent the party suffering such event
is affected in a disproportionate manner relative to other companies in the industry in which such party conducts business), (iii)
any proposal, enactment or change in interpretation of, or other change in, applicable law, U.S. GAAP (or equivalent accounting
practice in any other jurisdiction) or governmental policy or any development or effect of any investigation, audit or review of
such Person or any of its Subsidiaries by any Governmental Entity commencing from and after the date hereof, (iv) general conditions
in the industries in which such Person or any of its Subsidiaries operate (except to the extent the party suffering such event
is affected in a disproportionate manner relative to other companies in the industry in which such party conducts business), (v)
the failure, in and of itself, of such Person or any of its Subsidiaries to meet any internal or published projections, forecasts,
estimates or predictions in respect of revenue, earnings or other financial or operating metrics before, on or after the date of
this Agreement, or changes in the credit rating of such Person or any of its Subsidiaries (it being understood that the underlying
facts giving rise or contributing to such failure or change may be taken into account in determining whether there has been a Material
Adverse Effect if otherwise contemplated by this definition), (vi) changes attributable to the public announcement or pendency
of the transactions contemplated hereby, and (vii) any action taken or omitted to be taken by such Person or any of its Subsidiaries
at the other party&rsquo;s direction or written request (including any action not taken as a result of the failure of such other
party to consent to any action requiring its consent hereunder) or otherwise required or permitted to be taken or omitted to be
taken by this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Permitted Liens</U>&rdquo; means any and all Liens (a) which result from all statutory or other liens for Taxes
or assessments and are not yet due and payable or delinquent or the validity of which is being contested in good faith by appropriate
proceedings along with the posting of any security or bond required under applicable Law in connection with such contest, (b) imposed
or promulgated by law or any Governmental Entity, (c) arising in connection with any cashiers&rsquo;, landlords&rsquo;, workers&rsquo;,
mechanics&rsquo;, carriers&rsquo;, repairers&rsquo; or other similar lien imposed by law and arising out of obligations incurred
in the ordinary course of business, (d) created as a result of any action taken by Cambridge or any of its Affiliates, (e) that
are expressly listed as exceptions in insurance policies, (f) listed on <U>Schedule 10.2(g)</U>, (g) covenants, conditions, restrictions,
encroachments, liens, easements, rights of way, licenses, grants, building or use restrictions, exceptions, reservations, limitations
or other imperfections of title with respect to such asset which, individually or in the aggregate, does not materially detract
from the value of, or materially interfere with the present occupancy or use of, such asset and the continuation of the present
occupancy or use of such asset, (h) purchase money liens or liens securing rental payments under capital lease arrangements; and
(i) which individually or in the aggregate do not materially detract from the value of or materially interfere with the present
use of the property subject thereto or affected thereby and would not otherwise have a Material Adverse Effect on such Person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Person</U>&rdquo; shall mean any individual, corporation (including any non-profit corporation), general partnership,
limited partnership, limited liability partnership, joint venture, estate, trust, company (including any limited liability company
or joint stock company), firm or other enterprise, association, organization, entity or Governmental Entity;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
term &ldquo;<U>Subsidiary</U>&rdquo; of a Person means any corporation or other entity (including a limited liability company,
partnership or other business association) in which such Person, directly or indirectly, owns outstanding capital stock or other
voting securities having the power, under ordinary circumstances, to elect a majority of the directors or similar members of the
governing body of such corporation or other entity, or otherwise to direct the management and policies of such corporation or other
entity; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>all
monetary amounts set forth herein are referenced in United States dollars, unless otherwise noted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 .5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Counterparts;
Facsimile Signatures</U></B>. This Agreement and each other document executed in connection with the transactions contemplated
hereby, and the consummation thereof, may be executed in one or more counterparts, all of which shall be considered one and the
same document and shall become effective when one or more counterparts have been signed by each of the parties and delivered to
the other party, it being understood that all parties need not sign the same counterpart. Delivery by email or facsimile to counsel
for the other party of a counterpart executed by a party shall be deemed to meet the requirements of the previous sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Entire
Agreement; Third Party Beneficiaries</U></B>. This Agreement and the documents and instruments and other agreements among the parties
hereto as contemplated by or referred to herein, including the Exhibits and Schedules hereto (a) constitute the entire agreement
among the parties with respect to the subject matter hereof and supersede all prior agreements and understandings, both written
and oral, among the parties with respect to the subject matter hereof, it being understood that the letter of intent between Cambridge
and the Company dated June 29, 2015 is hereby terminated in its entirety and shall be of no further force and effect (except to
the extent expressly stated to survive the execution of this Agreement and the consummation of the transactions contemplated hereby);
and (b) are not intended to confer upon any other person any rights or remedies hereunder (except as specifically provided in this
Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Severability</U></B>.
In the event that any provision of this Agreement, or the application thereof, becomes or is declared by a court of competent jurisdiction
to be illegal, void or unenforceable, the remainder of this Agreement will continue in full force and effect and the application
of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties hereto.
The parties further agree to replace such void or unenforceable provision of this Agreement with a valid and enforceable provision
that will achieve, to the extent possible, the economic, business and other purposes of such void or unenforceable provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Other
Remedies; Specific Performance</U></B>. Except as otherwise provided herein, including Section 7.5, any and all remedies herein
expressly conferred upon a party will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law
or equity upon such party, and the exercise by a party of any one remedy will not preclude the exercise of any other remedy. The
parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise breached. It is accordingly agreed that, in addition to any other right
or remedy to which the non-breaching party may be entitled, it shall be entitled to enforce any provision of this Agreement by
a decree of specific performance and to temporary, preliminary and permanent injunctive relief to prevent breaches or threatened
breaches of any of the provisions of this Agreement, without posting any bond or other undertaking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>No
Recourse</U></B>. Except as expressly set forth in this Agreement, and other than in the case of fraud or willful and intentional
breach of this Agreement or any ancillary agreement hereto, notwithstanding any rights of Cambridge at law or in equity, in the
event of any default or breach by the Company under this Agreement or any ancillary agreement hereto, Cambridge&rsquo;s remedies
shall be restricted to enforcement of its rights against the property and assets of the Company, and no liability whatsoever shall
attach to, be imposed on or otherwise be incurred by, any former, current or future director, officer, employee, agent, general
or limited partner, manager, member, stockholder or Affiliate of any of the Company (other than the Company), any Stockholder,
or any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder or
Affiliate (other than the Company) of any of the foregoing, whether by the enforcement of any assessment or by any legal or equitable
proceeding, or by virtue of any statute, regulation or other applicable law, for any obligations or liabilities of the parties
to this Agreement or any ancillary agreement hereto or for any claim based on, in respect of, or by reason of, the transactions
contemplated hereby or thereby. Except as expressly set forth in this Agreement or any ancillary agreement, and other than in the
case of fraud or willful and intentional breach of this Agreement, notwithstanding any rights of the Company at law or in equity,
in the event of any default or breach by Cambridge, under this Agreement or any ancillary agreement hereto, the remedies of the
Company and the Stockholders shall be restricted to enforcement of its rights against any other property and assets of Cambridge,
and no liability whatsoever shall attach to, be imposed on or otherwise be, incurred by, any former, current or future director,
officer, employee, agent, general or limited partner, manager, member, stockholder or Affiliate of any of Cambridge, (other than
Cambridge) or any former, current or future director, officer, employee, agent, general or limited partner, manager, member, stockholder
or Affiliate of any of the foregoing (other than Cambridge), whether by the enforcement of any assessment or by any legal or equitable
proceeding, or by virtue of any statute, regulation or other applicable Law, for any obligations or Liabilities of the parties
to this Agreement or for any claim based on, in respect of, or by reason of, the transactions contemplated hereby. Without limiting
the generality of the foregoing, each party hereto agrees that it shall, and shall cause its Affiliate to, not file, or threaten
to file, any claim, suit, action or proceeding in violation of this Section 10.7. Cambridge and the Company will be liable for
all reasonable attorneys&rsquo; fees and court costs arising from a breach of this Section 10.7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Governing
Law</U></B>. This Agreement shall be governed by and construed in accordance with the law of the State of New York regardless of
the law that might otherwise govern under applicable principles of conflicts of law thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Rules
of Construction</U></B>. The parties hereto agree that they have been represented by counsel during the negotiation and execution
of this Agreement and, therefore, waive the application of any law, regulation, holding or rule of construction providing that
ambiguities in an agreement or other document will be construed against the party drafting such agreement or document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Assignment</U></B>.
No party may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval
of the other parties. Subject to the first sentence of this Section&nbsp;10.10, this Agreement shall be binding upon and shall
inure to the benefit of the parties hereto and their respective successors and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Amendment</U></B>.
This Agreement may be amended by the parties hereto at any time prior to the Closing Date by execution of an instrument in writing
signed on behalf of each of the parties. After the Closing Date, this Agreement may be amended only with the consent of the Cambridge
Representative, the Surviving Pubco and the Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Extension;
Waiver</U></B>. At any time prior to the Closing, any party hereto may, to the extent legally allowed, (i) extend the time for
the performance of any of the obligations or other acts of the other parties hereto, (ii) waive any inaccuracies in the representations
and warranties made to such party contained herein or in any document delivered pursuant hereto and (iii) waive compliance with
any of the agreements or conditions for the benefit of such party contained herein. Any agreement on the part of a party hereto
to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. Delay
in exercising any right under this Agreement shall not constitute a waiver of such right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>CONSENT
TO JURISDICTION AND SERVICE OF PROCESS</U></B>. <B>EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY FEDERAL
OR STATE COURT LOCATED IN THE COUNTY OF NEW YORK OF THE STATE OF NEW YORK IN RESPECT OF ANY ACTION, SUIT OR PROCEEDING ARISING
IN CONNECTION WITH THIS AGREEMENT AND THE DOCUMENTS AND THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY, AND AGREES THAT ANY SUCH
ACTION, SUIT OR PROCEEDING SHALL BE BROUGHT ONLY IN SUCH COURT (AND WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS<I> </I>OR
ANY OTHER OBJECTION TO VENUE THEREIN); PROVIDED, HOWEVER, THAT SUCH CONSENT TO JURISDICTION IS SOLELY FOR PURPOSES OF THIS AGREEMENT
OR ANY ANCILLARY AGREEMENT RELATED HERETO, OR ANY TRANSACTION RELATED HERETO (INCLUDING THE MERGER) OR THERETO</B>. Each of the
parties hereto irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim or otherwise, in any
action or proceeding with respect to this Agreement, (i) the defense of sovereign immunity, (ii) any claim that it is not personally
subject to the jurisdiction of the above-named courts for any reason, (iii) that it or its property is exempt or immune from jurisdiction
of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment,
attachment in aid of execution of judgment, execution of judgment or otherwise), and (iv) to the fullest extent permitted by applicable
law that (A) the suit, action or proceeding in any such court is brought in an inconvenient forum, (B) the venue of such suit,
action or proceeding is improper and (C) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.
Any and all process may be served in any action, suit or proceeding arising in connection with this Agreement by complying with
the provisions of Section&nbsp;10.1. Such service of process shall have the same effect as if the party being served were a resident
of the State of New York and had been lawfully served with such process in such jurisdiction. The parties hereby waive all claims
of error by reason of such service. Nothing herein shall affect the right of any party to service process in any other manner permitted
by law or to commence legal proceedings or otherwise proceed against the other in any other jurisdiction to enforce judgments or
rulings of the aforementioned courts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>WAIVER
OF JURY TRIAL</U></B>. <B>EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY
HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO
ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 10.14</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B><U>Currency</U></B>.
All references to currency amounts in this Agreement shall mean United States dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">[The Signature Page is the following page.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the
parties hereto have caused this Agreement to be executed as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: left; text-indent: 0"><B>CAMBRIDGE CAPITAL ACQUISITION CORPORATION</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; text-align: left; text-indent: 0; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-left: 0; text-align: left; text-indent: 0; width: 4%">By:</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: left; text-indent: 0; width: 36%">/s/ Benjamin Gordon</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Name: Benjamin Gordon</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Title: &nbsp;&nbsp;Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: left; text-indent: 0"><B>CAMBRIDGE HOLDCO CORP.</B> </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-left: 0; text-align: left; text-indent: 0">By:</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: left; text-indent: 0">/s/ Benjamin Gordon</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Name: Benjamin Gordon</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Title: &nbsp;&nbsp;Chief Executive Officer</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: left; text-indent: 0"><B>ABILITY <FONT STYLE="text-transform: uppercase">Computer</FONT> &amp; SOFTWARE INDUSTRIES LTD.</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0 0 1.5pt; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; padding-left: 0; text-align: left; text-indent: 0">By: </TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: left; text-indent: 0">/s/ Anatoly Hurgin</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Name: Anatoly Hurgin</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-align: left; text-indent: 0">Title: &nbsp;&nbsp;Chief Executive Officer</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left"></P>

<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0; width: 40%"><B>SIGNING SECURITYHOLDERS<I>, <BR>
for the purposes of Sections 1.10, 1.11(b), 1.12, 4.1, 5.12, 5.19 and Articles VII and X</I>:</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: left; padding-top: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding-top: 0; padding-right: 0; border-bottom: Black 1.5pt solid; padding-left: 0; text-align: left; text-indent: 0">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">81</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
